https://timmermanreport.com/2022/03/evidation-finding-tailwinds-for-pharma-companies-and-individual-patients/lemke/2022-03-08T23:26:29+00:00https://timmermanreport.com/wp-content/uploads/2022/03/lemke.jpeghttps://timmermanreport.com/everest-base-camp-2021/medable/2022-03-09T23:25:37+00:00https://timmermanreport.com/wp-content/uploads/2022/03/medable.pnghttps://timmermanreport.com/2022/03/returning-to-nepal-with-a-team/hosp/2022-03-10T23:39:31+00:00https://timmermanreport.com/wp-content/uploads/2022/03/hosp.pnghttps://timmermanreport.com/everest-base-camp-2021/medable-logo-color/2022-03-11T00:43:27+00:00https://timmermanreport.com/wp-content/uploads/2022/03/Medable-Logo-Color.pnghttps://timmermanreport.com/2022/03/returning-to-nepal-with-a-team/malik/2022-03-11T01:04:48+00:00https://timmermanreport.com/wp-content/uploads/2022/03/malik.pnghttps://timmermanreport.com/2022/04/versant-backed-cimeio-gets-50m-for-shielded-stem-cell-therapies/tfuchs/2022-04-12T22:17:21+00:00https://timmermanreport.com/wp-content/uploads/2022/04/tfuchs.jpghttps://timmermanreport.com/2022/04/microbiome-based-drug-development-bernat-olle-on-the-long-run/alpenglow-logo-white-words-right-400px-wide/2022-04-18T21:18:00+00:00https://timmermanreport.com/wp-content/uploads/2022/04/Alpenglow-logo-white-words-right-400px-wide.pnghttps://timmermanreport.com/2022/04/microbiome-based-drug-development-bernat-olle-on-the-long-run/bernat-2/2022-04-18T21:19:14+00:00https://timmermanreport.com/wp-content/uploads/2022/04/bernat.jpghttps://timmermanreport.com/2022/04/regeneron-buys-checkmate-bivalent-vaccine-progress-a-fitting-acronym/akiko/2022-04-21T22:15:55+00:00https://timmermanreport.com/wp-content/uploads/2022/04/akiko.pnghttps://timmermanreport.com/2022/04/regeneron-buys-checkmate-bivalent-vaccine-progress-a-fitting-acronym/storch/2022-04-21T22:17:32+00:00https://timmermanreport.com/wp-content/uploads/2022/04/storch.pnghttps://timmermanreport.com/2022/01/behind-the-scenes-of-bd-brad-prosek-on-getting-to-know-an-unconventional-acquirer/brad-3/2022-04-22T21:40:44+00:00https://timmermanreport.com/wp-content/uploads/2022/01/brad.jpghttps://timmermanreport.com/2022/04/inspired-by-bolero-creative-parallels-between-songwriting-and-biotech-building/maurice\_ravel\_1925/2022-04-22T21:50:59+00:00https://timmermanreport.com/wp-content/uploads/2022/04/Maurice\_Ravel\_1925.jpghttps://timmermanreport.com/2022/04/the-timmerman-traverse-for-life-science-cares-is-back-fighting-poverty/2022-timmerman-featured-image-1/2022-04-25T22:43:34+00:00https://timmermanreport.com/wp-content/uploads/2022/04/2022-Timmerman-Featured-Image-1.pnghttps://timmermanreport.com/2021/09/a-magical-time-in-the-presidential-range-giving-back-to-community/traversemontage/2022-04-25T23:05:29+00:00https://timmermanreport.com/wp-content/uploads/2021/09/traversemontage.pnghttps://timmermanreport.com/2022/04/the-timmerman-traverse-for-life-science-cares-is-back-fighting-poverty/2022-timmerman-featured-image-1-2/2022-04-25T23:07:49+00:00https://timmermanreport.com/wp-content/uploads/2022/04/2022-Timmerman-Featured-Image-1-1.pnghttps://timmermanreport.com/2022/04/a-big-opportunity-in-obesity/obesity/2022-04-28T23:33:49+00:00https://timmermanreport.com/wp-content/uploads/2022/04/obesity.pnghttps://timmermanreport.com/2022/05/biopharmas-digitizing-but-not-quite-digital/ross/2022-05-02T04:00:36+00:00https://timmermanreport.com/wp-content/uploads/2022/05/ross.pnghttps://timmermanreport.com/2022/05/biopharmas-digitizing-but-not-quite-digital/iansiti1/2022-05-02T04:01:22+00:00https://timmermanreport.com/wp-content/uploads/2022/05/iansiti1.pnghttps://timmermanreport.com/2022/05/dianthus-gets-100m-to-take-complement-inhibition-to-a-new-level/marino1/2022-05-02T21:01:43+00:00https://timmermanreport.com/wp-content/uploads/2022/05/marino1.jpghttps://timmermanreport.com/2022/05/dianthus-gets-100m-to-take-complement-inhibition-to-a-new-level/simrat-randhawa-4-23-220002cc/2022-05-02T21:02:21+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Simrat-Randhawa-4-23-220002CC.jpghttps://timmermanreport.com/2022/05/an-old-idea-whose-time-has-come/biden1/2022-05-06T02:38:05+00:00https://timmermanreport.com/wp-content/uploads/2022/05/biden1.pnghttps://timmermanreport.com/2022/05/an-old-idea-whose-time-has-come/bijan/2022-05-06T02:45:23+00:00https://timmermanreport.com/wp-content/uploads/2022/05/bijan.pnghttps://timmermanreport.com/2022/05/fighting-cancer-with-food-and-drugs-lew-cantley-and-sid-mukherjee-on-the-long-run/lewis-cantley-uai-258x258/2022-05-09T18:31:41+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Lewis-Cantley-uai-258x258-1.pnghttps://timmermanreport.com/2021/01/startup-profiles-senti-and-myeloid-raise-cash-to-push-cell-therapy-frontiers/sidmukherjee/2022-05-09T18:32:16+00:00https://timmermanreport.com/wp-content/uploads/2021/01/sidmukherjee.jpghttps://timmermanreport.com/2022/05/fighting-cancer-with-food-and-drugs-lew-cantley-and-sid-mukherjee-on-the-long-run/sid1/2022-05-09T18:33:17+00:00https://timmermanreport.com/wp-content/uploads/2022/05/sid1.pnghttps://timmermanreport.com/2022/05/moma-secures-150m-to-make-small-molecules-against-atpases-laborers-of-the-cell/asit-headshot-new-1-150x150/2022-05-09T23:26:06+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Asit-Headshot-New-1-150x150-1.jpghttps://timmermanreport.com/2020/03/doctor-mother-ceo-balancing-competing-needs-and-opting-for-the-front-lines/achristini/2022-05-10T18:17:44+00:00https://timmermanreport.com/wp-content/uploads/2020/03/achristini.pnghttps://timmermanreport.com/2020/12/14834/pete-smith-1/2022-05-16T22:22:57+00:00https://timmermanreport.com/wp-content/uploads/2020/12/Pete-Smith-1-scaled.jpghttps://timmermanreport.com/2022/05/a-path-forward-for-more-biotech-workers/karla-talanian9876-300x300/2022-05-19T22:21:49+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Karla-Talanian9876-300x300-1.jpghttps://timmermanreport.com/2022/05/a-path-forward-for-more-biotech-workers/al-boyle/2022-05-19T22:23:13+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Al-Boyle.jpghttps://timmermanreport.com/2022/05/a-path-forward-for-more-biotech-workers/massbioed/2022-05-19T22:23:53+00:00https://timmermanreport.com/wp-content/uploads/2022/05/massbioed.pnghttps://timmermanreport.com/2022/05/a-path-forward-for-more-biotech-workers/laurie-new-icon-5/2022-05-19T22:25:09+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Laurie-New-Icon-5.pnghttps://timmermanreport.com/2022/05/a-path-forward-for-more-biotech-workers/sek-3/2022-05-19T22:27:34+00:00https://timmermanreport.com/wp-content/uploads/2022/05/sek.pnghttps://timmermanreport.com/2022/05/sachi-bioworks-out-of-the-university-into-outer-space/anushree/2022-05-20T23:35:40+00:00https://timmermanreport.com/wp-content/uploads/2022/05/anushree.pnghttps://timmermanreport.com/2022/05/sachi-bioworks-out-of-the-university-into-outer-space/prashant/2022-05-20T23:36:22+00:00https://timmermanreport.com/wp-content/uploads/2022/05/prashant.pnghttps://timmermanreport.com/2022/05/seeking-wellness-through-more-data-less-technology-and-better-habits/seth51/2022-05-23T17:30:25+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Seth51.jpeghttps://timmermanreport.com/2022/05/seeking-wellness-through-more-data-less-technology-and-better-habits/johann/2022-05-23T17:34:15+00:00https://timmermanreport.com/wp-content/uploads/2022/05/johann.jpghttps://timmermanreport.com/2022/05/building-a-new-type-of-drug-discovery-engine-chris-gibson-on-the-long-run/gibson-2/2022-05-23T21:24:34+00:00https://timmermanreport.com/wp-content/uploads/2022/05/gibson.jpghttps://timmermanreport.com/2022/05/building-a-new-type-of-drug-discovery-engine-chris-gibson-on-the-long-run/calgarylogo/2022-05-23T21:26:05+00:00https://timmermanreport.com/wp-content/uploads/2022/05/calgarylogo.pnghttps://timmermanreport.com/2022/05/managing-through-a-hard-time-like-no-other/freeman\_hrabowski\_portrait\_20190206\_16x22\_300ppi\_dsc\_9181-768x1039/2022-05-26T23:48:14+00:00https://timmermanreport.com/wp-content/uploads/2022/05/Freeman\_Hrabowski\_portrait\_20190206\_16x22\_300PPI\_DSC\_9181-768x1039-1.jpghttps://timmermanreport.com/2017/09/long-run-ep-2-editas-medicine-ceo-katrine-bosley/katrine-bosley/2022-05-26T23:56:31+00:00https://timmermanreport.com/wp-content/uploads/2017/09/katrine-bosley.jpghttps://timmermanreport.com/2022/06/startup-profiles-upstream-gets-200m-for-asthma-antibody-transition-fetches-50m-for-condensate-drug-discovery/gregmiller/2022-06-01T19:58:43+00:00https://timmermanreport.com/wp-content/uploads/2022/06/gregmiller.jpghttps://timmermanreport.com/2022/06/rethinking-biotech-manufacturing-rahul-singhvi-on-the-long-run/rahul-s/2022-06-07T19:50:35+00:00https://timmermanreport.com/wp-content/uploads/2022/06/Rahul-S.jpghttps://timmermanreport.com/2020/04/juggling-all-the-balls-of-an-academic-lab-in-a-pandemic/james-olson/2022-06-13T21:20:51+00:00https://timmermanreport.com/wp-content/uploads/2020/04/james-olson.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/ucianescarlett/2022-06-13T21:22:02+00:00https://timmermanreport.com/wp-content/uploads/2018/12/ucianescarlett.jpghttps://timmermanreport.com/2022/06/seattle-childrens-invests-45m-in-plan-for-minority-scientists-tackling-pediatric-disease/williams/2022-06-13T21:23:42+00:00https://timmermanreport.com/wp-content/uploads/2022/06/williams.jpghttps://timmermanreport.com/2022/06/third-rock-raises-1-1b-fund-sticks-with-its-knitting-in-a-downturn/tong/2022-06-14T20:05:53+00:00https://timmermanreport.com/wp-content/uploads/2022/06/tong.pnghttps://timmermanreport.com/2022/06/third-rock-raises-1-1b-fund-sticks-with-its-knitting-in-a-downturn/gillis/2022-06-14T20:07:21+00:00https://timmermanreport.com/wp-content/uploads/2022/06/gillis.pnghttps://timmermanreport.com/2022/06/why-kymab-agreed-to-be-acquired-by-sanofi/brandon/2022-06-18T14:20:00+00:00https://timmermanreport.com/wp-content/uploads/2022/06/brandon.jpghttps://timmermanreport.com/2022/06/grace-science-turning-lemons-into-lemonade/mattw/2022-06-21T23:00:10+00:00https://timmermanreport.com/wp-content/uploads/2022/06/mattw.pnghttps://timmermanreport.com/2020/05/creating-leaner-and-meaner-clinical-trials-for-the-long-run/ctti\_pam\_tenaerts\_preferred/2022-06-23T22:24:27+00:00https://timmermanreport.com/wp-content/uploads/2020/05/CTTI\_Pam\_Tenaerts\_PREFERRED-scaled.jpghttps://timmermanreport.com/2022/06/making-clinical-trials-deliver-better-social-and-financial-returns/guindo/2022-06-23T22:28:39+00:00https://timmermanreport.com/wp-content/uploads/2022/06/guindo.jpghttps://timmermanreport.com/2022/06/making-clinical-trials-deliver-better-social-and-financial-returns/bradner/2022-06-23T22:29:37+00:00https://timmermanreport.com/wp-content/uploads/2022/06/bradner.pnghttps://timmermanreport.com/2022/06/what-we-saw-at-bio-the-second-hurdle/rogerlongman1/2022-06-24T19:27:01+00:00https://timmermanreport.com/wp-content/uploads/2022/06/rogerlongman1.pnghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/mira-square-site-e1522357939332/2022-06-25T01:35:33+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Mira-square-site-e1522357939332.jpghttps://timmermanreport.com/2022/06/nucleate-doubles-in-size-tapping-into-young-scientists-entrepreneurial-dreams/retchin/2022-06-25T01:37:13+00:00https://timmermanreport.com/wp-content/uploads/2022/06/retchin.jpghttps://timmermanreport.com/2022/06/recode-therapeutics-pockets-extra-120m-for-targeted-genetic-medicine-delivery/shehnaaz/2022-06-28T18:22:41+00:00https://timmermanreport.com/wp-content/uploads/2022/06/shehnaaz.jpghttps://timmermanreport.com/2022/06/recode-therapeutics-pockets-extra-120m-for-targeted-genetic-medicine-delivery/davidlockhart/2022-06-28T18:32:43+00:00https://timmermanreport.com/wp-content/uploads/2022/06/davidlockhart.jpghttps://timmermanreport.com/2017/06/long-distance-relationships-biotech-startups-make-work/team-j-owens-v4/2022-07-01T17:12:33+00:00https://timmermanreport.com/wp-content/uploads/2017/06/team-j-owens-v4.pnghttps://timmermanreport.com/2022/07/merck-circles-seagen-arch-triples-down-novartis-cuts-8000-jobs/newsom/2022-07-07T23:35:56+00:00https://timmermanreport.com/wp-content/uploads/2022/07/newsom.pnghttps://timmermanreport.com/2022/07/merck-circles-seagen-arch-triples-down-novartis-cuts-8000-jobs/vickers/2022-07-07T23:39:53+00:00https://timmermanreport.com/wp-content/uploads/2022/07/vickers.jpghttps://timmermanreport.com/2022/07/restoring-eyesight-in-the-developing-world-dr-sanduk-ruit-on-the-long-run/sandukruit/2022-07-11T23:22:51+00:00https://timmermanreport.com/wp-content/uploads/2022/07/sandukruit.pnghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/james/2022-07-12T16:48:33+00:00https://timmermanreport.com/wp-content/uploads/2021/06/james.jpghttps://timmermanreport.com/2022/07/the-new-frontier-of-cytokine-therapies-engineered-selectivity/santollani\_headshot\_2\_2020/2022-07-14T13:25:46+00:00https://timmermanreport.com/wp-content/uploads/2022/07/Santollani\_Headshot\_2\_2020.pnghttps://timmermanreport.com/2022/07/the-new-frontier-of-cytokine-therapies-engineered-selectivity/yik-andy-yeung-phd/2022-07-14T13:40:43+00:00https://timmermanreport.com/wp-content/uploads/2022/07/Yik-Andy-Yeung-PhD.jpghttps://timmermanreport.com/2022/07/novavax-cleared-verves-gene-editing-milestone-third-rock-reaches-out/reid/2022-07-14T22:30:11+00:00https://timmermanreport.com/wp-content/uploads/2022/07/reid.pnghttps://timmermanreport.com/2022/07/novavax-cleared-verves-gene-editing-milestone-third-rock-reaches-out/speakman/2022-07-14T22:30:51+00:00https://timmermanreport.com/wp-content/uploads/2022/07/speakman.pnghttps://timmermanreport.com/2022/07/novavax-cleared-verves-gene-editing-milestone-third-rock-reaches-out/jackie/2022-07-14T22:33:07+00:00https://timmermanreport.com/wp-content/uploads/2022/07/jackie.pnghttps://timmermanreport.com/2022/07/camp4-raises-100m-to-drug-the-dark-side-of-the-genome/bumcrot/2022-07-17T01:10:52+00:00https://timmermanreport.com/wp-content/uploads/2022/07/bumcrot.pnghttps://timmermanreport.com/2022/07/camp4-raises-100m-to-drug-the-dark-side-of-the-genome/mandelbrehm/2022-07-17T14:01:20+00:00https://timmermanreport.com/wp-content/uploads/2022/07/mandelbrehm.pnghttps://timmermanreport.com/2022/08/a-glimpse-into-the-adjacent-possible-incorporating-ai-into-medical-science/ellinor/2022-07-31T16:41:44+00:00https://timmermanreport.com/wp-content/uploads/2022/07/ellinor.jpghttps://timmermanreport.com/2022/08/elevatebio-boston-childrens-form-startup-to-turn-ipscs-into-mature-t-cells-for-cancer/davidhallal/2022-08-04T00:04:19+00:00https://timmermanreport.com/wp-content/uploads/2022/08/davidhallal.jpghttps://timmermanreport.com/2022/08/elevatebio-boston-childrens-form-startup-to-turn-ipscs-into-mature-t-cells-for-cancer/%ef%b8%8f2017-john-soares-for-hms/2022-08-04T00:11:08+00:00https://timmermanreport.com/wp-content/uploads/2022/08/George-Daley-1-by-John-Soares.jpghttps://timmermanreport.com/2020/01/eqrx-taps-zeitgeist-raises-200m-for-innovative-drugs-at-aggressive-low-prices/alexis-borisy-eqrx/2022-08-04T23:42:46+00:00https://timmermanreport.com/wp-content/uploads/2020/01/Alexis-Borisy-EQRX-scaled.jpghttps://timmermanreport.com/2022/08/alnylams-big-day-amgen-buys-chemocentryx-a-borisy-startup/kite/2022-08-04T23:44:48+00:00https://timmermanreport.com/wp-content/uploads/2022/08/kite.pnghttps://timmermanreport.com/2022/08/alnylams-big-day-amgen-buys-chemocentryx-a-borisy-startup/matterhorntwitter/2022-08-04T23:45:21+00:00https://timmermanreport.com/wp-content/uploads/2022/08/matterhorntwitter.pnghttps://timmermanreport.com/2022/08/assembling-accurate-genomes-and-interactomes-ivan-liachko-on-the-long-run/thermofisherlogo500pxwide/2022-08-08T18:49:03+00:00https://timmermanreport.com/wp-content/uploads/2022/08/ThermoFisherLogo500pxwide.jpghttps://timmermanreport.com/2022/08/assembling-accurate-genomes-and-interactomes-ivan-liachko-on-the-long-run/ivan\_headshot/2022-08-08T18:51:53+00:00https://timmermanreport.com/wp-content/uploads/2022/08/ivan\_headshot.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/howard/2022-08-11T22:16:34+00:00https://timmermanreport.com/wp-content/uploads/2021/06/howard.jpghttps://timmermanreport.com/2022/08/karunas-schizophrenia-advance-fda-clears-her2-low-drug-pfizer-buys-gbt/gallup/2022-08-11T22:22:20+00:00https://timmermanreport.com/wp-content/uploads/2022/08/gallup.pnghttps://timmermanreport.com/2022/08/startup-snapshots-aktis-fetches-84m-for-radiopharmaceuticals-3t-gets-40m-for-antigen-discovery/matt-standard/2022-08-24T23:30:43+00:00https://timmermanreport.com/wp-content/uploads/2022/08/Matt-Standard.jpghttps://timmermanreport.com/2022/08/startup-snapshots-aktis-fetches-84m-for-radiopharmaceuticals-3t-gets-40m-for-antigen-discovery/stefan/2022-08-24T23:31:49+00:00https://timmermanreport.com/wp-content/uploads/2022/08/stefan.jpghttps://timmermanreport.com/2022/08/a-leap-for-open-science-fauci-exits-nih-bivalent-boosters-on-deck/faucieffect/2022-08-25T22:11:53+00:00https://timmermanreport.com/wp-content/uploads/2022/08/faucieffect.pnghttps://timmermanreport.com/2022/08/a-leap-for-open-science-fauci-exits-nih-bivalent-boosters-on-deck/eisen/2022-08-25T22:12:42+00:00https://timmermanreport.com/wp-content/uploads/2022/08/eisen.pnghttps://timmermanreport.com/2022/08/a-leap-for-open-science-fauci-exits-nih-bivalent-boosters-on-deck/sarahgrant/2022-08-25T22:20:33+00:00https://timmermanreport.com/wp-content/uploads/2022/08/sarahgrant.pnghttps://timmermanreport.com/2022/09/amylyxs-als-surprise-regenerons-eye-franchise-win-roche-buys-good/john-headshot/2022-09-09T00:03:37+00:00https://timmermanreport.com/wp-content/uploads/2022/09/John-headshot.jpghttps://timmermanreport.com/2022/09/pretzel-pockets-72-5m-to-make-gene-editing-drugs-small-molecules-against-mitochondria/parrish/2022-09-10T23:26:43+00:00https://timmermanreport.com/wp-content/uploads/2022/09/parrish.pnghttps://timmermanreport.com/2022/09/pretzel-pockets-72-5m-to-make-gene-editing-drugs-small-molecules-against-mitochondria/martinez/2022-09-10T23:31:59+00:00https://timmermanreport.com/wp-content/uploads/2022/09/martinez.pnghttps://timmermanreport.com/2022/09/third-harmonic-revives-ipo-market-pdufa-deadline-nears-pfizer-aims-mrna-at-flu/tt5/2022-09-15T23:49:12+00:00https://timmermanreport.com/wp-content/uploads/2022/09/tt5.jpghttps://timmermanreport.com/2022/09/third-harmonic-revives-ipo-market-pdufa-deadline-nears-pfizer-aims-mrna-at-flu/tt3/2022-09-15T23:49:59+00:00https://timmermanreport.com/wp-content/uploads/2022/09/tt3.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/laurashawnew/2022-09-15T23:52:42+00:00https://timmermanreport.com/wp-content/uploads/2021/06/LauraShawNew.jpghttps://timmermanreport.com/2022/09/rivus-raises-132m-to-harness-mitochondrial-energy-to-combat-obesity/allen-cunningham/2022-09-22T03:47:41+00:00https://timmermanreport.com/wp-content/uploads/2022/09/Allen-Cunningham.jpeghttps://timmermanreport.com/2022/09/rivus-raises-132m-to-harness-mitochondrial-energy-to-combat-obesity/shaharyar-2-1/2022-09-22T03:48:09+00:00https://timmermanreport.com/wp-content/uploads/2022/09/Shaharyar-2-1.jpeghttps://timmermanreport.com/2022/09/gsk-lifts-up-spero-rivus-bets-big-on-obesity-and-a-microbiome-milestone/scott/2022-09-22T23:16:42+00:00https://timmermanreport.com/wp-content/uploads/2022/09/scott.pnghttps://timmermanreport.com/2022/09/gsk-lifts-up-spero-rivus-bets-big-on-obesity-and-a-microbiome-milestone/daphne-2/2022-09-22T23:18:57+00:00https://timmermanreport.com/wp-content/uploads/2022/09/daphne.pnghttps://timmermanreport.com/2022/09/gsk-lifts-up-spero-rivus-bets-big-on-obesity-and-a-microbiome-milestone/abigail/2022-09-23T13:54:22+00:00https://timmermanreport.com/wp-content/uploads/2022/09/abigail.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/1-5/2022-09-26T15:47:38+00:00https://timmermanreport.com/wp-content/uploads/2022/09/1.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/2-3/2022-09-26T15:47:39+00:00https://timmermanreport.com/wp-content/uploads/2022/09/2.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/3-3/2022-09-26T15:47:39+00:00https://timmermanreport.com/wp-content/uploads/2022/09/3.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/attachment/4/2022-09-26T15:47:40+00:00https://timmermanreport.com/wp-content/uploads/2022/09/4.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/attachment/5/2022-09-26T15:47:41+00:00https://timmermanreport.com/wp-content/uploads/2022/09/5.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/9cd6c427-8de3-4a14-af49-43133c14e992\_1\_105\_c/2022-09-26T18:33:14+00:00https://timmermanreport.com/wp-content/uploads/2022/09/9CD6C427-8DE3-4A14-AF49-43133C14E992\_1\_105\_c.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/9dad7ded-dc9f-4fba-b109-b2940b9ab03c\_1\_105\_c/2022-09-26T18:33:15+00:00https://timmermanreport.com/wp-content/uploads/2022/09/9DAD7DED-DC9F-4FBA-B109-B2940B9AB03C\_1\_105\_c.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/9067b0b0-32bf-46ba-a407-c60593f217d7/2022-09-26T18:33:16+00:00https://timmermanreport.com/wp-content/uploads/2022/09/9067B0B0-32BF-46BA-A407-C60593F217D7-scaled.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/dinner-day-1/2022-09-26T18:33:21+00:00https://timmermanreport.com/wp-content/uploads/2022/09/Dinner-Day-1.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/ef015c28-9bd4-43b9-90dc-b37a60d30638\_1\_105\_c/2022-09-26T18:33:23+00:00https://timmermanreport.com/wp-content/uploads/2022/09/EF015C28-9BD4-43B9-90DC-B37A60D30638\_1\_105\_c.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/d72916a4-3011-4ea2-b24e-da4546bbc3c3\_1\_105\_c/2022-09-26T18:40:08+00:00https://timmermanreport.com/wp-content/uploads/2022/09/D72916A4-3011-4EA2-B24E-DA4546BBC3C3\_1\_105\_c.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/day-2-ca-hikers/2022-09-26T18:40:08+00:00https://timmermanreport.com/wp-content/uploads/2022/09/Day-2-CA-Hikers.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/day-2-rain/2022-09-26T18:40:09+00:00https://timmermanreport.com/wp-content/uploads/2022/09/Day-2-Rain.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/dd63004d-0bb7-4ca3-b551-32823df0b38a\_1\_105\_c/2022-09-26T18:40:11+00:00https://timmermanreport.com/wp-content/uploads/2022/09/DD63004D-0BB7-4CA3-B551-32823DF0B38A\_1\_105\_c.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/img\_1699/2022-09-26T18:40:11+00:00https://timmermanreport.com/wp-content/uploads/2022/09/IMG\_1699.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/img\_2088/2022-09-26T18:40:13+00:00https://timmermanreport.com/timmerman-traverse-for-lsc-2022/img\_2099/2022-09-26T18:40:13+00:00https://timmermanreport.com/wp-content/uploads/2022/09/IMG\_2099-scaled.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/img\_8593/2022-09-26T18:40:19+00:00https://timmermanreport.com/wp-content/uploads/2022/09/IMG\_8593-scaled.jpghttps://timmermanreport.com/2022/09/eisai-and-biogen-bounce-back-amylyx-approved-genentech-taps-into-arsenal/barnett/2022-09-30T02:26:54+00:00https://timmermanreport.com/wp-content/uploads/2022/09/barnett.pnghttps://timmermanreport.com/2022/09/eisai-and-biogen-bounce-back-amylyx-approved-genentech-taps-into-arsenal/fdesouza/2022-09-30T02:28:27+00:00https://timmermanreport.com/wp-content/uploads/2022/09/fdesouza.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/portrait-darrin-miles-agios/2022-10-06T02:43:01+00:00https://timmermanreport.com/wp-content/uploads/2021/06/portrait-darrin-miles-agios.jpghttps://timmermanreport.com/2022/10/red-tree-debuts-with-272m-zeroing-in-on-west-coast-startups/heath/2022-10-06T02:51:27+00:00https://timmermanreport.com/wp-content/uploads/2022/10/heath.jpghttps://timmermanreport.com/2022/10/red-tree-debuts-with-272m-zeroing-in-on-west-coast-startups/jon-b/2022-10-06T02:52:53+00:00https://timmermanreport.com/wp-content/uploads/2022/10/jon-b-scaled.jpghttps://timmermanreport.com/2022/10/neumora-tacks-on-112m-to-advance-precision-neuroscience-work-through-clinic/joshpinto/2022-10-10T23:09:56+00:00https://timmermanreport.com/wp-content/uploads/2022/10/joshpinto.jpghttps://timmermanreport.com/kilimanjaro-2023/megafeboxdesk-climb-luke-kili/2022-10-12T17:24:41+00:00https://timmermanreport.com/wp-content/uploads/2022/10/MegaFeBoxDesk-Climb-Luke-Kili.jpghttps://timmermanreport.com/kilimanjaro-2023/megafeboxdesk-climb-luke-kili-2/2022-10-12T17:28:39+00:00https://timmermanreport.com/wp-content/uploads/2022/10/MegaFeBoxDesk-Climb-Luke-Kili-1.jpghttps://timmermanreport.com/2022/10/matchpoint-gets-100m-to-take-covalent-binders-into-autoimmune-disease/nathanael-gray/2022-10-14T03:12:53+00:00https://timmermanreport.com/wp-content/uploads/2022/10/nathanael-gray.pnghttps://timmermanreport.com/2022/10/matchpoint-gets-100m-to-take-covalent-binders-into-autoimmune-disease/andre/2022-10-14T03:13:31+00:00https://timmermanreport.com/wp-content/uploads/2022/10/andre.pnghttps://timmermanreport.com/community-action/fredhutchlogo2022/2022-10-15T14:30:33+00:00https://timmermanreport.com/wp-content/uploads/2022/10/fredhutchlogo2022.pnghttps://timmermanreport.com/about-luke-timmerman/igf1/2022-10-15T17:22:34+00:00https://timmermanreport.com/wp-content/uploads/2022/10/IGF1-scaled.jpeghttps://timmermanreport.com/2018/05/re-starting-a-company-keeping-hope-alive-chip-clark-on-the-long-run/chip-clark-genocea/2022-10-17T23:18:13+00:00https://timmermanreport.com/wp-content/uploads/2018/05/Chip-Clark-Genocea.jpghttps://timmermanreport.com/kilimanjaro-2023/oncoresponse-logo-for-web/2022-10-20T17:42:46+00:00https://timmermanreport.com/wp-content/uploads/2022/10/oncoresponse-logo-for-web.pnghttps://timmermanreport.com/2022/10/bezos-bets-on-fred-hutch-prime-medicine-bucks-the-trend-and-pacbio-throws-down/mike-and-jackie-1-1260x836/2022-10-20T23:44:55+00:00https://timmermanreport.com/wp-content/uploads/2022/10/mike-and-jackie-1-1260x836-1.jpeghttps://timmermanreport.com/2022/10/bezos-bets-on-fred-hutch-prime-medicine-bucks-the-trend-and-pacbio-throws-down/booth1/2022-10-20T23:46:30+00:00https://timmermanreport.com/wp-content/uploads/2022/10/booth1.pnghttps://timmermanreport.com/2022/10/bezos-bets-on-fred-hutch-prime-medicine-bucks-the-trend-and-pacbio-throws-down/bernat-3/2022-10-20T23:47:27+00:00https://timmermanreport.com/wp-content/uploads/2022/10/bernat.pnghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/bob-more1-2/2022-10-25T22:08:45+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Bob-More1-1.pnghttps://timmermanreport.com/2015/09/more-than-just-science-relationships-between-vcs-and-pharma-drive-deals/bobmore/2022-10-25T22:09:17+00:00https://timmermanreport.com/wp-content/uploads/2015/01/bobmore.jpghttps://timmermanreport.com/about-luke-timmerman/igf1-1/2022-10-26T18:35:47+00:00https://timmermanreport.com/wp-content/uploads/2022/10/igf1.1.pnghttps://timmermanreport.com/2022/10/you-have-chosen-poorly-why-drug-developers-make-bad-decisions/grainger-2/2022-10-27T14:57:28+00:00https://timmermanreport.com/wp-content/uploads/2022/10/grainger.jpghttps://timmermanreport.com/2022/10/you-have-chosen-poorly-why-drug-developers-make-bad-decisions/jackscannell/2022-10-27T15:19:45+00:00https://timmermanreport.com/wp-content/uploads/2022/10/jackscannell.jpghttps://timmermanreport.com/2022/10/vaxcyte-takes-on-pfizer-novartis-challenges-az-time-gets-100m/pickering/2022-10-28T00:04:39+00:00https://timmermanreport.com/wp-content/uploads/2022/10/pickering.jpghttps://timmermanreport.com/2022/10/vaxcyte-takes-on-pfizer-novartis-challenges-az-time-gets-100m/gouge/2022-10-28T00:06:05+00:00https://timmermanreport.com/wp-content/uploads/2022/10/gouge.pnghttps://timmermanreport.com/2016/03/draft-joe-biden-and-roy-vagelos-for-a-fair-deal-on-drug-pricing/kenfrazier/2022-10-28T00:06:44+00:00https://timmermanreport.com/wp-content/uploads/2016/03/kenfrazier-e1457218843995.jpghttps://timmermanreport.com/2022/11/icymi-recommended-reading-and-listening-for-biotech-innovators/marca/2022-11-12T19:50:12+00:00https://timmermanreport.com/wp-content/uploads/2022/11/marca.jpghttps://timmermanreport.com/2022/11/icymi-recommended-reading-and-listening-for-biotech-innovators/anne-klibanski-standing-1150x1110/2022-11-12T19:55:48+00:00https://timmermanreport.com/wp-content/uploads/2022/11/anne-klibanski-standing-1150x1110-1.jpeghttps://timmermanreport.com/2022/11/team-julie-fighting-back-against-glioblastoma/scottrakestraw/2022-11-13T23:23:28+00:00https://timmermanreport.com/wp-content/uploads/2022/11/scottrakestraw.jpghttps://timmermanreport.com/2022/11/team-julie-fighting-back-against-glioblastoma/mission-gbm-header-collage/2022-11-13T23:30:18+00:00https://timmermanreport.com/wp-content/uploads/2022/11/Mission-GBM-Header-Collage.jpghttps://timmermanreport.com/2022/11/cajal-comes-out-of-stealth-with-96m-for-alzheimers-parkinsons-drug-discovery/ignacio/2022-11-29T01:41:23+00:00https://timmermanreport.com/wp-content/uploads/2022/11/ignacio.pnghttps://timmermanreport.com/2022/11/cajal-comes-out-of-stealth-with-96m-for-alzheimers-parkinsons-drug-discovery/andrew/2022-11-29T01:42:19+00:00https://timmermanreport.com/wp-content/uploads/2022/11/andrew.pnghttps://timmermanreport.com/2022/11/cajal-comes-out-of-stealth-with-96m-for-alzheimers-parkinsons-drug-discovery/ian/2022-11-29T01:43:01+00:00https://timmermanreport.com/wp-content/uploads/2022/11/ian.pnghttps://timmermanreport.com/2022/11/cajal-comes-out-of-stealth-with-96m-for-alzheimers-parkinsons-drug-discovery/ian2/2022-11-29T01:47:08+00:00https://timmermanreport.com/wp-content/uploads/2022/11/ian2.pnghttps://timmermanreport.com/2022/12/sutro-delivers-complete-responses-against-deadly-pediatric-acute-myeloid-leukemia/soheil-meshinchi/2022-12-10T04:14:04+00:00https://timmermanreport.com/wp-content/uploads/2022/12/soheil-meshinchi.jpghttps://timmermanreport.com/2022/12/reprofiling-drug-repurposing/olympus-digital-camera-2/2022-12-13T20:12:14+00:00https://timmermanreport.com/wp-content/uploads/2022/12/mikerea.jpeghttps://timmermanreport.com/2022/12/reprofiling-drug-repurposing/rutter\_900x600/2022-12-13T20:16:54+00:00https://timmermanreport.com/wp-content/uploads/2022/12/Rutter\_900x600.jpghttps://timmermanreport.com/2022/12/reprofiling-drug-repurposing/david/2022-12-13T20:18:23+00:00https://timmermanreport.com/wp-content/uploads/2022/12/david.jpghttps://timmermanreport.com/kilimanjaro-2023/elevatebio\_logo\_rgb/2022-12-14T18:03:48+00:00https://timmermanreport.com/wp-content/uploads/2022/12/ElevateBio\_logo\_rgb.jpghttps://timmermanreport.com/kilimanjaro-2023/goodwinlogo/2022-12-14T18:05:43+00:00https://timmermanreport.com/wp-content/uploads/2022/12/goodwinlogo.pnghttps://timmermanreport.com/kilimanjaro-2023/canaan\_partner\_logotype/2022-12-14T18:10:47+00:00https://timmermanreport.com/wp-content/uploads/2022/12/Canaan\_Partner\_Logotype.jpghttps://timmermanreport.com/kilimanjaro-2023/wecanriselogo/2022-12-14T18:12:40+00:00https://timmermanreport.com/wp-content/uploads/2022/12/wecanriselogo.pnghttps://timmermanreport.com/kilimanjaro-2023/linusgroup/2022-12-14T18:13:47+00:00https://timmermanreport.com/wp-content/uploads/2022/12/linusgroup.pnghttps://timmermanreport.com/kilimanjaro-2023/axiom/2022-12-14T20:34:44+00:00https://timmermanreport.com/wp-content/uploads/2022/12/axiom.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/jingyiliu/2022-12-14T22:28:07+00:00https://timmermanreport.com/wp-content/uploads/2021/05/jingyiliu.pnghttps://timmermanreport.com/2022/12/prescribing-cancer-drugs-off-label-is-tricky-transparency-and-standards-are-needed/candace\_haddox/2022-12-14T22:32:39+00:00https://timmermanreport.com/wp-content/uploads/2022/12/candace\_haddox.jpghttps://timmermanreport.com/2022/12/amgen-buys-horizon-miratis-kras-drug-ok-nimbuss-tyk2-windfall/nvax/2022-12-16T00:15:13+00:00https://timmermanreport.com/wp-content/uploads/2022/12/nvax.pnghttps://timmermanreport.com/2022/12/a-new-way-to-treat-depression-barry-greene-on-the-long-run/barry/2022-12-20T00:01:11+00:00https://timmermanreport.com/wp-content/uploads/2022/12/barry.pnghttps://timmermanreport.com/kilimanjaro-2023/puretech/2022-12-20T00:23:16+00:00https://timmermanreport.com/wp-content/uploads/2022/12/puretech.pnghttps://timmermanreport.com/kilimanjaro-2023/lw/2022-12-20T00:25:01+00:00https://timmermanreport.com/wp-content/uploads/2022/12/lw.pnghttps://timmermanreport.com/kilimanjaro-2023/stifel/2022-12-20T00:26:26+00:00https://timmermanreport.com/wp-content/uploads/2022/12/stifel.pnghttps://timmermanreport.com/kilimanjaro-2023/agilent/2022-12-20T00:28:00+00:00https://timmermanreport.com/wp-content/uploads/2022/12/agilent.pnghttps://timmermanreport.com/kilimanjaro-2023/ttalumni/2022-12-20T00:38:56+00:00https://timmermanreport.com/wp-content/uploads/2022/12/TTalumni.pnghttps://timmermanreport.com/kilimanjaro-2023/ttfinal/2022-12-20T22:20:44+00:00https://timmermanreport.com/wp-content/uploads/2022/12/ttfinal.pnghttps://timmermanreport.com/kilimanjaro-2023/affini-t/2022-12-21T16:32:02+00:00https://timmermanreport.com/wp-content/uploads/2022/12/affini-t.pnghttps://timmermanreport.com/2022/12/madrigals-nash-persistence-pays-gileads-mixed-tigit-bag-zymeworks-rebound/cj4/2022-12-22T00:10:55+00:00https://timmermanreport.com/wp-content/uploads/2022/12/cj4.jpghttps://timmermanreport.com/kilimanjaro-2023/archventure\_logo\_stacked/2022-12-22T15:08:46+00:00https://timmermanreport.com/wp-content/uploads/2017/12/ArchVenture\_logo\_stacked-e1513541854100.jpghttps://timmermanreport.com/kilimanjaro-2023/apollohealth/2022-12-29T15:10:01+00:00https://timmermanreport.com/wp-content/uploads/2022/12/apollohealth.pnghttps://timmermanreport.com/kilimanjaro-2023/imugene\_logo\_rgb1/2022-12-29T15:10:01+00:00https://timmermanreport.com/wp-content/uploads/2022/12/Imugene\_Logo\_RGB1.pnghttps://timmermanreport.com/2023/01/from-musician-to-tech-to-biotech-investor-d-a-wallach-on-the-long-run/bioceo/2023-01-03T21:27:10+00:00https://timmermanreport.com/wp-content/uploads/2023/01/bioceo.pnghttps://timmermanreport.com/2023/01/from-musician-to-tech-to-biotech-investor-d-a-wallach-on-the-long-run/bio-pic-da3x/2023-01-03T21:28:37+00:00https://timmermanreport.com/wp-content/uploads/2023/01/BIO-PIC-DA@3x.jpghttps://timmermanreport.com/2023/01/belharra-gets-130m-from-versant-genentech-for-chemoproteomic-discovery/jeff-jonker\_ceo/2023-01-04T01:05:24+00:00https://timmermanreport.com/wp-content/uploads/2023/01/jeff-jonker\_ceo.jpghttps://timmermanreport.com/2023/01/oui-therapeutics-shifting-the-clinical-societal-and-business-impact-of-suicide/seth/2023-01-05T01:16:15+00:00https://timmermanreport.com/wp-content/uploads/2023/01/seth.jpghttps://timmermanreport.com/2023/01/jj-walks-away-from-fate-century-cuts-back-modernas-strategic-buy/scott-wolchko/2023-01-06T00:41:38+00:00https://timmermanreport.com/wp-content/uploads/2023/01/Scott-Wolchko.jpghttps://timmermanreport.com/kilimanjaro-2023/alloy\_therapeutics\_logo\_black\_rgb/2023-01-19T21:31:11+00:00https://timmermanreport.com/wp-content/uploads/2023/01/Alloy\_Therapeutics\_logo\_black\_RGB.pnghttps://timmermanreport.com/kilimanjaro-2023/alexandria/2023-01-19T21:56:30+00:00https://timmermanreport.com/wp-content/uploads/2023/01/alexandria.pnghttps://timmermanreport.com/2022/03/structural-biology-driven-drug-discovery-ray-stevens-on-the-long-run/raystevens/2023-01-20T01:31:26+00:00https://timmermanreport.com/wp-content/uploads/2022/03/raystevens.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/leslie/2023-01-20T01:52:14+00:00https://timmermanreport.com/wp-content/uploads/2022/05/leslie.pnghttps://timmermanreport.com/kilimanjaro-2023/vertex/2023-01-20T17:19:42+00:00https://timmermanreport.com/wp-content/uploads/2023/01/vertex.pnghttps://timmermanreport.com/2023/01/dimension-debuts-with-350m-to-back-startups-that-digitize-biology/dimensionpartners/2023-01-25T00:06:25+00:00https://timmermanreport.com/wp-content/uploads/2023/01/dimensionpartners.pnghttps://timmermanreport.com/2023/01/virs-scangos-retires-pliants-ipf-win-some-painful-decisions/pliantstock/2023-01-27T01:45:40+00:00https://timmermanreport.com/wp-content/uploads/2023/01/pliantstock.pnghttps://timmermanreport.com/kilimanjaro-2023/omegafunds/2023-01-30T22:30:18+00:00https://timmermanreport.com/wp-content/uploads/2023/01/omegafunds.pnghttps://timmermanreport.com/2023/02/a-biotech-journalism-outlet-built-to-last-rick-berke-on-the-long-run/rickberke/2023-02-01T17:00:22+00:00https://timmermanreport.com/wp-content/uploads/2023/02/rickberke.jpghttps://timmermanreport.com/2023/02/engineered-b-cell-therapies-for-cancer-rare-diseases-joanne-smith-farrell-on-the-long-run/joanne/2023-02-06T21:51:52+00:00https://timmermanreport.com/wp-content/uploads/2023/02/joanne.jpghttps://timmermanreport.com/2023/02/engineered-b-cell-therapies-for-cancer-rare-diseases-joanne-smith-farrell-on-the-long-run/scientist-logo\_rgb/2023-02-06T21:52:43+00:00https://timmermanreport.com/wp-content/uploads/2023/02/SCIENTIST.com\_Logo\_CMYK-5-scaled.jpghttps://timmermanreport.com/2023/02/first-we-need-to-generate-the-right-data-then-ai-will-shine/victor/2023-02-08T20:58:50+00:00https://timmermanreport.com/wp-content/uploads/2023/02/victor.jpghttps://timmermanreport.com/2023/02/first-we-need-to-generate-the-right-data-then-ai-will-shine/alice-zhang-1/2023-02-09T15:23:45+00:00https://timmermanreport.com/wp-content/uploads/2023/02/Alice-Zhang-1-scaled.jpghttps://timmermanreport.com/2023/02/first-we-need-to-generate-the-right-data-then-ai-will-shine/azhang/2023-02-09T15:26:02+00:00https://timmermanreport.com/wp-content/uploads/2023/02/azhang.jpghttps://timmermanreport.com/2023/02/first-we-need-to-generate-the-right-data-then-ai-will-shine/victor1/2023-02-09T15:26:37+00:00https://timmermanreport.com/wp-content/uploads/2023/02/Victor1.jpghttps://timmermanreport.com/2023/02/the-success-of-your-tech-deployment-depends-on-a-role-youve-probably-never-heard-of/richarddaly/2023-02-26T21:04:43+00:00https://timmermanreport.com/wp-content/uploads/2023/02/richarddaly.pnghttps://timmermanreport.com/2023/03/lilly-cuts-insulin-prices-reatas-dramatic-fda-approval-seagen-ma-rumors-resurface/clint/2023-03-03T01:42:11+00:00https://timmermanreport.com/wp-content/uploads/2023/03/clint.jpghttps://timmermanreport.com/2023/03/lilly-cuts-insulin-prices-reatas-dramatic-fda-approval-seagen-ma-rumors-resurface/cfc-women-and-miriam2/2023-03-03T01:56:44+00:00https://timmermanreport.com/wp-content/uploads/2023/03/CFC-women-and-Miriam2.jpghttps://timmermanreport.com/2023/03/lilly-cuts-insulin-prices-reatas-dramatic-fda-approval-seagen-ma-rumors-resurface/eric-2/2023-03-03T01:56:47+00:00https://timmermanreport.com/wp-content/uploads/2023/03/eric-rotated.jpghttps://timmermanreport.com/2023/03/lilly-cuts-insulin-prices-reatas-dramatic-fda-approval-seagen-ma-rumors-resurface/orientation/2023-03-03T01:56:49+00:00https://timmermanreport.com/wp-content/uploads/2023/03/orientation.jpghttps://timmermanreport.com/2023/03/lilly-cuts-insulin-prices-reatas-dramatic-fda-approval-seagen-ma-rumors-resurface/shiracamp/2023-03-03T01:56:52+00:00https://timmermanreport.com/wp-content/uploads/2023/03/shiracamp.jpghttps://timmermanreport.com/2023/03/lilly-cuts-insulin-prices-reatas-dramatic-fda-approval-seagen-ma-rumors-resurface/summit/2023-03-03T01:56:54+00:00https://timmermanreport.com/wp-content/uploads/2023/03/summit.jpghttps://timmermanreport.com/2023/03/lilly-cuts-insulin-prices-reatas-dramatic-fda-approval-seagen-ma-rumors-resurface/img\_4397-1/2023-03-03T02:26:08+00:00https://timmermanreport.com/wp-content/uploads/2023/03/IMG\_4397.1.jpghttps://timmermanreport.com/2020/07/the-road-less-traveled-in-biotech-abe-ceesay-on-the-long-run/abe-ceesay-45-cropped/2023-03-06T22:14:42+00:00https://timmermanreport.com/wp-content/uploads/2020/07/abe-ceesay-45-cropped-scaled.jpghttps://timmermanreport.com/2023/03/third-rock-arch-jj-pump-100m-into-rapport-to-develop-precision-neuro-drugs/group-far/2023-03-07T16:07:51+00:00https://timmermanreport.com/wp-content/uploads/2023/03/Group-far.jpghttps://timmermanreport.com/2023/03/svbs-dark-day-biogens-leadership-change-and-a-plan-to-crush-hepc/svb/2023-03-10T01:32:41+00:00https://timmermanreport.com/wp-content/uploads/2023/03/svb.pnghttps://timmermanreport.com/2023/03/svbs-dark-day-biogens-leadership-change-and-a-plan-to-crush-hepc/booth/2023-03-10T01:33:07+00:00https://timmermanreport.com/wp-content/uploads/2023/03/booth.pnghttps://timmermanreport.com/2023/03/svbs-dark-day-biogens-leadership-change-and-a-plan-to-crush-hepc/lessin/2023-03-10T01:33:08+00:00https://timmermanreport.com/wp-content/uploads/2023/03/lessin.pnghttps://timmermanreport.com/2023/03/svbs-dark-day-biogens-leadership-change-and-a-plan-to-crush-hepc/suster/2023-03-10T01:33:09+00:00https://timmermanreport.com/wp-content/uploads/2023/03/suster.pnghttps://timmermanreport.com/2023/03/svbs-dark-day-biogens-leadership-change-and-a-plan-to-crush-hepc/suster-2/2023-03-10T01:33:30+00:00https://timmermanreport.com/wp-content/uploads/2023/03/suster-1.pnghttps://timmermanreport.com/2023/03/svbs-dark-day-biogens-leadership-change-and-a-plan-to-crush-hepc/john/2023-03-10T01:35:27+00:00https://timmermanreport.com/wp-content/uploads/2023/03/john.pnghttps://timmermanreport.com/2023/03/svbs-dark-day-biogens-leadership-change-and-a-plan-to-crush-hepc/plump-2/2023-03-10T01:35:29+00:00https://timmermanreport.com/wp-content/uploads/2023/03/plump.pnghttps://timmermanreport.com/2023/03/big-pharma-vcs-bet-105m-on-mediars-antibodies-for-fibrotic-diseases/mediar/2023-03-14T21:50:46+00:00https://timmermanreport.com/wp-content/uploads/2023/03/mediar-CSO-1758-Paul-Yaworsky-sm.jpghttps://timmermanreport.com/2023/03/big-pharma-vcs-bet-105m-on-mediars-antibodies-for-fibrotic-diseases/mediar-2/2023-03-14T21:51:42+00:00https://timmermanreport.com/wp-content/uploads/2023/03/mediar-CEO-1779-Rahul-Ballal-sm.jpghttps://timmermanreport.com/2023/03/the-future-of-neuroscience-drug-rd-ryan-watts-on-the-long-run/ryan-watts-headshot/2023-03-14T22:21:39+00:00https://timmermanreport.com/wp-content/uploads/2023/03/Ryan-Watts-Headshot-scaled.jpghttps://timmermanreport.com/2023/03/pfizer-acquires-seagen-sanofi-novo-cut-insulin-prices-illuminas-proxy-fight/ab\_headshot\_2021\_300x170/2023-03-17T01:51:21+00:00https://timmermanreport.com/wp-content/uploads/2023/03/ab\_headshot\_2021\_300x170.jpghttps://timmermanreport.com/2023/03/pfizer-acquires-seagen-sanofi-novo-cut-insulin-prices-illuminas-proxy-fight/jessica\_federer\_color\_002/2023-03-17T01:58:59+00:00https://timmermanreport.com/wp-content/uploads/2023/03/Jessica\_Federer\_color\_002.jpghttps://timmermanreport.com/2023/03/pfizer-acquires-seagen-sanofi-novo-cut-insulin-prices-illuminas-proxy-fight/dlee/2023-03-17T02:01:10+00:00https://timmermanreport.com/wp-content/uploads/2023/03/dlee.pnghttps://timmermanreport.com/2023/03/flare-therapeutics-gets-123m-to-make-drugs-against-elusive-transcription-factors/flare-tx\_cso\_robsims\_/2023-03-22T02:54:27+00:00https://timmermanreport.com/wp-content/uploads/2023/03/Flare-Tx\_CSO\_RobSims\_.jpghttps://timmermanreport.com/2023/03/flare-therapeutics-gets-123m-to-make-drugs-against-elusive-transcription-factors/flaretx\_ceo\_amitrakhit1/2023-03-22T02:57:09+00:00https://timmermanreport.com/wp-content/uploads/2023/03/FlareTx\_CEO\_AmitRakhit1.jpghttps://timmermanreport.com/2023/03/welcome-to-the-ai-irruption/kohane\_nejm\_ann\_850\_430/2023-03-23T21:34:30+00:00https://timmermanreport.com/wp-content/uploads/2023/03/kohane\_nejm\_ann\_850\_430.pnghttps://timmermanreport.com/2020/11/rebuffed-as-overlords-ai-experts-return-in-peace-seeking-partnership-with-clinicians/petelee-0618\_07-jpeg/2023-03-23T21:35:13+00:00https://timmermanreport.com/wp-content/uploads/2020/11/PeteLee-0618\_07.jpeg.jpghttps://timmermanreport.com/2021/04/building-momentum-and-leverage-how-pandion-ended-up-acquired-by-merck/vikas/2023-03-28T21:38:14+00:00https://timmermanreport.com/wp-content/uploads/2021/04/vikas.jpghttps://timmermanreport.com/2023/03/jan-skvarka-former-trillium-ceo-on-driving-a-turnaround/skvarka/2023-03-28T21:46:15+00:00https://timmermanreport.com/wp-content/uploads/2023/03/skvarka.jpghttps://timmermanreport.com/2023/03/treating-a-common-underappreciated-disease-eric-dobmeier-on-the-long-run/occam-2023-logo-refresh-high-res/2023-03-28T23:08:05+00:00https://timmermanreport.com/wp-content/uploads/2023/03/Occam-2023-Logo-Refresh-High-Res.pnghttps://timmermanreport.com/2023/04/new-book-contemplates-how-generative-ai-will-serve-man/proxima/2023-04-02T21:59:51+00:00https://timmermanreport.com/wp-content/uploads/2023/04/proxima.pnghttps://timmermanreport.com/2023/04/new-book-contemplates-how-generative-ai-will-serve-man/screenshot-2023-04-02-144840/2023-04-02T22:05:46+00:00https://timmermanreport.com/wp-content/uploads/2023/04/Screenshot-2023-04-02-144840.pnghttps://timmermanreport.com/2023/04/new-book-contemplates-how-generative-ai-will-serve-man/goldberg/2023-04-02T22:07:53+00:00https://timmermanreport.com/wp-content/uploads/2023/04/goldberg.pnghttps://timmermanreport.com/2023/04/new-book-contemplates-how-generative-ai-will-serve-man/allison/2023-04-02T22:08:52+00:00https://timmermanreport.com/wp-content/uploads/2023/04/allison.pnghttps://timmermanreport.com/2023/04/new-book-contemplates-how-generative-ai-will-serve-man/kevinscott/2023-04-02T22:09:25+00:00https://timmermanreport.com/wp-content/uploads/2023/04/kevinscott.pnghttps://timmermanreport.com/2023/04/translating-crispr-gene-editing-into-a-groundbreaking-cell-therapy/sickle\_cell\_disease\_27249799083/2023-04-03T18:57:41+00:00https://timmermanreport.com/wp-content/uploads/2023/04/Sickle\_Cell\_Disease\_27249799083.jpghttps://timmermanreport.com/2023/04/tech-pharma-and-the-uneven-distribution-of-the-ai-enabled-future/noam/2023-04-08T22:59:58+00:00https://timmermanreport.com/wp-content/uploads/2023/04/noam.jpghttps://timmermanreport.com/2023/04/tech-pharma-and-the-uneven-distribution-of-the-ai-enabled-future/white/2023-04-08T23:04:04+00:00https://timmermanreport.com/wp-content/uploads/2023/04/white.jpghttps://timmermanreport.com/2023/04/function-gets-28m-to-make-personalized-cancer-genomics-to-the-next-level/functiononcology/2023-04-11T22:55:05+00:00https://timmermanreport.com/wp-content/uploads/2023/04/functiononcology.jpghttps://timmermanreport.com/2019/05/third-rock-and-friends-bet-110m-on-thrive-a-hopkins-born-cancer-screening-startup/skafka/2023-04-11T22:59:13+00:00https://timmermanreport.com/wp-content/uploads/2019/05/skafka.jpghttps://timmermanreport.com/2023/04/function-gets-28m-to-make-personalized-cancer-genomics-to-the-next-level/stevek/2023-04-11T23:42:27+00:00https://timmermanreport.com/wp-content/uploads/2023/04/stevek.jpghttps://timmermanreport.com/2023/04/aer-therapeutics-gets-36m-series-a-to-break-down-mucus-in-lungs/timshannon/2023-04-12T21:39:41+00:00https://timmermanreport.com/wp-content/uploads/2023/04/timshannon.jpghttps://timmermanreport.com/2023/04/aer-therapeutics-gets-36m-series-a-to-break-down-mucus-in-lungs/johnfahy/2023-04-12T21:43:04+00:00https://timmermanreport.com/wp-content/uploads/2023/04/johnfahy.jpghttps://timmermanreport.com/2023/04/aer-therapeutics-gets-36m-series-a-to-break-down-mucus-in-lungs/jimshaffer/2023-04-12T21:44:31+00:00https://timmermanreport.com/wp-content/uploads/2023/04/jimshaffer.jpghttps://timmermanreport.com/2021/09/a-magical-time-in-the-presidential-range-giving-back-to-community/katherine/2023-04-13T23:25:36+00:00https://timmermanreport.com/wp-content/uploads/2021/09/katherine.pnghttps://timmermanreport.com/2023/04/the-fdas-hour-of-need-digital-tx-pioneer-shuts-down-hsbc-hires-svb-vets/srinath-sampath/2023-04-13T23:26:44+00:00https://timmermanreport.com/wp-content/uploads/2023/04/Srinath-Sampath.jpghttps://timmermanreport.com/2023/04/the-d-word-delivery-is-the-next-frontier-for-genetic-medicines/fphar-11-00937-g003/2023-04-18T15:47:52+00:00https://timmermanreport.com/wp-content/uploads/2023/04/Fphar-11-00937-g003.jpghttps://timmermanreport.com/2023/04/the-d-word-delivery-is-the-next-frontier-for-genetic-medicines/zhangf\_justinknight\_ownedbymcgovern-413/2023-04-18T15:50:26+00:00https://timmermanreport.com/wp-content/uploads/2023/04/zhangf\_JustinKnight\_OwnedbyMcGovern-413.pnghttps://timmermanreport.com/2023/04/abdera-gets-142m-to-make-potent-safe-radioantibodies-for-cancer/llyons/2023-04-19T23:42:05+00:00https://timmermanreport.com/wp-content/uploads/2023/04/llyons.jpghttps://timmermanreport.com/2023/04/abdera-gets-142m-to-make-potent-safe-radioantibodies-for-cancer/joel/2023-04-19T23:59:51+00:00https://timmermanreport.com/wp-content/uploads/2023/04/joel.jpghttps://timmermanreport.com/2023/04/abdera-gets-142m-to-make-potent-safe-radioantibodies-for-cancer/adamjudge/2023-04-20T00:01:26+00:00https://timmermanreport.com/wp-content/uploads/2023/04/adamjudge.jpghttps://timmermanreport.com/2023/04/the-supreme-court-and-the-fda/trust/2023-04-21T00:12:18+00:00https://timmermanreport.com/wp-content/uploads/2023/04/trust.pnghttps://timmermanreport.com/2023/04/the-supreme-court-and-the-fda/vagelos/2023-04-21T00:12:57+00:00https://timmermanreport.com/wp-content/uploads/2023/04/vagelos.jpeghttps://timmermanreport.com/2018/09/telling-biotech-stories-on-tv-listen-to-meg-tirrell-on-the-long-run-podcast/megtirrell/2023-04-21T00:13:59+00:00https://timmermanreport.com/wp-content/uploads/2018/08/megtirrell.jpghttps://timmermanreport.com/2023/04/gene-editing-therapies-delivered-in-vivo-ensomas-emile-nuwaysir-on-the-long-run/bio\_23\_logo-h-date-core-2/2023-04-24T22:55:42+00:00https://timmermanreport.com/wp-content/uploads/2023/04/BIO\_23\_Logo-H-Date-Core-2.jpghttps://timmermanreport.com/2023/04/orbital-secures-270m-to-make-new-rna-medicines/pino/2023-04-25T22:54:43+00:00https://timmermanreport.com/wp-content/uploads/2023/04/pino.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/yvonne\_resized/2023-04-27T23:59:22+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Yvonne\_resized.jpghttps://timmermanreport.com/2023/05/preserving-the-biotech-social-contract-we-should-all-be-pitching-in/table1potts/2023-04-29T14:55:59+00:00https://timmermanreport.com/wp-content/uploads/2023/04/table1potts.pnghttps://timmermanreport.com/2023/05/preserving-the-biotech-social-contract-we-should-all-be-pitching-in/table2potts/2023-04-29T14:57:07+00:00https://timmermanreport.com/wp-content/uploads/2023/04/table2potts.pnghttps://timmermanreport.com/2023/05/preserving-the-biotech-social-contract-we-should-all-be-pitching-in/rodwong/2023-04-29T14:59:43+00:00https://timmermanreport.com/wp-content/uploads/2023/04/rodwong.pnghttps://timmermanreport.com/2023/05/lillys-alzheimers-win-astellas-breaks-out-checkbook-a-rsv-vaccine-first/coloma/2023-05-04T23:09:30+00:00https://timmermanreport.com/wp-content/uploads/2023/05/coloma.pnghttps://timmermanreport.com/2020/07/barring-foreign-talent-is-an-assault-on-biotech-innovation/john\_maraganore/2023-05-08T23:15:49+00:00https://timmermanreport.com/wp-content/uploads/2020/07/John\_Maraganore.jpghttps://timmermanreport.com/2023/05/thinking-big-about-community-impact/lsc1/2023-05-11T22:47:05+00:00https://timmermanreport.com/wp-content/uploads/2023/05/LSC1.jpghttps://timmermanreport.com/2023/05/thinking-big-about-community-impact/ring/2023-05-11T22:51:12+00:00https://timmermanreport.com/wp-content/uploads/2023/05/ring.pnghttps://timmermanreport.com/2023/05/thinking-big-about-community-impact/maria2/2023-05-11T22:52:45+00:00https://timmermanreport.com/wp-content/uploads/2023/05/maria2.jpghttps://timmermanreport.com/2023/05/biopharma-innovation-beyond-the-breathless-headlines/sachin/2023-05-15T19:37:36+00:00https://timmermanreport.com/wp-content/uploads/2023/05/sachin.jpghttps://timmermanreport.com/2023/05/biopharma-innovation-beyond-the-breathless-headlines/munos/2023-05-15T19:41:35+00:00https://timmermanreport.com/wp-content/uploads/2023/05/munos.jpghttps://timmermanreport.com/2023/05/boundless-bio-gets-100m-to-fight-cancer-newlimit-gets-40m-to-defy-aging/blake/2023-05-15T22:56:48+00:00https://timmermanreport.com/wp-content/uploads/2023/05/blake.jpeghttps://timmermanreport.com/2023/05/anthony-mancini-of-genmab-on-growing-your-company-together-with-partners/anthony-mancini\_photo-rights-genmab\_photo-credit-andrei-jackamets-copy2/2023-05-18T01:05:47+00:00https://timmermanreport.com/wp-content/uploads/2023/05/Anthony-Mancini\_photo-rights-Genmab\_photo-credit-Andrei-Jackamets-copy2.jpghttps://timmermanreport.com/2023/05/big-if-true-opportunities-and-obstacles-facing-ai-plus-summer-reading/dall%c2%b7e-2023-05-20-11-39-17-futuristic-fantasy-digital-art-capturing-the-integration-of-biology-digital-technology-physicians-scientists-and-patients/2023-05-21T20:08:11+00:00https://timmermanreport.com/wp-content/uploads/2023/05/DALL%C2%B7E-2023-05-20-11.39.17-futuristic-fantasy-digital-art-capturing-the-integration-of-biology-digital-technology-physicians-scientists-and-patients.pnghttps://timmermanreport.com/2023/05/big-if-true-opportunities-and-obstacles-facing-ai-plus-summer-reading/dall%c2%b7e-2023-05-20-11-50-52-painting-in-style-of-matisse-capturing-the-integration-of-biology-dna-technology-and-data-female-and-male-physicians-scientists-and-patients/2023-05-21T20:09:20+00:00https://timmermanreport.com/wp-content/uploads/2023/05/DALL%C2%B7E-2023-05-20-11.50.52-painting-in-style-of-matisse-capturing-the-integration-of-biology-DNA-technology-and-data-female-and-male-physicians-scientists-and-patients.pnghttps://timmermanreport.com/2023/05/big-if-true-opportunities-and-obstacles-facing-ai-plus-summer-reading/dall%c2%b7e-2023-05-20-11-45-26-marvel-comic-style-art-capturing-the-integration-of-biology-and-dna-digital-technology-and-data-physicians-scientists-and-patients-please-include/2023-05-21T20:14:37+00:00https://timmermanreport.com/wp-content/uploads/2023/05/DALL%C2%B7E-2023-05-20-11.45.26-marvel-comic-style-art-capturing-the-integration-of-biology-and-DNA-digital-technology-and-data-physicians-scientists-and-patients-please-include-.pnghttps://timmermanreport.com/2023/05/big-if-true-opportunities-and-obstacles-facing-ai-plus-summer-reading/dall%c2%b7e-2023-05-20-11-45-06-marvel-comic-style-art-capturing-the-integration-of-biology-and-dna-digital-technology-and-data-physicians-scientists-and-patients-please-include/2023-05-21T20:15:50+00:00https://timmermanreport.com/wp-content/uploads/2023/05/DALL%C2%B7E-2023-05-20-11.45.06-marvel-comic-style-art-capturing-the-integration-of-biology-and-DNA-digital-technology-and-data-physicians-scientists-and-patients-please-include-.pnghttps://timmermanreport.com/2023/05/big-if-true-opportunities-and-obstacles-facing-ai-plus-summer-reading/dall%c2%b7e-2023-05-20-11-39-28-futuristic-fantasy-digital-art-capturing-the-integration-of-biology-digital-technology-physicians-scientists-and-patients/2023-05-21T20:16:56+00:00https://timmermanreport.com/wp-content/uploads/2023/05/DALL%C2%B7E-2023-05-20-11.39.28-futuristic-fantasy-digital-art-capturing-the-integration-of-biology-digital-technology-physicians-scientists-and-patients.pnghttps://timmermanreport.com/2023/05/big-if-true-opportunities-and-obstacles-facing-ai-plus-summer-reading/dall%c2%b7e-2023-05-20-11-39-17-futuristic-fantasy-digital-art-capturing-the-integration-of-biology-digital-technology-physicians-scientists-and-patients-2/2023-05-21T20:24:33+00:00https://timmermanreport.com/wp-content/uploads/2023/05/DALL%C2%B7E-2023-05-20-11.39.17-futuristic-fantasy-digital-art-capturing-the-integration-of-biology-digital-technology-physicians-scientists-and-patients-1.pnghttps://timmermanreport.com/2023/05/larkspur-gets-35-5m-to-make-small-molecule-cancer-immunotherapies/casp1/2023-05-23T01:38:36+00:00https://timmermanreport.com/wp-content/uploads/2023/05/CASP1.jpghttps://timmermanreport.com/2023/05/from-structural-biology-to-structuring-companies-deb-palestrant-on-the-long-run/deb-palestrant\_2022-cropped/2023-05-30T21:17:25+00:00https://timmermanreport.com/wp-content/uploads/2023/05/Deb-Palestrant\_2022-cropped.jpghttps://timmermanreport.com/2023/06/pfizers-rsv-vaccine-okd-coherus-challenges-humira-eikon-gets-a-pipeline/bradner1/2023-06-01T23:57:22+00:00https://timmermanreport.com/wp-content/uploads/2023/06/Bradner1.pnghttps://timmermanreport.com/2022/02/for-china-made-drugs-sintilimab-was-the-exception-not-the-rule/brad-4/2023-06-01T23:58:37+00:00https://timmermanreport.com/wp-content/uploads/2022/02/brad.jpghttps://timmermanreport.com/2023/06/alkeus-a-bootstrap-success-story-graduates-with-150m-series-b/leo/2023-06-04T01:21:01+00:00https://timmermanreport.com/wp-content/uploads/2023/06/leo.pnghttps://timmermanreport.com/2023/06/alkeus-a-bootstrap-success-story-graduates-with-150m-series-b/boger/2023-06-04T01:21:47+00:00https://timmermanreport.com/wp-content/uploads/2023/06/boger.jpghttps://timmermanreport.com/2023/06/pharma-rd-execs-offer-extravagant-expectations-for-ai-but-few-proof-points/meyers/2023-06-04T23:43:26+00:00https://timmermanreport.com/wp-content/uploads/2023/06/meyers.pnghttps://timmermanreport.com/2023/06/pharma-rd-execs-offer-extravagant-expectations-for-ai-but-few-proof-points/berry/2023-06-04T23:48:44+00:00https://timmermanreport.com/wp-content/uploads/2023/06/berry.jpghttps://timmermanreport.com/2023/06/pharma-rd-execs-offer-extravagant-expectations-for-ai-but-few-proof-points/bingo/2023-06-05T15:05:01+00:00https://timmermanreport.com/wp-content/uploads/2023/06/bingo.jpghttps://timmermanreport.com/2023/06/pharma-rd-execs-offer-extravagant-expectations-for-ai-but-few-proof-points/magicvat/2023-06-05T15:07:39+00:00https://timmermanreport.com/wp-content/uploads/2023/06/magicvat.jpghttps://timmermanreport.com/2023/06/startup-profiles-upstream-bio-gets-another-200m-kate-therapeutics-debuts-with-51m/forrest/2023-06-08T02:36:53+00:00https://timmermanreport.com/wp-content/uploads/2023/06/forrest.jpghttps://timmermanreport.com/2023/06/gilead-test-drives-a-alpha-bio-platform-to-find-long-acting-biologics-against-hiv/younger/2023-06-09T00:46:00+00:00https://timmermanreport.com/wp-content/uploads/2023/06/younger.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2023/timmerman-traverse2022/2023-06-09T16:19:35+00:00https://timmermanreport.com/wp-content/uploads/2023/06/timmerman-traverse2022.jpghttps://timmermanreport.com/2023/06/learning-from-history-how-to-think-about-the-technology-of-the-moment/cperez/2023-06-17T11:47:32+00:00https://timmermanreport.com/wp-content/uploads/2023/06/cperez.pnghttps://timmermanreport.com/2023/06/learning-from-history-how-to-think-about-the-technology-of-the-moment/bessen/2023-06-17T11:52:09+00:00https://timmermanreport.com/wp-content/uploads/2023/06/bessen.pnghttps://timmermanreport.com/2023/06/learning-from-history-how-to-think-about-the-technology-of-the-moment/pauldavid1/2023-06-17T12:06:11+00:00https://timmermanreport.com/wp-content/uploads/2023/06/pauldavid1.pnghttps://timmermanreport.com/2023/06/learning-from-history-how-to-think-about-the-technology-of-the-moment/vonhippel/2023-06-17T12:09:42+00:00https://timmermanreport.com/wp-content/uploads/2023/06/vonhippel.pnghttps://timmermanreport.com/2023/06/artbio-backed-by-f-prime-and-omega-gets-23m-for-targeted-radiotherapies-for-cancer/ostuni/2023-06-20T22:38:15+00:00https://timmermanreport.com/wp-content/uploads/2023/06/ostuni.jpghttps://timmermanreport.com/2023/06/altpep-backed-by-section32-and-lilly-gets-53m-to-catch-and-treat-early-alzheimers/valerie-daggett-cropped-2-1-2048x2048/2023-06-21T22:27:04+00:00https://timmermanreport.com/wp-content/uploads/2023/06/Valerie-Daggett-Cropped-2-1-2048x2048-1.jpghttps://timmermanreport.com/readers-saying/kjudice2/2023-06-22T23:08:27+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kjudice2.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2023/mt-washington-sponsors/2023-06-29T14:15:32+00:00https://timmermanreport.com/wp-content/uploads/2023/06/Mt.-Washington-Sponsors.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2023/mt-monroe-mt-eisenhower-sponsors/2023-06-29T14:16:23+00:00https://timmermanreport.com/wp-content/uploads/2023/06/Mt.-Monroe-Mt.-Eisenhower-Sponsors.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2023/mt-pierce-sponsors/2023-06-29T14:16:51+00:00https://timmermanreport.com/wp-content/uploads/2023/06/Mt.-Pierce-Sponsors.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2023/trailhead-friends-sponsors/2023-06-29T14:17:13+00:00https://timmermanreport.com/wp-content/uploads/2023/06/Trailhead-Friends-Sponsors.pnghttps://timmermanreport.com/in-the-news/screen-shot-2023-06-29-at-8-50-36-pm/2023-06-30T00:56:29+00:00https://timmermanreport.com/wp-content/uploads/2023/06/Screen-Shot-2023-06-29-at-8.50.36-PM.pnghttps://timmermanreport.com/2023/07/lessons-learned-from-the-intense-back-and-forth-over-a-1b-acquisition/albireo/2023-07-09T21:06:53+00:00https://timmermanreport.com/wp-content/uploads/2023/07/albireo.pnghttps://timmermanreport.com/2023/07/detecting-cancer-early-when-its-most-treatable-kevin-conroy-on-the-long-run/kevinconroy/2023-07-10T20:39:32+00:00https://timmermanreport.com/wp-content/uploads/2023/07/kevinconroy.pnghttps://timmermanreport.com/2023/07/septerna-backed-by-third-rock-and-ra-gets-150m-for-gpcr-drug-discovery/jeff-finer\_2384crop2/2023-07-10T21:22:09+00:00https://timmermanreport.com/wp-content/uploads/2023/07/Jeff-Finer\_2384crop2.pnghttps://timmermanreport.com/2023/07/septerna-backed-by-third-rock-and-ra-gets-150m-for-gpcr-drug-discovery/finer/2023-07-10T21:23:14+00:00https://timmermanreport.com/wp-content/uploads/2023/07/finer.pnghttps://timmermanreport.com/2023/07/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty/lsctt23logos/2023-07-12T15:19:31+00:00https://timmermanreport.com/wp-content/uploads/2023/07/LSCTT23Logos.jpghttps://timmermanreport.com/2023/07/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty/e5e2df32-92f3-4157-96aa-92edeefad13e\_1\_105\_c/2023-07-12T15:30:22+00:00https://timmermanreport.com/wp-content/uploads/2023/07/E5E2DF32-92F3-4157-96AA-92EDEEFAD13E\_1\_105\_c.jpghttps://timmermanreport.com/2023/07/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty/group-mt-wash/2023-07-12T15:32:15+00:00https://timmermanreport.com/wp-content/uploads/2023/07/Group-Mt-Wash.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2023/2023-tt-sponsor-mt-washington-level/2023-07-13T18:16:03+00:00https://timmermanreport.com/wp-content/uploads/2023/07/2023-TT-Sponsor-Mt.-Washington-Level.jpghttps://timmermanreport.com/2023/07/recursions-big-day-fda-oks-otc-birth-control-gpcr-drug-discovery-advances/recursioncnbc/2023-07-13T22:15:41+00:00https://timmermanreport.com/wp-content/uploads/2023/07/recursioncnbc.pnghttps://timmermanreport.com/2023/07/recursions-big-day-fda-oks-otc-birth-control-gpcr-drug-discovery-advances/jadams/2023-07-13T22:18:45+00:00https://timmermanreport.com/wp-content/uploads/2023/07/jadams.pnghttps://timmermanreport.com/2023/07/westlake-village-raises-450m-for-biotech-startups-in-la-and-beyond/beth-seidenberg/2023-07-14T20:21:46+00:00https://timmermanreport.com/wp-content/uploads/2023/07/Beth-Seidenberg.jpghttps://timmermanreport.com/2023/07/westlake-village-raises-450m-for-biotech-startups-in-la-and-beyond/mira/2023-07-14T20:22:35+00:00https://timmermanreport.com/wp-content/uploads/2023/07/mira.jpghttps://timmermanreport.com/2023/07/westlake-village-raises-450m-for-biotech-startups-in-la-and-beyond/david-allison/2023-07-14T20:23:16+00:00https://timmermanreport.com/wp-content/uploads/2023/07/David-Allison.jpghttps://timmermanreport.com/2021/10/neumora-secures-500m-amgen-deal-in-quest-for-precision-neuroscience-rd/rbnc\_paul-berns/2023-07-18T02:31:37+00:00https://timmermanreport.com/wp-content/uploads/2021/10/RBNC\_Paul-Berns.jpghttps://timmermanreport.com/2023/07/neumora-advances-to-phase-iii-with-depression-drug-hires-abbvie-vet-as-ceo/henryg/2023-07-18T02:32:52+00:00https://timmermanreport.com/wp-content/uploads/2023/07/henryg.jpghttps://timmermanreport.com/2023/07/ftc-scrutinizes-ma-tessier-lavigne-steps-down-and-bridgebios-comeback/khan-200x200/2023-07-21T01:34:57+00:00https://timmermanreport.com/wp-content/uploads/2023/07/khan-200x200-1.jpghttps://timmermanreport.com/2021/01/fungus-based-startup-lifemine-fetches-50m-arsenal-attracts-bms-cell-therapy/verdine-2/2023-07-21T01:40:05+00:00https://timmermanreport.com/wp-content/uploads/2021/01/verdine.pnghttps://timmermanreport.com/2023/07/ftc-scrutinizes-ma-tessier-lavigne-steps-down-and-bridgebios-comeback/bbio/2023-07-21T01:42:08+00:00https://timmermanreport.com/wp-content/uploads/2023/07/bbio.pnghttps://timmermanreport.com/2023/07/ftc-scrutinizes-ma-tessier-lavigne-steps-down-and-bridgebios-comeback/mtl/2023-07-21T13:21:52+00:00https://timmermanreport.com/wp-content/uploads/2023/07/mtl.jpghttps://timmermanreport.com/2023/07/betting-on-bold-and-brave-ideas-for-cancer-yung-lie-on-the-long-run/yunglie/2023-07-24T21:51:00+00:00https://timmermanreport.com/wp-content/uploads/2023/07/yunglie.pnghttps://timmermanreport.com/2023/07/versant-backed-nexo-gets-60m-for-small-molecule-cancer-drug-discovery/aphillips/2023-07-25T23:09:49+00:00https://timmermanreport.com/wp-content/uploads/2023/07/aphillips.jpghttps://timmermanreport.com/2023/07/alnylams-big-roche-deal-biogen-cuts-1000-jobs-pneumococcal-vaccine-competition/jon1/2023-07-27T23:45:15+00:00https://timmermanreport.com/wp-content/uploads/2023/07/jon1.pnghttps://timmermanreport.com/2023/07/alnylams-big-roche-deal-biogen-cuts-1000-jobs-pneumococcal-vaccine-competition/burkly/2023-07-27T23:46:55+00:00https://timmermanreport.com/wp-content/uploads/2023/07/burkly.pnghttps://timmermanreport.com/2023/07/alnylams-big-roche-deal-biogen-cuts-1000-jobs-pneumococcal-vaccine-competition/art/2023-07-27T23:47:28+00:00https://timmermanreport.com/wp-content/uploads/2023/07/art.pnghttps://timmermanreport.com/2023/07/lessons-for-biopharma-from-a-healthcare-ai-pioneer/ziad/2023-07-31T23:15:49+00:00https://timmermanreport.com/wp-content/uploads/2023/07/ziad.pnghttps://timmermanreport.com/2023/07/lessons-for-biopharma-from-a-healthcare-ai-pioneer/cutler/2023-07-31T23:18:08+00:00https://timmermanreport.com/wp-content/uploads/2023/07/cutler.pnghttps://timmermanreport.com/2023/08/kyverna-tacks-on-60m-to-take-car-t-for-autoimmunity-further-in-the-clinic/peter-magg\_1x1-504x500/2023-08-03T00:05:57+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Peter-Magg\_1x1-504x500-1.jpghttps://timmermanreport.com/2023/08/revolution-absorbs-eqrx-pfizer-itches-to-close-seagen-boundless-preps-for-ipo/jr\_headshot\_preferred\_cropped/2023-08-04T03:43:27+00:00https://timmermanreport.com/wp-content/uploads/2023/08/JR\_Headshot\_preferred\_CROPPED.jpghttps://timmermanreport.com/2023/08/revolution-absorbs-eqrx-pfizer-itches-to-close-seagen-boundless-preps-for-ipo/20230808-jeanne-marrazzo/2023-08-04T03:44:10+00:00https://timmermanreport.com/wp-content/uploads/2023/08/20230808-jeanne-marrazzo.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/colin/2023-08-08T20:46:18+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Colin.pnghttps://timmermanreport.com/2023/08/challenges-of-adopting-data-science-ai-in-pharma-biotech/satya/2023-08-09T22:08:03+00:00https://timmermanreport.com/wp-content/uploads/2023/08/satya.pnghttps://timmermanreport.com/2023/08/sage-gets-fda-ok-for-ppd-wegovys-home-run-regeneron-ventures-into-gene-therapy/sen/2023-08-11T01:23:19+00:00https://timmermanreport.com/wp-content/uploads/2023/08/sen.jpghttps://timmermanreport.com/2023/08/sage-gets-fda-ok-for-ppd-wegovys-home-run-regeneron-ventures-into-gene-therapy/sean-mcclain/2023-08-11T01:25:44+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Sean-McClain.pnghttps://timmermanreport.com/2023/08/sage-gets-fda-ok-for-ppd-wegovys-home-run-regeneron-ventures-into-gene-therapy/hastings-2/2023-08-11T01:27:01+00:00https://timmermanreport.com/wp-content/uploads/2023/08/hastings.pnghttps://timmermanreport.com/2023/08/gilead-bets-on-multi-functional-proteins-taysha-revived-google-spotlights-illumina-rival/yvonne-necklace-use-this-300x300/2023-08-18T00:06:31+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Yvonne-Necklace-USE-THIS-300x300-1.pnghttps://timmermanreport.com/2023/08/how-living-medicine-came-to-be-fred-appelbaum-on-the-long-run/fred-appelbaum/2023-08-18T15:55:32+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Fred-Appelbaum.jpghttps://timmermanreport.com/2023/08/rapports-150m-advance-regenerons-new-covid-challenge-and-a-traverse-for-the-ages/abe/2023-08-24T22:30:27+00:00https://timmermanreport.com/wp-content/uploads/2023/08/abe.pnghttps://timmermanreport.com/2023/08/rapports-150m-advance-regenerons-new-covid-challenge-and-a-traverse-for-the-ages/ajax\_therapeutics\_cmo\_david\_steensma\_md\_facp/2023-08-24T22:32:09+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Ajax\_Therapeutics\_CMO\_David\_Steensma\_MD\_FACP.jpghttps://timmermanreport.com/2023/08/rapports-150m-advance-regenerons-new-covid-challenge-and-a-traverse-for-the-ages/christina-yi-2023/2023-08-24T22:33:04+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Christina-Yi-2023.jpghttps://timmermanreport.com/2023/08/rapports-150m-advance-regenerons-new-covid-challenge-and-a-traverse-for-the-ages/screenshot-2023-08-24-144726/2023-08-24T22:34:14+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Screenshot-2023-08-24-144726.pnghttps://timmermanreport.com/the-long-run/elligo\_logo\_screen/2023-08-30T21:35:45+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Elligo\_Logo\_Screen.jpghttps://timmermanreport.com/the-long-run/bif23/2023-08-30T21:36:15+00:00https://timmermanreport.com/wp-content/uploads/2023/08/bif23.jpghttps://timmermanreport.com/2023/09/freeing-the-biotech-founders-zach-weinberg-and-alexis-borisy-on-the-long-run/alexis-borisy/2023-08-30T22:07:43+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Alexis-Borisy.jpghttps://timmermanreport.com/2023/09/freeing-the-biotech-founders-zach-weinberg-and-alexis-borisy-on-the-long-run/elligo\_logo\_screen-2/2023-08-30T22:08:46+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Elligo\_Logo\_Screen-1.jpghttps://timmermanreport.com/2023/09/freeing-the-biotech-founders-zach-weinberg-and-alexis-borisy-on-the-long-run/230112-bio-bif-logo-color-horiz-date-loc/2023-08-30T22:12:43+00:00https://timmermanreport.com/wp-content/uploads/2023/08/230112-bio-bif-logo-color-horiz-date-loc.jpghttps://timmermanreport.com/tr-advisory-board/rob-perez/2023-08-30T22:16:11+00:00https://timmermanreport.com/wp-content/uploads/2022/10/rob-perez.pnghttps://timmermanreport.com/2023/10/catching-cancer-early-investing-in-data-and-ai-jeff-huber-on-the-long-run/jhuber-round/2023-08-30T22:29:29+00:00https://timmermanreport.com/wp-content/uploads/2023/08/jhuber-round.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2023/wash23/2023-08-31T15:56:31+00:00https://timmermanreport.com/wp-content/uploads/2023/08/wash23.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/madisonhut-2/2023-08-31T16:28:39+00:00https://timmermanreport.com/wp-content/uploads/2023/08/madisonhut.pnghttps://timmermanreport.com/2023/08/danaher-wins-over-abcam-sage-cuts-ftc-ceases-fire-with-amgen/jcg-headshot-1/2023-08-31T21:17:29+00:00https://timmermanreport.com/wp-content/uploads/2023/08/JCG-headshot-1.jpghttps://timmermanreport.com/2023/08/danaher-wins-over-abcam-sage-cuts-ftc-ceases-fire-with-amgen/hunter\_s-\_thompson\_las\_vegas\_1971/2023-08-31T21:26:19+00:00https://timmermanreport.com/wp-content/uploads/2023/08/Hunter\_S.\_Thompson\_Las\_Vegas\_1971.jpghttps://timmermanreport.com/2023/09/a-return-to-kilimanjaro-in-2024-timmerman-traverse-for-damon-runyon-cancer-research/shiracamp\_jpg-1693325156\_large/2023-09-02T04:43:51+00:00https://timmermanreport.com/wp-content/uploads/2023/09/shiracamp\_jpg-1693325156\_large.jpghttps://timmermanreport.com/2023/09/a-return-to-kilimanjaro-in-2024-timmerman-traverse-for-damon-runyon-cancer-research/ppdbiotech/2023-09-02T04:59:58+00:00https://timmermanreport.com/wp-content/uploads/2023/09/ppdbiotech.jpghttps://timmermanreport.com/2023/09/a-return-to-kilimanjaro-in-2024-timmerman-traverse-for-damon-runyon-cancer-research/ppd-part-of-tfs-01/2023-09-03T20:41:31+00:00https://timmermanreport.com/wp-content/uploads/2023/09/PPD-Part-of-TFS-01.pnghttps://timmermanreport.com/2023/09/a-return-to-kilimanjaro-in-2024-timmerman-traverse-for-damon-runyon-cancer-research/biotech-font-treatment-2023/2023-09-03T20:42:14+00:00https://timmermanreport.com/wp-content/uploads/2023/09/Biotech-Font-Treatment-2023.pnghttps://timmermanreport.com/2023/09/a-return-to-kilimanjaro-in-2024-timmerman-traverse-for-damon-runyon-cancer-research/thermo-fisher-scientific/2023-09-03T20:42:16+00:00https://timmermanreport.com/wp-content/uploads/2023/09/Thermo-Fisher-Scientific.pnghttps://timmermanreport.com/2023/05/biopharma-innovation-beyond-the-breathless-headlines/skovronsky/2023-09-11T13:07:01+00:00https://timmermanreport.com/wp-content/uploads/2023/05/skovronsky.jpghttps://timmermanreport.com/2023/10/an-mrna-nobel-lilly-acquires-point-and-investment-in-singapore/isaacson/2023-10-06T01:16:25+00:00https://timmermanreport.com/wp-content/uploads/2023/10/isaacson.pnghttps://timmermanreport.com/2023/10/aiolos-bio-with-245m-from-atlas-bain-aims-at-tslp-for-asthma/anthony-adamis/2023-10-23T23:22:31+00:00https://timmermanreport.com/wp-content/uploads/2023/10/Anthony-Adamis.jpghttps://timmermanreport.com/2017/06/asco-notebook-observations-cancer-rd-foundation-medicine-halozyme-blueprint-nektar/jeffalbers/2023-10-27T00:27:02+00:00https://timmermanreport.com/wp-content/uploads/2017/06/jeffalbers.jpghttps://timmermanreport.com/2023/10/how-the-unmet-needs-of-patients-made-me-a-grounded-biotechno-optimist/shaywitzoncharles/2023-10-28T23:29:45+00:00https://timmermanreport.com/wp-content/uploads/2023/10/shaywitzoncharles.jpghttps://timmermanreport.com/2023/10/how-the-unmet-needs-of-patients-made-me-a-grounded-biotechno-optimist/charlesmgh/2023-10-28T23:30:47+00:00https://timmermanreport.com/wp-content/uploads/2023/10/charlesmgh.jpghttps://timmermanreport.com/2023/10/how-the-unmet-needs-of-patients-made-me-a-grounded-biotechno-optimist/olga/2023-10-28T23:32:28+00:00https://timmermanreport.com/wp-content/uploads/2023/10/olga.jpghttps://timmermanreport.com/2023/10/how-the-unmet-needs-of-patients-made-me-a-grounded-biotechno-optimist/aihard/2023-10-28T23:33:23+00:00https://timmermanreport.com/wp-content/uploads/2023/10/aihard.pnghttps://timmermanreport.com/2023/10/how-the-unmet-needs-of-patients-made-me-a-grounded-biotechno-optimist/ghodsi/2023-10-28T23:35:39+00:00https://timmermanreport.com/wp-content/uploads/2023/10/ghodsi.jpghttps://timmermanreport.com/2023/11/gate-bioscience-backed-by-versant-a16z-arch-gets-60m-to-block-protein-secretion/jordi/2023-10-31T22:44:01+00:00https://timmermanreport.com/wp-content/uploads/2023/10/jordi.jpghttps://timmermanreport.com/2023/11/gate-bioscience-backed-by-versant-a16z-arch-gets-60m-to-block-protein-secretion/tomdaniel/2023-10-31T22:47:11+00:00https://timmermanreport.com/wp-content/uploads/2023/10/tomdaniel.pnghttps://timmermanreport.com/2023/11/lilly-doubles-down-on-base-editing-biomarin-ceo-exits-and-layoffs-mount/jean-jacques-bienaime/2023-11-02T23:27:09+00:00https://timmermanreport.com/wp-content/uploads/2023/11/jean-jacques-bienaime.jpghttps://timmermanreport.com/2022/02/rethinking-the-cell-therapy-business-derrell-porter-of-cellevolve-on-the-long-run/derrell-2/2023-11-02T23:28:03+00:00https://timmermanreport.com/wp-content/uploads/2022/02/derrell.jpeghttps://timmermanreport.com/2023/11/profoundbio-challenging-immunogen-delivers-responses-in-first-clinical-trial/naomi-1/2023-11-03T02:15:01+00:00https://timmermanreport.com/wp-content/uploads/2023/11/Naomi-1.jpghttps://timmermanreport.com/2023/11/profoundbio-challenging-immunogen-delivers-responses-in-first-clinical-trial/tae/2023-11-03T02:15:44+00:00https://timmermanreport.com/wp-content/uploads/2023/11/tae.jpghttps://timmermanreport.com/2023/11/think-clinical-trials-are-working-ok-ask-a-cancer-patient/bess/2023-11-06T22:03:56+00:00https://timmermanreport.com/wp-content/uploads/2023/11/bess.pnghttps://timmermanreport.com/2023/11/kynexis-gets-e57m-to-pursue-new-treatment-pathway-for-schizophrenia/kees/2023-11-07T02:47:49+00:00https://timmermanreport.com/wp-content/uploads/2023/11/kees.jpghttps://timmermanreport.com/2023/11/architects-and-gardeners-a-captivating-development-biology-book-an-inspiring-immigrant-story/iman\_abuzeid-192x192/2023-11-09T02:10:22+00:00https://timmermanreport.com/wp-content/uploads/2023/11/iman\_abuzeid-192x192-1.pnghttps://timmermanreport.com/2023/11/architects-and-gardeners-a-captivating-development-biology-book-an-inspiring-immigrant-story/stan6318/2023-11-09T02:16:49+00:00https://timmermanreport.com/wp-content/uploads/2023/11/stan6318.jpghttps://timmermanreport.com/2023/11/architects-and-gardeners-a-captivating-development-biology-book-an-inspiring-immigrant-story/fei-fei-li\_profilephoto/2023-11-09T02:20:38+00:00https://timmermanreport.com/wp-content/uploads/2023/11/fei-fei-li\_profilephoto.jpghttps://timmermanreport.com/2023/11/vor-bio-shows-crisprd-stem-cell-transplants-take-hold-in-aml-patients-enable-adcs/rang/2023-11-09T20:14:46+00:00https://timmermanreport.com/wp-content/uploads/2023/11/rang.pnghttps://timmermanreport.com/2023/11/obesity-drug-rivalry-intensifies-takedas-big-fda-week-vor-takes-on-aml/matt-tremblay-bricks/2023-11-10T02:36:01+00:00https://timmermanreport.com/wp-content/uploads/2023/11/matt-tremblay-bricks.jpghttps://timmermanreport.com/community-action/damonrunyon/2023-11-10T22:48:34+00:00https://timmermanreport.com/wp-content/uploads/2023/11/DamonRunyon.jpghttps://timmermanreport.com/2023/11/leading-the-fight-against-infectious-disease-diana-brainard-on-the-long-run/diana/2023-11-13T23:54:31+00:00https://timmermanreport.com/wp-content/uploads/2023/11/diana.pnghttps://timmermanreport.com/2023/11/uk-clears-1st-crispr-drug-lillys-sirna-for-cv-disease-blackstones-anti-clotting-win/vince\_lombardi\_1913-1970\_in\_1964/2023-11-17T01:19:45+00:00https://timmermanreport.com/wp-content/uploads/2023/11/Vince\_Lombardi\_1913-1970\_in\_1964.jpghttps://timmermanreport.com/2023/11/uk-clears-1st-crispr-drug-lillys-sirna-for-cv-disease-blackstones-anti-clotting-win/kathyb\_headshot/2023-11-17T01:21:18+00:00https://timmermanreport.com/wp-content/uploads/2023/11/KathyB\_headshot.jpghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/neilk/2023-11-17T01:23:51+00:00https://timmermanreport.com/wp-content/uploads/2021/05/neilk.pnghttps://timmermanreport.com/2023/11/the-final-frontier-of-brain-science-nancy-stagliano-on-the-long-run/nancystagliano/2023-11-29T22:50:48+00:00https://timmermanreport.com/wp-content/uploads/2023/11/nancystagliano.pnghttps://timmermanreport.com/2023/11/immunogens-payday-fda-jolts-car-t-field-another-dupixent-win/screenshot-2023-11-30-142632/2023-12-01T00:04:22+00:00https://timmermanreport.com/wp-content/uploads/2023/11/Screenshot-2023-11-30-142632.pnghttps://timmermanreport.com/2023/11/immunogens-payday-fda-jolts-car-t-field-another-dupixent-win/screenshot-2023-11-30-160613/2023-12-01T00:06:39+00:00https://timmermanreport.com/wp-content/uploads/2023/11/Screenshot-2023-11-30-160613.pnghttps://timmermanreport.com/2023/08/challenges-of-adopting-data-science-ai-in-pharma-biotech/allgood1/2023-12-01T02:11:31+00:00https://timmermanreport.com/wp-content/uploads/2023/08/allgood1.jpghttps://timmermanreport.com/2023/12/join-me-and-a-terrific-lineup-for-bridging-the-gap-jan-23-in-cambridge-mass/timmerman\_traverse\_logo\_color\_cmyk/2023-12-03T15:59:25+00:00https://timmermanreport.com/wp-content/uploads/2023/12/Timmerman\_Traverse\_LOGO\_COLOR\_CMYK.pnghttps://timmermanreport.com/2023/12/join-me-and-a-terrific-lineup-for-bridging-the-gap-jan-23-in-cambridge-mass/shiracamp\_jpg-1693325156\_large-2/2023-12-03T16:01:04+00:00https://timmermanreport.com/wp-content/uploads/2023/12/shiracamp\_jpg-1693325156\_large.jpghttps://timmermanreport.com/2023/12/join-me-and-a-terrific-lineup-for-bridging-the-gap-jan-23-in-cambridge-mass/bridginggapbanner/2023-12-03T23:26:10+00:00https://timmermanreport.com/wp-content/uploads/2023/12/BridgingGapBanner.pnghttps://timmermanreport.com/2023/12/join-me-and-a-terrific-lineup-for-bridging-the-gap-jan-23-in-cambridge-mass/bridging-the-gap-event-speakers-only1/2023-12-03T23:34:16+00:00https://timmermanreport.com/wp-content/uploads/2023/12/Bridging-the-Gap-event-Speakers-Only1.jpghttps://timmermanreport.com/2023/12/join-me-and-a-terrific-lineup-for-bridging-the-gap-jan-23-in-cambridge-mass/dna\_strands\_1\_jpg-1701371289\_large/2023-12-03T23:43:34+00:00https://timmermanreport.com/wp-content/uploads/2023/12/dna\_strands\_1\_jpg-1701371289\_large.jpghttps://timmermanreport.com/2023/12/join-me-and-a-terrific-lineup-for-bridging-the-gap-jan-23-in-cambridge-mass/screenshot-2023-12-03-174634/2023-12-04T01:47:32+00:00https://timmermanreport.com/wp-content/uploads/2023/12/Screenshot-2023-12-03-174634.pnghttps://timmermanreport.com/2023/12/abbvie-buys-cerevel-roche-buys-carmot-crowley-steps-into-the-lions-den/marchin/2023-12-08T02:00:10+00:00https://timmermanreport.com/wp-content/uploads/2023/12/marchin.pnghttps://timmermanreport.com/2023/12/abbvie-buys-cerevel-roche-buys-carmot-crowley-steps-into-the-lions-den/cerevel/2023-12-08T02:00:38+00:00https://timmermanreport.com/wp-content/uploads/2023/12/cerevel.pnghttps://timmermanreport.com/2023/12/11-strategies-for-motivating-and-holding-a-biotech-team-together-for-a-long-time/angelos-photo-8/2023-12-09T00:28:24+00:00https://timmermanreport.com/wp-content/uploads/2023/12/Angelos-photo-8.jpghttps://timmermanreport.com/2019/04/ifm-nails-second-big-deal-selling-nlrp3-inhibitors-to-novartis-for-310m-upfront/mar-07-2018-genzyme-cancer-summit-0046/2023-12-15T01:53:27+00:00https://timmermanreport.com/wp-content/uploads/2019/03/Mar-07-2018-Genzyme-Cancer-Summit-0046.jpghttps://timmermanreport.com/2023/12/pfizer-closes-seagen-a-historic-crispr-approval-ftc-takes-shot-at-sanofi/bourlaseagen/2023-12-15T01:54:47+00:00https://timmermanreport.com/wp-content/uploads/2023/12/bourlaseagen.pnghttps://timmermanreport.com/2023/12/pfizer-closes-seagen-a-historic-crispr-approval-ftc-takes-shot-at-sanofi/ashley-magargee\_headshot\_1200x1800/2023-12-15T01:58:07+00:00https://timmermanreport.com/wp-content/uploads/2023/12/Ashley-Magargee\_Headshot\_1200x1800.jpghttps://timmermanreport.com/2018/09/health-data-that-can-meet-pharma-standards-amy-abernethy-on-the-long-run/amy-headshot\_2018/2023-12-21T18:28:42+00:00https://timmermanreport.com/wp-content/uploads/2018/09/Amy-headshot\_2018.jpghttps://timmermanreport.com/2023/12/bispecific-antibodies-for-cancer-shelley-force-aldred-and-nathan-trinklein-on-the-long-run/2024-bridging-the-gap-updated12-19-23-1/2023-12-25T18:28:11+00:00https://timmermanreport.com/wp-content/uploads/2023/12/2024-Bridging-the-Gap.Updated12.19.23.1.jpghttps://timmermanreport.com/2023/12/give-to-the-next-generation-of-scientists/ttdrcrstacked/2023-12-26T16:46:17+00:00https://timmermanreport.com/wp-content/uploads/2023/12/TTDRCRstacked.pnghttps://timmermanreport.com/2023/12/give-to-the-next-generation-of-scientists/ttdrcrstacked-2/2023-12-26T16:47:27+00:00https://timmermanreport.com/wp-content/uploads/2023/12/TTDRCRstacked-1.pnghttps://timmermanreport.com/2024/01/rebooting-ai-in-drug-discovery-on-the-slope-of-enlightenment/steiner/2024-01-01T21:22:59+00:00https://timmermanreport.com/wp-content/uploads/2024/01/steiner.jpghttps://timmermanreport.com/2019/12/biotechs-build-on-single-cell-analytics-for-drug-rd-as-human-cell-atlas-is-mapped/avivregev/2024-01-01T21:35:23+00:00https://timmermanreport.com/wp-content/uploads/2019/12/AvivRegev.jpghttps://timmermanreport.com/2024/01/moma-gets-roche-deal-66m-upfront-to-discover-novel-small-molecule-cancer-drugs/asit-parikh/2024-01-04T00:27:58+00:00https://timmermanreport.com/wp-content/uploads/2024/01/Asit-Parikh.jpghttps://timmermanreport.com/2024/01/moma-gets-roche-deal-66m-upfront-to-discover-novel-small-molecule-cancer-drugs/221109\_moma\_peterhammerman\_hires-9911/2024-01-04T00:28:39+00:00https://timmermanreport.com/wp-content/uploads/2024/01/221109\_MOMA\_PeterHammerman\_HiRes-9911.jpghttps://timmermanreport.com/2017/10/alzheimers-rd-go-now-plenty-directions/steven-paul-1/2024-01-05T03:08:18+00:00https://timmermanreport.com/wp-content/uploads/2017/10/Steven-Paul-1.jpghttps://timmermanreport.com/2024/01/karuna-and-rayzebio-acquired-tcgxs-1b-crossover-bet-cytokinetics-breakout-moment/chen-yu-resize-500x500/2024-01-05T03:09:59+00:00https://timmermanreport.com/wp-content/uploads/2024/01/Chen-Yu-resize-500x500-1.jpghttps://timmermanreport.com/2024/01/karuna-and-rayzebio-acquired-tcgxs-1b-crossover-bet-cytokinetics-breakout-moment/draetta/2024-01-05T03:11:14+00:00https://timmermanreport.com/wp-content/uploads/2024/01/Draetta.pnghttps://timmermanreport.com/2021/12/apollo-health-ventures-gets-180m-to-invest-in-extending-human-healthspan/jenseckstein/2024-01-08T01:49:03+00:00https://timmermanreport.com/wp-content/uploads/2021/11/jenseckstein.jpghttps://timmermanreport.com/2020/07/simcha-therapeutics-locks-in-25-million-in-series-a-renews-interest-in-il-18/aring-hs/2024-01-12T01:17:21+00:00https://timmermanreport.com/wp-content/uploads/2020/07/ARing-HS.pnghttps://timmermanreport.com/2015/02/third-rocks-obesity-hopeful-ember-therapeutics-closes/kstarr/2024-01-12T01:18:11+00:00https://timmermanreport.com/wp-content/uploads/2015/02/kstarr.pnghttps://timmermanreport.com/2024/01/one-thing-is-harder-to-get-from-investors-than-money-candid-feedback/bernat-4/2024-01-16T21:05:54+00:00https://timmermanreport.com/wp-content/uploads/2024/01/bernat.jpghttps://timmermanreport.com/2024/01/one-thing-is-harder-to-get-from-investors-than-money-candid-feedback/330px-jackwelchapril2012/2024-01-16T21:15:18+00:00https://timmermanreport.com/wp-content/uploads/2024/01/330px-JackWelchApril2012.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/beam-terry-ann-burrell/2024-01-18T22:26:42+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Beam-Terry-Ann-Burrell.jpghttps://timmermanreport.com/2024/01/arena-debuts-with-a-bang-vertex-extends-crispr-bridgebio-builds-war-chest/nina/2024-01-19T02:23:12+00:00https://timmermanreport.com/wp-content/uploads/2024/01/nina.jpghttps://timmermanreport.com/2024/01/gene-expression-in-therapeutic-rd-rick-young-on-the-long-run/screenshot-2024-01-22-062657/2024-01-22T14:28:07+00:00https://timmermanreport.com/wp-content/uploads/2024/01/Screenshot-2024-01-22-062657.pnghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/arthur\_kuan\_popup\_profile/2024-01-26T00:01:03+00:00https://timmermanreport.com/wp-content/uploads/2024/01/arthur\_kuan\_popup\_profile.pnghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/thilo-2/2024-01-26T00:02:26+00:00https://timmermanreport.com/wp-content/uploads/2024/01/thilo.pnghttps://timmermanreport.com/2019/12/sticking-with-epigenetics-during-lean-times-jigar-raythatha-on-the-long-run/jigar/2024-01-26T00:02:55+00:00https://timmermanreport.com/wp-content/uploads/2019/12/Jigar.jpghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/seemi/2024-01-26T00:05:35+00:00https://timmermanreport.com/wp-content/uploads/2024/01/seemi.jpghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/bruce-3/2024-01-26T00:08:26+00:00https://timmermanreport.com/wp-content/uploads/2024/01/bruce.pnghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/screenshot-2024-01-24-131644/2024-01-26T00:09:54+00:00https://timmermanreport.com/wp-content/uploads/2024/01/Screenshot-2024-01-24-131644.pnghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/keynotes/2024-01-26T00:15:46+00:00https://timmermanreport.com/wp-content/uploads/2024/01/keynotes.jpghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/kilidrcrteam2024/2024-01-26T00:17:12+00:00https://timmermanreport.com/wp-content/uploads/2024/01/KiliDRCRteam2024.jpghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/biotechwomen/2024-01-26T00:25:01+00:00https://timmermanreport.com/wp-content/uploads/2024/01/biotechwomen.jpghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/closers/2024-01-26T00:25:05+00:00https://timmermanreport.com/wp-content/uploads/2024/01/closers.jpghttps://timmermanreport.com/2024/01/sanofi-shells-out-for-inhibrx-cg-oncologys-breakout-a-cure-for-a-rare-deafness/crowd/2024-01-26T00:25:07+00:00https://timmermanreport.com/wp-content/uploads/2024/01/crowd.jpghttps://timmermanreport.com/2024/02/botox-a-luminous-example-of-field-discovery/jeancarruthers/2024-01-30T22:30:00+00:00https://timmermanreport.com/wp-content/uploads/2024/01/jeancarruthers.jpghttps://timmermanreport.com/2024/02/vertexs-next-big-thing-regenerons-cell-therapy-play-takeda-bets-on-protagonist/vineeta/2024-02-02T04:04:01+00:00https://timmermanreport.com/wp-content/uploads/2024/02/vineeta.pnghttps://timmermanreport.com/2020/11/creating-the-future-of-microbiome-based-therapies-simba-gill-on-the-long-run/simba-gill-2/2024-02-02T04:09:15+00:00https://timmermanreport.com/wp-content/uploads/2020/11/Simba-Gill.jpghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/reshma/2024-02-02T04:11:39+00:00https://timmermanreport.com/wp-content/uploads/2021/05/reshma.pnghttps://timmermanreport.com/2024/02/scion-starts-with-310m-to-build-exceptional-biotech-startups/swh\_scion-headshot/2024-02-06T20:27:18+00:00https://timmermanreport.com/wp-content/uploads/2024/02/SWH\_Scion-Headshot.jpghttps://timmermanreport.com/2024/02/scion-starts-with-310m-to-build-exceptional-biotech-startups/amk\_scion-headshot1/2024-02-06T20:27:53+00:00https://timmermanreport.com/wp-content/uploads/2024/02/AMK\_Scion-Headshot1.jpghttps://timmermanreport.com/2024/02/scion-starts-with-310m-to-build-exceptional-biotech-startups/tw\_scion/2024-02-06T21:26:43+00:00https://timmermanreport.com/wp-content/uploads/2024/02/TW\_Scion.jpghttps://timmermanreport.com/2024/02/new-medical-podcast-like-winter-and-the-2024-red-sox-offers-bleak-outlook-while-four-books-instill-hope/lisar/2024-02-17T13:38:31+00:00https://timmermanreport.com/wp-content/uploads/2024/02/lisar.jpghttps://timmermanreport.com/2024/02/new-medical-podcast-like-winter-and-the-2024-red-sox-offers-bleak-outlook-while-four-books-instill-hope/am/2024-02-17T13:43:46+00:00https://timmermanreport.com/wp-content/uploads/2024/02/AM.jpghttps://timmermanreport.com/2024/02/new-medical-podcast-like-winter-and-the-2024-red-sox-offers-bleak-outlook-while-four-books-instill-hope/venki\_ramakrishnan\_cropped/2024-02-17T13:45:14+00:00https://timmermanreport.com/wp-content/uploads/2024/02/Venki\_Ramakrishnan\_cropped.jpghttps://timmermanreport.com/2024/02/new-medical-podcast-like-winter-and-the-2024-red-sox-offers-bleak-outlook-while-four-books-instill-hope/screenshot-2024-02-17-054730/2024-02-17T13:48:38+00:00https://timmermanreport.com/wp-content/uploads/2024/02/Screenshot-2024-02-17-054730.pnghttps://timmermanreport.com/2024/02/joy-gratitude-and-next-steps-for-timmerman-traverse/shiracamp2024/2024-02-19T08:57:47+00:00https://timmermanreport.com/wp-content/uploads/2024/02/ShiraCamp2024.jpghttps://timmermanreport.com/2024/02/joy-gratitude-and-next-steps-for-timmerman-traverse/ttdrsummitshot/2024-02-19T09:05:23+00:00https://timmermanreport.com/wp-content/uploads/2024/02/TTDRsummitshot.pnghttps://timmermanreport.com/2024/02/joy-gratitude-and-next-steps-for-timmerman-traverse/sickleforward/2024-02-19T09:18:14+00:00https://timmermanreport.com/wp-content/uploads/2024/02/SickleForward.pnghttps://timmermanreport.com/2024/02/timmerman-traverse-for-damon-runyon-kilimanjaro-2024-photo-gallery/img\_5751/2024-02-19T10:15:51+00:00https://timmermanreport.com/wp-content/uploads/2024/02/IMG\_5751.jpghttps://timmermanreport.com/2016/01/big-pharma-may-be-a-dinosaur-but-it-can-move-fast-when-it-wants/avaishnaw/2024-03-07T23:07:03+00:00https://timmermanreport.com/wp-content/uploads/2016/01/avaishnaw.jpghttps://timmermanreport.com/2024/03/startups-challenge-vertex-bms-takeda-the-weight-loss-drug-revival-continues/teri/2024-03-07T23:10:00+00:00https://timmermanreport.com/wp-content/uploads/2024/03/teri.pnghttps://timmermanreport.com/2024/03/startups-challenge-vertex-bms-takeda-the-weight-loss-drug-revival-continues/scott-myers-1280x720/2024-03-07T23:11:11+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Scott-Myers-1280x720-1.jpghttps://timmermanreport.com/2024/03/startups-challenge-vertex-bms-takeda-the-weight-loss-drug-revival-continues/jeancui/2024-03-07T23:13:51+00:00https://timmermanreport.com/wp-content/uploads/2024/03/jeancui.pnghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/nwankwo/2024-03-07T23:14:25+00:00https://timmermanreport.com/wp-content/uploads/2021/06/nwankwo.pnghttps://timmermanreport.com/2018/06/bio18-reflections-axovant-and-ophthotech-reboot-with-gene-therapy-more/sibold/2024-03-14T22:34:07+00:00https://timmermanreport.com/wp-content/uploads/2018/06/sibold.jpghttps://timmermanreport.com/2024/03/madrigals-historic-first-for-mash-ifms-hat-trick-bio-on-election-defense/marcela/2024-03-14T22:37:55+00:00https://timmermanreport.com/wp-content/uploads/2024/03/marcela.jpghttps://timmermanreport.com/2024/03/madrigals-historic-first-for-mash-ifms-hat-trick-bio-on-election-defense/enoch-2/2024-03-14T22:39:37+00:00https://timmermanreport.com/wp-content/uploads/2024/03/enoch.pnghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/nolan/2024-03-14T22:40:24+00:00https://timmermanreport.com/wp-content/uploads/2021/06/nolan.jpghttps://timmermanreport.com/2024/03/madrigals-historic-first-for-mash-ifms-hat-trick-bio-on-election-defense/jullianjones/2024-03-14T22:50:44+00:00https://timmermanreport.com/wp-content/uploads/2024/03/JullianJones.jpghttps://timmermanreport.com/2024/03/clasp-backed-by-catalio-third-rock-novo-gets-150m-for-specific-t-cell-engagers/robross/2024-03-20T01:26:48+00:00https://timmermanreport.com/wp-content/uploads/2024/03/robross.jpghttps://timmermanreport.com/2024/03/clasp-backed-by-catalio-third-rock-novo-gets-150m-for-specific-t-cell-engagers/andrea/2024-03-20T01:31:48+00:00https://timmermanreport.com/wp-content/uploads/2024/03/andrea.pnghttps://timmermanreport.com/life-science-cares-2024/timmerman-traverse-for-life-science-cares-2024/2024-03-24T17:46:33+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Timmerman-Traverse-for-Life-Science-Cares-2024.jpghttps://timmermanreport.com/life-science-cares-2024/timmerman-traverse-for-life-science-cares-2024-2/2024-03-24T18:02:05+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Timmerman-Traverse-for-Life-Science-Cares-2024-1.jpghttps://timmermanreport.com/sickle-forward-2024/screenshot-2024-03-24-at-2-28-04%e2%80%afpm/2024-03-24T18:28:26+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Screenshot-2024-03-24-at-2.28.04%E2%80%AFPM.pnghttps://timmermanreport.com/sickle-forward-2024/summit-feb-2024/2024-03-24T18:33:56+00:00https://timmermanreport.com/wp-content/uploads/2024/03/summit-feb-2024.pnghttps://timmermanreport.com/sickle-forward-2024/summit-feb-2024-2/2024-03-24T18:34:51+00:00https://timmermanreport.com/wp-content/uploads/2024/03/summit-feb-2024.jpghttps://timmermanreport.com/sickle-forward-2024/nina-kjellson-3/2024-03-24T18:36:06+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Nina-Kjellson.pnghttps://timmermanreport.com/sickle-forward-2024/screenshot-2024-03-24-at-2-37-03%e2%80%afpm/2024-03-24T18:43:54+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Screenshot-2024-03-24-at-2.37.03%E2%80%AFPM.pnghttps://timmermanreport.com/sickle-forward-2024/screenshot-2024-03-24-at-2-37-08%e2%80%afpm/2024-03-24T18:44:23+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Screenshot-2024-03-24-at-2.37.08%E2%80%AFPM.pnghttps://timmermanreport.com/sickle-forward-2024/screenshot-2024-03-24-at-2-37-14%e2%80%afpm/2024-03-24T18:45:06+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Screenshot-2024-03-24-at-2.37.14%E2%80%AFPM.pnghttps://timmermanreport.com/sickle-forward-2024/screenshot-2024-03-24-at-2-56-15%e2%80%afpm/2024-03-24T18:56:34+00:00https://timmermanreport.com/wp-content/uploads/2024/03/Screenshot-2024-03-24-at-2.56.15%E2%80%AFPM.pnghttps://timmermanreport.com/sickle-forward-2024/kilimanjaro/2024-03-24T19:03:15+00:00https://timmermanreport.com/wp-content/uploads/2024/03/kilimanjaro.jpghttps://timmermanreport.com/2022/06/daiichis-game-changer-resiliences-big-week-and-the-ftc-scrutinizes-pbms/athena/2024-03-29T00:12:45+00:00https://timmermanreport.com/wp-content/uploads/2022/06/athena.pnghttps://timmermanreport.com/2021/07/payers-revolt-against-biogens-aduhelm-fda-credibility-crisis-and-a-prime-financing/jodie/2024-03-29T00:13:26+00:00https://timmermanreport.com/wp-content/uploads/2021/07/jodie.jpghttps://timmermanreport.com/2024/03/boundless-ipo-mercks-acceleron-win-modernas-750m-flu-vaccine-boost/alam/2024-03-29T00:16:06+00:00https://timmermanreport.com/wp-content/uploads/2024/03/alam.pnghttps://timmermanreport.com/2024/03/boundless-ipo-mercks-acceleron-win-modernas-750m-flu-vaccine-boost/habib/2024-03-29T00:19:22+00:00https://timmermanreport.com/wp-content/uploads/2024/03/habib.pnghttps://timmermanreport.com/2024/03/boundless-ipo-mercks-acceleron-win-modernas-750m-flu-vaccine-boost/enyedy/2024-03-29T00:21:22+00:00https://timmermanreport.com/wp-content/uploads/2024/03/enyedy.pnghttps://timmermanreport.com/2024/03/boundless-ipo-mercks-acceleron-win-modernas-750m-flu-vaccine-boost/sujal/2024-03-29T00:22:40+00:00https://timmermanreport.com/wp-content/uploads/2024/03/sujal.jpghttps://timmermanreport.com/2024/03/boundless-ipo-mercks-acceleron-win-modernas-750m-flu-vaccine-boost/nicole/2024-03-29T00:46:04+00:00https://timmermanreport.com/wp-content/uploads/2024/03/nicole.pnghttps://timmermanreport.com/2024/04/can-bayer-ceo-liberate-pharma-from-stultifying-bureaucracy/anderson/2024-04-01T15:34:56+00:00https://timmermanreport.com/wp-content/uploads/2024/04/anderson.pnghttps://timmermanreport.com/2024/04/can-bayer-ceo-liberate-pharma-from-stultifying-bureaucracy/catmull/2024-04-01T15:37:34+00:00https://timmermanreport.com/wp-content/uploads/2024/04/catmull.pnghttps://timmermanreport.com/2024/04/how-cymabay-survived-a-safety-scare-and-bounced-back-with-an-acquisition-by-gilead/dylan/2024-04-03T20:38:50+00:00https://timmermanreport.com/wp-content/uploads/2024/04/dylan.jpghttps://timmermanreport.com/2024/03/boundless-ipo-mercks-acceleron-win-modernas-750m-flu-vaccine-boost/sujal1/2024-04-03T20:45:41+00:00https://timmermanreport.com/wp-content/uploads/2024/03/sujal1.pnghttps://timmermanreport.com/2024/04/how-cymabay-survived-a-safety-scare-and-bounced-back-with-an-acquisition-by-gilead/asish/2024-04-03T20:55:56+00:00https://timmermanreport.com/wp-content/uploads/2024/04/asish.jpghttps://timmermanreport.com/2024/04/a-profoundbio-windfall-amylyx-yanks-failed-als-drug-verves-rough-patch/lawrence\_vf/2024-04-05T00:26:25+00:00https://timmermanreport.com/wp-content/uploads/2024/04/Lawrence\_vF.pnghttps://timmermanreport.com/2024/04/a-profoundbio-windfall-amylyx-yanks-failed-als-drug-verves-rough-patch/eric\_3534\_sd-headshots\_forweb-1/2024-04-05T00:27:35+00:00https://timmermanreport.com/wp-content/uploads/2024/04/Eric\_3534\_SD-HEADSHOTS\_FORWEB-1.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/charlottehubbert-2/2024-04-05T00:28:06+00:00https://timmermanreport.com/wp-content/uploads/2015/02/charlottehubbert.jpghttps://timmermanreport.com/2024/04/a-profoundbio-windfall-amylyx-yanks-failed-als-drug-verves-rough-patch/julie/2024-04-05T00:28:52+00:00https://timmermanreport.com/wp-content/uploads/2024/04/julie.jpghttps://timmermanreport.com/2024/04/a-profoundbio-windfall-amylyx-yanks-failed-als-drug-verves-rough-patch/amylyxfounders/2024-04-05T00:30:38+00:00https://timmermanreport.com/wp-content/uploads/2024/04/amylyxfounders.pnghttps://timmermanreport.com/2024/04/meet-the-timmerman-traverse-for-life-science-cares-2024-team/ttlsc24banner/2024-04-07T18:37:18+00:00https://timmermanreport.com/wp-content/uploads/2024/04/TTLSC24banner.pnghttps://timmermanreport.com/2024/04/meet-the-timmerman-traverse-for-sickle-forward-team/scd1/2024-04-08T23:34:47+00:00https://timmermanreport.com/wp-content/uploads/2024/04/scd1.pnghttps://timmermanreport.com/2024/04/meet-the-timmerman-traverse-for-sickle-forward-team/ttsf24banner/2024-04-08T23:35:52+00:00https://timmermanreport.com/wp-content/uploads/2024/04/ttsf24banner.pnghttps://timmermanreport.com/2024/02/joy-gratitude-and-next-steps-for-timmerman-traverse/alananderson/2024-04-09T22:04:54+00:00https://timmermanreport.com/wp-content/uploads/2024/02/alananderson.pnghttps://timmermanreport.com/2021/05/spotting-trends-and-starting-edgy-companies-daphne-zohar-on-the-long-run/daphne/2024-04-12T00:05:42+00:00https://timmermanreport.com/wp-content/uploads/2021/05/daphne.pnghttps://timmermanreport.com/2024/04/vertex-antes-for-alpine-regeneron-faces-doj-illumina-shakeup-continues/bharatt/2024-04-12T00:11:21+00:00https://timmermanreport.com/wp-content/uploads/2024/04/bharatt.pnghttps://timmermanreport.com/2024/04/vertex-antes-for-alpine-regeneron-faces-doj-illumina-shakeup-continues/jacob-thayson/2024-04-12T00:12:44+00:00https://timmermanreport.com/wp-content/uploads/2024/04/jacob-thayson.jpghttps://timmermanreport.com/2024/04/vertex-antes-for-alpine-regeneron-faces-doj-illumina-shakeup-continues/houston-2/2024-04-12T00:16:59+00:00https://timmermanreport.com/wp-content/uploads/2024/04/houston.pnghttps://timmermanreport.com/2024/04/metsera-secures-290m-to-follow-fast-in-obesity-drug-rd/clive-2/2024-04-17T17:30:31+00:00https://timmermanreport.com/wp-content/uploads/2024/04/clive.jpghttps://timmermanreport.com/2024/04/wuxi-feels-heat-cerevel-hits-parkinsons-goal-more-glp-1-good-news/najat-khan-headshot-high-res/2024-04-18T23:41:19+00:00https://timmermanreport.com/wp-content/uploads/2024/04/najat-khan-headshot-high-res.jpghttps://timmermanreport.com/2024/04/wuxi-feels-heat-cerevel-hits-parkinsons-goal-more-glp-1-good-news/uwe/2024-04-18T23:43:25+00:00https://timmermanreport.com/wp-content/uploads/2024/04/uwe.pnghttps://timmermanreport.com/2024/04/wuxi-feels-heat-cerevel-hits-parkinsons-goal-more-glp-1-good-news/vineetalsinw/2024-04-18T23:45:42+00:00https://timmermanreport.com/wp-content/uploads/2024/04/vineetalsinw.pnghttps://timmermanreport.com/2016/02/drugmakers-are-lousy-at-communicating-heres-how-to-improve/ddunsire/2024-04-18T23:56:13+00:00https://timmermanreport.com/wp-content/uploads/2016/02/ddunsire.jpghttps://timmermanreport.com/2024/04/day-ones-home-run-big-pharmas-missed-opportunity-and-tessier-lavigne-rides-again/jeremy/2024-04-25T22:31:29+00:00https://timmermanreport.com/wp-content/uploads/2024/04/jeremy.pnghttps://timmermanreport.com/2024/04/day-ones-home-run-big-pharmas-missed-opportunity-and-tessier-lavigne-rides-again/grainger-3/2024-04-25T22:37:58+00:00https://timmermanreport.com/wp-content/uploads/2024/04/grainger.pnghttps://timmermanreport.com/2022/01/immpact-bio-with-bispecific-car-t-showing-durable-crs-raises-111m-series-b/sheila/2024-04-25T22:39:30+00:00https://timmermanreport.com/wp-content/uploads/2022/01/sheila.jpghttps://timmermanreport.com/2015/12/why-im-not-buying-any-consumer-genetic-tests-this-holiday-season/jstein/2024-04-25T22:40:33+00:00https://timmermanreport.com/wp-content/uploads/2015/12/jstein.pnghttps://timmermanreport.com/2024/04/day-ones-home-run-big-pharmas-missed-opportunity-and-tessier-lavigne-rides-again/bancel/2024-04-25T22:41:49+00:00https://timmermanreport.com/wp-content/uploads/2024/04/bancel.jpghttps://timmermanreport.com/2019/01/finding-a-way-in-genomic-diagnostics-bonnie-anderson-of-veracyte-on-the-long-run/bonnie\_cropped/2024-04-25T22:42:42+00:00https://timmermanreport.com/wp-content/uploads/2019/01/Bonnie\_Cropped-e1596736764296.jpghttps://timmermanreport.com/2024/04/day-ones-home-run-big-pharmas-missed-opportunity-and-tessier-lavigne-rides-again/katalink/2024-04-25T22:44:00+00:00https://timmermanreport.com/wp-content/uploads/2024/04/katalink.jpghttps://timmermanreport.com/2024/05/delphia-raises-67m-to-nudge-cancer-cells-beyond-the-red-line/kmarks/2024-05-01T18:24:11+00:00https://timmermanreport.com/wp-content/uploads/2024/05/kmarks.jpghttps://timmermanreport.com/2024/05/investing-in-biotech-healthcare-delivery-vineeta-agarwala-on-the-long-run/vineeta2024/2024-05-01T18:52:36+00:00https://timmermanreport.com/wp-content/uploads/2024/05/vineeta2024.pnghttps://timmermanreport.com/2024/05/novartis-doubles-down-on-radiopharma-gv-bets-on-activation-lethality-and-ftc-nastygrams/headshot-tom-dubensky-min/2024-05-02T23:11:01+00:00https://timmermanreport.com/wp-content/uploads/2024/05/headshot-Tom-Dubensky-min.jpghttps://timmermanreport.com/2024/05/success-in-film-and-pharma-contingent-but-not-random/jon\_favreau\_2016/2024-05-04T15:42:08+00:00https://timmermanreport.com/wp-content/uploads/2024/05/Jon\_Favreau\_2016.jpeghttps://timmermanreport.com/2024/05/reinventing-old-drugs-for-new-uses-with-ai/john-halamka-21690049/2024-05-04T19:24:30+00:00https://timmermanreport.com/wp-content/uploads/2024/05/John-Halamka-21690049.jpghttps://timmermanreport.com/2024/02/new-medical-podcast-like-winter-and-the-2024-red-sox-offers-bleak-outlook-while-four-books-instill-hope/fajg1468/2024-05-04T19:28:21+00:00https://timmermanreport.com/wp-content/uploads/2024/02/fajg1468.jpghttps://timmermanreport.com/2024/05/enduring-uncertainty-hoping-for-luck-touched-by-magic/800px-michael\_moritz\_2013/2024-05-08T22:51:00+00:00https://timmermanreport.com/wp-content/uploads/2024/05/800px-Michael\_Moritz\_2013.jpghttps://timmermanreport.com/2024/05/alphafold3-dazzles-regenerons-gene-therapy-for-deafness-pfizers-new-strategist/kosinski/2024-05-09T22:09:31+00:00https://timmermanreport.com/wp-content/uploads/2024/05/kosinski.pnghttps://timmermanreport.com/2024/05/alphafold3-dazzles-regenerons-gene-therapy-for-deafness-pfizers-new-strategist/faheem-hasnain-1/2024-05-09T22:21:48+00:00https://timmermanreport.com/wp-content/uploads/2024/05/faheem-hasnain-1.jpghttps://timmermanreport.com/2023/02/grand-defi-ou-goulot-detranglement-ultime-a-french-pharma-tackles-data-science/nestle/2024-05-09T22:22:20+00:00https://timmermanreport.com/wp-content/uploads/2023/02/nestle.jpghttps://timmermanreport.com/2024/05/alphafold3-dazzles-regenerons-gene-therapy-for-deafness-pfizers-new-strategist/kai/2024-05-09T22:23:46+00:00https://timmermanreport.com/wp-content/uploads/2024/05/kai.pnghttps://timmermanreport.com/2024/05/alphafold3-dazzles-regenerons-gene-therapy-for-deafness-pfizers-new-strategist/sickle/2024-05-09T22:26:00+00:00https://timmermanreport.com/wp-content/uploads/2024/05/sickle.pnghttps://timmermanreport.com/2024/05/heres-the-skinny-on-four-new-glp-1-podcasts/topolpodcast/2024-05-14T03:22:07+00:00https://timmermanreport.com/wp-content/uploads/2024/05/TopolPodcast.jpghttps://timmermanreport.com/2024/05/heres-the-skinny-on-four-new-glp-1-podcasts/bari/2024-05-14T03:23:50+00:00https://timmermanreport.com/wp-content/uploads/2024/05/bari.pnghttps://timmermanreport.com/2024/05/heres-the-skinny-on-four-new-glp-1-podcasts/lotte/2024-05-14T03:29:02+00:00https://timmermanreport.com/wp-content/uploads/2024/05/lotte.pnghttps://timmermanreport.com/2024/05/maze-bounces-back-tslp-investment-surges-biosecure-breather/quinn/2024-05-17T04:20:23+00:00https://timmermanreport.com/wp-content/uploads/2024/05/quinn.pnghttps://timmermanreport.com/2024/05/timmerman-traverse-eclipses-10m-to-tackle-cancer-poverty-and-sickle-cell-disease/tt1/2024-05-18T22:57:56+00:00https://timmermanreport.com/wp-content/uploads/2024/05/tt1.pnghttps://timmermanreport.com/2024/05/synbio-and-ai-for-discovery-david-younger-and-randolph-lopez-on-the-long-run/randolph/2024-05-20T23:12:07+00:00https://timmermanreport.com/wp-content/uploads/2024/05/randolph.jpghttps://timmermanreport.com/2024/05/sixpeaks-snags-110m-from-versant-az-for-drugs-to-preserve-muscle-and-shed-fat/larsen/2024-05-21T22:46:11+00:00https://timmermanreport.com/wp-content/uploads/2024/05/larsen.jpghttps://timmermanreport.com/2024/05/biogen-buys-hi-bio-endeavor-reverses-lung-scarring-pfizers-latest-cuts/otello/2024-05-23T22:53:52+00:00https://timmermanreport.com/wp-content/uploads/2024/05/otello.pnghttps://timmermanreport.com/2024/05/biogen-buys-hi-bio-endeavor-reverses-lung-scarring-pfizers-latest-cuts/murdoch/2024-05-23T22:54:49+00:00https://timmermanreport.com/wp-content/uploads/2024/05/murdoch.pnghttps://timmermanreport.com/2024/05/biogen-buys-hi-bio-endeavor-reverses-lung-scarring-pfizers-latest-cuts/julianne/2024-05-23T22:56:07+00:00https://timmermanreport.com/wp-content/uploads/2024/05/julianne.pnghttps://timmermanreport.com/2024/05/biogen-buys-hi-bio-endeavor-reverses-lung-scarring-pfizers-latest-cuts/lachelle/2024-05-23T22:57:58+00:00https://timmermanreport.com/wp-content/uploads/2024/05/lachelle.pnghttps://timmermanreport.com/2024/05/biogen-buys-hi-bio-endeavor-reverses-lung-scarring-pfizers-latest-cuts/tata-kavlashvili/2024-05-23T22:59:36+00:00https://timmermanreport.com/wp-content/uploads/2024/05/Tata-Kavlashvili.jpghttps://timmermanreport.com/2024/05/biogen-buys-hi-bio-endeavor-reverses-lung-scarring-pfizers-latest-cuts/shaohuazhang/2024-05-23T23:00:35+00:00https://timmermanreport.com/wp-content/uploads/2024/05/shaohuazhang.jpghttps://timmermanreport.com/2024/05/the-tao-of-drucker-lessons-for-drug-developers-from-glp-1/danieldrucker/2024-05-26T17:15:51+00:00https://timmermanreport.com/wp-content/uploads/2024/05/danieldrucker.jpghttps://timmermanreport.com/2024/05/on-the-bright-side-better-medicines-shared-purpose-good-listens/garthwaite-2/2024-05-29T20:41:28+00:00https://timmermanreport.com/wp-content/uploads/2024/05/garthwaite.jpghttps://timmermanreport.com/2024/05/on-the-bright-side-better-medicines-shared-purpose-good-listens/shaywitzfamily/2024-05-29T20:46:41+00:00https://timmermanreport.com/wp-content/uploads/2024/05/shaywitzfamily.jpghttps://timmermanreport.com/2024/05/recognizing-11-asian-american-executives-shaping-the-future-of-biopharmaceuticals/ericdai/2024-05-30T18:40:16+00:00https://timmermanreport.com/wp-content/uploads/2024/05/ericdai.pnghttps://timmermanreport.com/2024/05/recognizing-11-asian-american-executives-shaping-the-future-of-biopharmaceuticals/arthur/2024-05-30T18:44:36+00:00https://timmermanreport.com/wp-content/uploads/2024/05/arthur.pnghttps://timmermanreport.com/2024/05/recognizing-11-asian-american-executives-shaping-the-future-of-biopharmaceuticals/ying-huang/2024-05-30T18:46:40+00:00https://timmermanreport.com/wp-content/uploads/2024/05/ying-huang.jpghttps://timmermanreport.com/2024/05/recognizing-11-asian-american-executives-shaping-the-future-of-biopharmaceuticals/akuan/2024-05-30T18:47:32+00:00https://timmermanreport.com/wp-content/uploads/2024/05/akuan.pnghttps://timmermanreport.com/2024/05/recognizing-11-asian-american-executives-shaping-the-future-of-biopharmaceuticals/jjeancui/2024-05-30T18:50:42+00:00https://timmermanreport.com/wp-content/uploads/2024/05/jjeancui.pnghttps://timmermanreport.com/2024/05/recognizing-11-asian-american-executives-shaping-the-future-of-biopharmaceuticals/rodwong-2/2024-05-30T18:55:28+00:00https://timmermanreport.com/wp-content/uploads/2024/05/rodwong.pnghttps://timmermanreport.com/2024/05/recognizing-11-asian-american-executives-shaping-the-future-of-biopharmaceuticals/brinda/2024-05-30T18:57:29+00:00https://timmermanreport.com/wp-content/uploads/2024/05/brinda.pnghttps://timmermanreport.com/2024/05/merck-bets-on-the-eye-merus-raises-a-fortune-roche-leadership-change/guyer/2024-05-30T23:51:15+00:00https://timmermanreport.com/wp-content/uploads/2024/05/guyer.pnghttps://timmermanreport.com/2024/06/a-new-outlook-on-life-with-sickle-cell-disease-jimi-olaghere-on-the-long-run/jimi/2024-05-31T21:25:41+00:00https://timmermanreport.com/wp-content/uploads/2024/05/jimi.jpghttps://timmermanreport.com/2024/06/a-new-outlook-on-life-with-sickle-cell-disease-jimi-olaghere-on-the-long-run/ttsf24banner-2/2024-05-31T21:27:44+00:00https://timmermanreport.com/wp-content/uploads/2024/05/ttsf24banner.pnghttps://timmermanreport.com/2024/06/a-new-outlook-on-life-with-sickle-cell-disease-jimi-olaghere-on-the-long-run/raisinghealth/2024-05-31T21:33:07+00:00https://timmermanreport.com/wp-content/uploads/2024/05/raisinghealth.pnghttps://timmermanreport.com/2024/06/astrazenecas-big-asco-summit-breaks-out-structures-oral-glp-1-advance/tedandluke/2024-06-07T01:36:27+00:00https://timmermanreport.com/wp-content/uploads/2024/06/tedandluke.jpghttps://timmermanreport.com/2024/06/astrazenecas-big-asco-summit-breaks-out-structures-oral-glp-1-advance/summitstock/2024-06-07T01:37:54+00:00https://timmermanreport.com/wp-content/uploads/2024/06/summitstock.pnghttps://timmermanreport.com/2024/06/astrazenecas-big-asco-summit-breaks-out-structures-oral-glp-1-advance/illumina-everett-cunningham/2024-06-07T01:39:21+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Illumina\_Everett\_Cunningham.jpghttps://timmermanreport.com/2023/04/translating-crispr-gene-editing-into-a-groundbreaking-cell-therapy/bill/2024-06-07T01:40:43+00:00https://timmermanreport.com/wp-content/uploads/2023/04/bill.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/peter\_emtage-1566\_proper\_size/2024-06-13T00:12:17+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Peter\_Emtage-1566\_proper\_size.jpghttps://timmermanreport.com/2024/06/avidity-delivers-foresite-raises-900m-lilly-alzheimers-drug-passes-scrutiny/reddoch/2024-06-13T22:45:03+00:00https://timmermanreport.com/wp-content/uploads/2024/06/reddoch.pnghttps://timmermanreport.com/2024/06/avidity-delivers-foresite-raises-900m-lilly-alzheimers-drug-passes-scrutiny/hait/2024-06-13T22:48:34+00:00https://timmermanreport.com/wp-content/uploads/2024/06/hait.pnghttps://timmermanreport.com/2024/06/avidity-delivers-foresite-raises-900m-lilly-alzheimers-drug-passes-scrutiny/sarah-boyce/2024-06-13T22:51:55+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Sarah-Boyce.jpghttps://timmermanreport.com/2024/06/avidity-delivers-foresite-raises-900m-lilly-alzheimers-drug-passes-scrutiny/jim-reddoch-1-e1704386235126/2024-06-13T22:59:56+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Jim-Reddoch-1-e1704386235126.jpghttps://timmermanreport.com/2024/06/marea-incubated-by-third-rock-gets-190m-to-take-aim-at-remnant-cholesterol/ethan-weiss10/2024-06-17T15:28:59+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Ethan-Weiss10.jpghttps://timmermanreport.com/2024/06/marea-incubated-by-third-rock-gets-190m-to-take-aim-at-remnant-cholesterol/josh-lehrer-headshot/2024-06-17T15:29:23+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Josh-Lehrer-Headshot.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/abreu/2024-06-18T01:41:57+00:00https://timmermanreport.com/wp-content/uploads/2024/06/abreu.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/bowie/2024-06-18T01:42:57+00:00https://timmermanreport.com/wp-content/uploads/2024/06/bowie.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/estepan/2024-06-18T01:44:08+00:00https://timmermanreport.com/wp-content/uploads/2024/06/estepan.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/yusri/2024-06-18T01:44:55+00:00https://timmermanreport.com/wp-content/uploads/2024/06/yusri.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/cotton/2024-06-18T01:45:56+00:00https://timmermanreport.com/wp-content/uploads/2024/06/cotton.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/harris/2024-06-18T01:47:15+00:00https://timmermanreport.com/wp-content/uploads/2024/06/harris.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/hayes/2024-06-18T01:48:18+00:00https://timmermanreport.com/wp-content/uploads/2024/06/hayes.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/hicks/2024-06-18T01:49:16+00:00https://timmermanreport.com/wp-content/uploads/2024/06/hicks.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/johnson/2024-06-18T01:49:57+00:00https://timmermanreport.com/wp-content/uploads/2024/06/johnson.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/jones/2024-06-18T01:50:45+00:00https://timmermanreport.com/wp-content/uploads/2024/06/jones.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/jones-burton/2024-06-18T01:51:32+00:00https://timmermanreport.com/wp-content/uploads/2024/06/jones-burton.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/mazareas/2024-06-18T01:52:26+00:00https://timmermanreport.com/wp-content/uploads/2024/06/mazareas.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/karen-nelson-edit-gray/2024-06-18T01:53:07+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Karen-Nelson-edit-gray.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/jeff/2024-06-18T01:53:50+00:00https://timmermanreport.com/wp-content/uploads/2024/06/jeff.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/deborah-telman-526/2024-06-18T01:54:45+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Deborah-Telman-526.jpghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/tamar/2024-06-18T01:55:48+00:00https://timmermanreport.com/wp-content/uploads/2024/06/tamar.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/chidozie/2024-06-18T01:56:50+00:00https://timmermanreport.com/wp-content/uploads/2024/06/chidozie.pnghttps://timmermanreport.com/2024/06/on-juneteenth-recognizing-18-black-biopharma-industry-leaders/alethia/2024-06-18T01:58:11+00:00https://timmermanreport.com/wp-content/uploads/2024/06/alethia.jpghttps://timmermanreport.com/2024/06/exsilio-gets-82m-to-make-mrna-therapies-that-integrate-and-endure/tal-zaks\_3663bsq-print/2024-06-19T14:17:22+00:00https://timmermanreport.com/wp-content/uploads/2024/06/Tal-Zaks\_3663Bsq-Print.jpghttps://timmermanreport.com/2024/07/lilly-buys-morphic-flagship-dreams-big-and-element-challenges-illumina/leadership-molly-he/2024-07-11T23:26:55+00:00https://timmermanreport.com/wp-content/uploads/2024/07/leadership-molly-he.jpghttps://timmermanreport.com/2024/07/lilly-buys-morphic-flagship-dreams-big-and-element-challenges-illumina/noubar/2024-07-12T00:27:56+00:00https://timmermanreport.com/wp-content/uploads/2024/07/noubar.pnghttps://timmermanreport.com/2024/07/ai-if-not-now-when-no-really-when/daron/2024-07-14T21:20:42+00:00https://timmermanreport.com/wp-content/uploads/2024/07/daron.jpghttps://timmermanreport.com/2024/07/attia-and-kohane-examine-what-it-takes-to-drive-ai-into-clinical-practice/peter-attia-c57a2508-square/2024-07-17T20:04:42+00:00https://timmermanreport.com/wp-content/uploads/2024/07/Peter-Attia-C57A2508-Square.jpghttps://timmermanreport.com/2023/07/lessons-learned-from-the-intense-back-and-forth-over-a-1b-acquisition/roncooper/2024-07-25T22:09:01+00:00https://timmermanreport.com/wp-content/uploads/2023/07/roncooper.jpghttps://timmermanreport.com/2024/07/pbms-feel-the-heat-megarounds-abound-and-the-xbi-tops-100/auchincloss/2024-07-25T22:10:28+00:00https://timmermanreport.com/wp-content/uploads/2024/07/auchincloss.pnghttps://timmermanreport.com/2024/08/ai-in-pharma-can-we-get-beyond-assent-without-belief-by-channeling-ethan-mollick/professional-headshots-in-philadelphia/2024-08-05T14:26:32+00:00https://timmermanreport.com/wp-content/uploads/2024/08/ethan-happy-hour-headshot-philadelphia-2023-45934-129x139-1.jpghttps://timmermanreport.com/2024/08/ai-in-pharma-can-we-get-beyond-assent-without-belief-by-channeling-ethan-mollick/colleen/2024-08-05T14:29:32+00:00https://timmermanreport.com/wp-content/uploads/2024/08/colleen.jpghttps://timmermanreport.com/2021/08/kidney-companies-taking-pages-from-the-oncology-playbook-with-precision-medicine/eric/2024-08-08T23:37:00+00:00https://timmermanreport.com/wp-content/uploads/2021/07/eric-e1680045131907.jpghttps://timmermanreport.com/2020/03/singapore-what-we-can-learn-from-a-high-risk-countrys-response-to-covid19/carolynng/2024-08-08T23:39:25+00:00https://timmermanreport.com/wp-content/uploads/2020/03/carolynng.jpghttps://timmermanreport.com/2023/10/an-mrna-nobel-lilly-acquires-point-and-investment-in-singapore/marianne\_de\_backer/2024-08-08T23:39:55+00:00https://timmermanreport.com/wp-content/uploads/2023/10/marianne\_de\_backer.jpghttps://timmermanreport.com/2024/08/recursion-scoops-up-rival-serviers-brain-cancer-win-cell-therapy-for-solid-tumors/shayrxrx/2024-08-08T23:40:42+00:00https://timmermanreport.com/wp-content/uploads/2024/08/shayrxrx.pnghttps://timmermanreport.com/2024/08/recursion-scoops-up-rival-serviers-brain-cancer-win-cell-therapy-for-solid-tumors/exai/2024-08-08T23:41:25+00:00https://timmermanreport.com/wp-content/uploads/2024/08/exai.pnghttps://timmermanreport.com/2024/08/recursion-scoops-up-rival-serviers-brain-cancer-win-cell-therapy-for-solid-tumors/rxrx/2024-08-08T23:41:46+00:00https://timmermanreport.com/wp-content/uploads/2024/08/rxrx.pnghttps://timmermanreport.com/2024/08/recursion-scoops-up-rival-serviers-brain-cancer-win-cell-therapy-for-solid-tumors/joanne-2/2024-08-08T23:42:20+00:00https://timmermanreport.com/wp-content/uploads/2024/08/joanne.pnghttps://timmermanreport.com/2024/08/recursion-scoops-up-rival-serviers-brain-cancer-win-cell-therapy-for-solid-tumors/ricks/2024-08-08T23:43:29+00:00https://timmermanreport.com/wp-content/uploads/2024/08/ricks.pnghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/1-6/2024-08-27T00:06:41+00:00https://timmermanreport.com/wp-content/uploads/2024/08/1.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/2-4/2024-08-27T00:06:52+00:00https://timmermanreport.com/wp-content/uploads/2024/08/2.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/3-4/2024-08-27T00:07:15+00:00https://timmermanreport.com/wp-content/uploads/2024/08/3.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/4-2/2024-08-27T00:07:21+00:00https://timmermanreport.com/wp-content/uploads/2024/08/4.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/5-2/2024-08-27T00:07:27+00:00https://timmermanreport.com/wp-content/uploads/2024/08/5.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/6/2024-08-27T00:07:38+00:00https://timmermanreport.com/wp-content/uploads/2024/08/6.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/7/2024-08-27T00:08:17+00:00https://timmermanreport.com/wp-content/uploads/2024/08/7.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/8/2024-08-27T00:08:42+00:00https://timmermanreport.com/wp-content/uploads/2024/08/8.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/9/2024-08-27T00:08:51+00:00https://timmermanreport.com/wp-content/uploads/2024/08/9.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/10/2024-08-27T00:09:15+00:00https://timmermanreport.com/wp-content/uploads/2024/08/10.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/11-3/2024-08-27T00:09:52+00:00https://timmermanreport.com/wp-content/uploads/2024/08/11.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/12/2024-08-27T00:10:48+00:00https://timmermanreport.com/wp-content/uploads/2024/08/12.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/13/2024-08-27T00:11:01+00:00https://timmermanreport.com/wp-content/uploads/2024/08/13.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/14/2024-08-27T00:11:07+00:00https://timmermanreport.com/wp-content/uploads/2024/08/14.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/15-2/2024-08-27T00:12:43+00:00https://timmermanreport.com/wp-content/uploads/2024/08/15.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/attachment/16/2024-08-27T00:13:03+00:00https://timmermanreport.com/wp-content/uploads/2024/08/16.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/caycephotos/2024-08-27T00:13:34+00:00https://timmermanreport.com/wp-content/uploads/2024/08/caycephotos.jpghttps://timmermanreport.com/2024/08/timmerman-traverse-for-life-science-cares-hits-1m-goal-to-fight-poverty-2/screenshot-2024-08-26-170551/2024-08-27T00:31:47+00:00https://timmermanreport.com/wp-content/uploads/2024/08/Screenshot-2024-08-26-170551.pnghttps://timmermanreport.com/2024/08/two-new-books-about-risk-luck-and-skill-offer-insights-for-rd-leaders/sunstein/2024-08-30T18:39:14+00:00https://timmermanreport.com/wp-content/uploads/2024/08/sunstein.pnghttps://timmermanreport.com/2024/08/two-new-books-about-risk-luck-and-skill-offer-insights-for-rd-leaders/silver/2024-08-30T18:40:29+00:00https://timmermanreport.com/wp-content/uploads/2024/08/silver.pnghttps://timmermanreport.com/2024/09/arsenal-bio-fetches-325m-to-make-programmed-car-t-cell-therapies-for-solid-tumors/kole/2024-09-03T22:45:15+00:00https://timmermanreport.com/wp-content/uploads/2024/09/kole.jpghttps://timmermanreport.com/2024/09/arsenal-bio-fetches-325m-to-make-programmed-car-t-cell-therapies-for-solid-tumors/ken-drazan-1/2024-09-03T22:46:31+00:00https://timmermanreport.com/wp-content/uploads/2024/09/ken-drazan-1.jpghttps://timmermanreport.com/2024/09/raising-the-bar-for-sickle-cell-patients-ted-love-and-alan-anderson-on-the-long-run/alan/2024-09-05T12:40:16+00:00https://timmermanreport.com/wp-content/uploads/2024/09/alan.pnghttps://timmermanreport.com/2021/11/reviving-targeted-radiopharmaceuticals-for-cancer-ken-song-on-the-long-run/kensong/2024-09-08T20:15:47+00:00https://timmermanreport.com/wp-content/uploads/2021/11/kensong.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten1/2024-09-08T21:58:41+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten1.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten2/2024-09-08T21:58:45+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten2.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten3/2024-09-08T21:58:48+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten3.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten4/2024-09-08T21:58:52+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten4.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten5/2024-09-08T21:58:54+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten5.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten6/2024-09-08T21:58:56+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten6.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten7/2024-09-08T21:58:58+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten7.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten8/2024-09-08T21:59:03+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten8.jpghttps://timmermanreport.com/2024/09/the-enchantments-traverse-a-photo-gallery/tten9/2024-09-08T21:59:08+00:00https://timmermanreport.com/wp-content/uploads/2024/09/tten9.jpghttps://timmermanreport.com/2024/09/amy-abernethy-brad-hirsch-take-two-prong-fix-to-medical-evidence-at-highlander-health/amy-and-brad-portrait-1/2024-09-08T23:34:23+00:00https://timmermanreport.com/wp-content/uploads/2024/09/Amy-and-Brad-Portrait-1.jpghttps://timmermanreport.com/2024/09/amy-abernethy-brad-hirsch-take-two-prong-fix-to-medical-evidence-at-highlander-health/amy-and-brad-portrait-1-2/2024-09-08T23:38:38+00:00https://timmermanreport.com/wp-content/uploads/2024/09/Amy-and-Brad-Portrait-1-1.jpghttps://timmermanreport.com/2024/09/sickle-cell-patient-cured-with-crispr-summits-kilimanjaro-setting-world-record/kilisfsummit24/2024-09-17T14:51:31+00:00https://timmermanreport.com/wp-content/uploads/2024/09/kilisfsummit24.jpghttps://timmermanreport.com/2024/09/sickle-cell-patient-cured-with-crispr-summits-kilimanjaro-setting-world-record/kilisfsummit24-2/2024-09-17T14:52:03+00:00https://timmermanreport.com/wp-content/uploads/2024/09/kilisfsummit24-1.jpghttps://timmermanreport.com/2024/09/sickle-cell-patient-cured-with-crispr-summits-kilimanjaro-setting-world-record/kilisfsummit24peyton/2024-09-17T14:52:17+00:00https://timmermanreport.com/wp-content/uploads/2024/09/kilisfsummit24peyton.jpghttps://timmermanreport.com/2024/09/sickle-cell-patient-cured-with-crispr-summits-kilimanjaro-setting-world-record/kilisfsummit24-1/2024-09-17T15:31:17+00:00https://timmermanreport.com/wp-content/uploads/2024/09/kilisfsummit24.1.jpghttps://timmermanreport.com/2024/09/pfizer-withdraws-sickle-cell-drug-arch-hauls-in-3b-and-enanta-challenges-rsv/nelsen-2/2024-09-26T23:12:19+00:00https://timmermanreport.com/wp-content/uploads/2024/09/nelsen.pnghttps://timmermanreport.com/2024/09/pfizer-withdraws-sickle-cell-drug-arch-hauls-in-3b-and-enanta-challenges-rsv/claire/2024-09-26T23:13:17+00:00https://timmermanreport.com/wp-content/uploads/2024/09/claire.jpghttps://timmermanreport.com/2024/09/pfizer-withdraws-sickle-cell-drug-arch-hauls-in-3b-and-enanta-challenges-rsv/maria/2024-09-26T23:15:03+00:00https://timmermanreport.com/wp-content/uploads/2024/09/maria.pnghttps://timmermanreport.com/in-the-news/biotech-tv-logo/2024-09-27T15:46:49+00:00https://timmermanreport.com/wp-content/uploads/2024/09/biotech-tv-logo.pnghttps://timmermanreport.com/2024/10/triveni-bio-secures-115m-to-treat-immune-inflammatory-diseases/vishalpatelceotrivenibio-web/2024-10-01T21:30:19+00:00https://timmermanreport.com/wp-content/uploads/2024/10/VishalPatelCEOTriveniBio-web.jpghttps://timmermanreport.com/2024/10/triveni-bio-secures-115m-to-treat-immune-inflammatory-diseases/jenniferdoveycsotrivenibio-web/2024-10-01T21:30:57+00:00https://timmermanreport.com/wp-content/uploads/2024/10/JenniferDoveyCSOTriveniBio-web.jpghttps://timmermanreport.com/2024/10/triveni-bio-secures-115m-to-treat-immune-inflammatory-diseases/bhaskarsrivastavacmotrivenibio-web/2024-10-01T21:31:29+00:00https://timmermanreport.com/wp-content/uploads/2024/10/BhaskarSrivastavaCMOTriveniBio-web.jpghttps://timmermanreport.com/2024/10/bioage-goes-public-kailera-piles-into-glp-1-and-lilly-bets-big-on-indiana/lukeandjimi/2024-10-03T22:27:08+00:00https://timmermanreport.com/wp-content/uploads/2024/10/lukeandjimi.jpghttps://timmermanreport.com/2024/10/bioage-goes-public-kailera-piles-into-glp-1-and-lilly-bets-big-on-indiana/kristen-removebg-preview\_1/2024-10-03T22:33:59+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Kristen-removebg-preview\_1.pnghttps://timmermanreport.com/2018/12/messenger-rna-therapies-that-you-may-not-have-heard-of-ron-renaud-on-the-long-run/renaud/2024-10-03T22:34:24+00:00https://timmermanreport.com/wp-content/uploads/2018/12/renaud.jpghttps://timmermanreport.com/2024/10/bioage-goes-public-kailera-piles-into-glp-1-and-lilly-bets-big-on-indiana/kailera\_ron\_renaud/2024-10-03T22:35:21+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Kailera\_Ron\_Renaud.jpghttps://timmermanreport.com/2024/10/basecamp-research-secures-60m-to-hone-first-principles-for-ai-drug-discovery/oliver/2024-10-08T14:18:13+00:00https://timmermanreport.com/wp-content/uploads/2024/10/oliver.pnghttps://timmermanreport.com/2024/10/basecamp-research-secures-60m-to-hone-first-principles-for-ai-drug-discovery/gowers/2024-10-08T14:19:41+00:00https://timmermanreport.com/wp-content/uploads/2024/10/gowers.pnghttps://timmermanreport.com/2024/10/booster-gets-15m-from-apollo-novo-to-develop-proteasome-activators-for-neurodegeneration/dr-diogo-r-feleciano\_1/2024-10-09T01:30:59+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Dr.-Diogo-R.-Feleciano\_1.jpghttps://timmermanreport.com/2024/10/nobel-for-protein-design-and-alphafold-scholar-rock-shines-and-a-city-is-born/david-baker-nobel-prize-phone-call-with-demis-hassabis-and-john-jumper-4-e1728523751259/2024-10-10T23:13:28+00:00https://timmermanreport.com/wp-content/uploads/2024/10/David-Baker-Nobel-Prize-phone-call-with-Demis-Hassabis-and-John-Jumper-4-e1728523751259.jpeghttps://timmermanreport.com/2024/10/nobel-for-protein-design-and-alphafold-scholar-rock-shines-and-a-city-is-born/nobel2024/2024-10-10T23:20:51+00:00https://timmermanreport.com/wp-content/uploads/2024/10/nobel2024.pnghttps://timmermanreport.com/2024/10/engineering-protein-drugs-for-cancer-autoimmunity-chris-garcia-on-the-long-run/garcia-chris\_faculty/2024-10-15T21:57:12+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Garcia-Chris\_Faculty.jpghttps://timmermanreport.com/2024/10/can-we-pick-winners-with-causal-human-biology-vertex-makes-the-case/welsh/2024-10-22T15:31:37+00:00https://timmermanreport.com/wp-content/uploads/2024/10/welsh.pnghttps://timmermanreport.com/2024/10/can-we-pick-winners-with-causal-human-biology-vertex-makes-the-case/pauln/2024-10-22T15:34:38+00:00https://timmermanreport.com/wp-content/uploads/2024/10/pauln.pnghttps://timmermanreport.com/2024/10/can-we-pick-winners-with-causal-human-biology-vertex-makes-the-case/sabine/2024-10-22T15:36:52+00:00https://timmermanreport.com/wp-content/uploads/2024/10/sabine.pnghttps://timmermanreport.com/2024/10/can-we-pick-winners-with-causal-human-biology-vertex-makes-the-case/altshuler\_david\_500x500/2024-10-22T15:39:07+00:00https://timmermanreport.com/wp-content/uploads/2024/10/altshuler\_david\_500x500.jpghttps://timmermanreport.com/2024/10/can-we-pick-winners-with-causal-human-biology-vertex-makes-the-case/vangoor/2024-10-22T15:46:26+00:00https://timmermanreport.com/wp-content/uploads/2024/10/vangoor.jpghttps://timmermanreport.com/2024/10/a-life-in-biotech-journalism-and-reaching-new-heights-for-good-causes/ltanniversary/2024-10-23T02:35:24+00:00https://timmermanreport.com/wp-content/uploads/2024/10/LTanniversary.jpghttps://timmermanreport.com/2024/10/yes-we-can-my-response-to-skeptical-readers/frankdavid/2024-10-24T20:47:15+00:00https://timmermanreport.com/wp-content/uploads/2024/10/frankdavid.jpghttps://timmermanreport.com/2024/10/yes-we-can-my-response-to-skeptical-readers/princess-bride-movie-poster/2024-10-24T20:51:28+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Princess-Bride-movie-poster.jpghttps://timmermanreport.com/2024/10/intellia-in-vivo-disappoints-seaport-aims-at-anxiety-wave-shows-rna-editing-promise/gibson-3/2024-10-24T23:01:59+00:00https://timmermanreport.com/wp-content/uploads/2024/10/gibson.pnghttps://timmermanreport.com/2024/10/intellia-in-vivo-disappoints-seaport-aims-at-anxiety-wave-shows-rna-editing-promise/john-leonard/2024-10-24T23:03:08+00:00https://timmermanreport.com/wp-content/uploads/2024/10/John-Leonard.jpghttps://timmermanreport.com/in-the-news/nucleatepodcast/2024-10-29T13:35:14+00:00https://timmermanreport.com/wp-content/uploads/2024/10/nucleatepodcast.pnghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/tr-damon/2024-10-29T13:45:34+00:00https://timmermanreport.com/wp-content/uploads/2024/10/TR-damon.pnghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/nageshmahanthappa/2024-10-29T13:51:01+00:00https://timmermanreport.com/wp-content/uploads/2024/10/nageshmahanthappa.pnghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/luke-teamleader/2024-10-29T13:52:14+00:00https://timmermanreport.com/wp-content/uploads/2024/10/luke-teamleader.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/orientationday/2024-10-29T13:54:46+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Orientationday.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/celebration/2024-10-29T13:54:48+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Celebration.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/summit-day/2024-10-29T13:54:51+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Summit-Day.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/l-to-r/2024-10-29T13:54:53+00:00https://timmermanreport.com/wp-content/uploads/2024/10/L-to-R.jpghttps://timmermanreport.com/2024/10/archon-biosciences-gets-20m-to-translate-nobel-winning-science-into-antibody-cages/lazarovits/2024-10-30T00:16:20+00:00https://timmermanreport.com/wp-content/uploads/2024/10/lazarovits.jpghttps://timmermanreport.com/2024/10/archon-biosciences-gets-20m-to-translate-nobel-winning-science-into-antibody-cages/screenshot-2024-10-29-170125/2024-10-30T00:19:17+00:00https://timmermanreport.com/wp-content/uploads/2024/10/Screenshot-2024-10-29-170125.pnghttps://timmermanreport.com/2024/10/aliadas-mega-return-gsk-abbvie-eye-t-cell-engagers-and-ipo-scorecard/nakada/2024-10-31T22:03:40+00:00https://timmermanreport.com/wp-content/uploads/2024/10/nakada.pnghttps://timmermanreport.com/2023/03/pfizer-acquires-seagen-sanofi-novo-cut-insulin-prices-illuminas-proxy-fight/david-epstein-0722-color/2024-10-31T22:04:37+00:00https://timmermanreport.com/wp-content/uploads/2023/03/David-Epstein-0722-Color.jpghttps://timmermanreport.com/2019/12/designer-proteins-as-better-therapies-david-baker-on-the-long-run/david-baker/2024-10-31T22:05:44+00:00https://timmermanreport.com/wp-content/uploads/2019/12/david-baker.pnghttps://timmermanreport.com/2024/11/when-business-and-politics-collide/rogerlongman/2024-11-02T16:39:40+00:00https://timmermanreport.com/wp-content/uploads/2022/10/rogerlongman.pnghttps://timmermanreport.com/2024/11/when-business-and-politics-collide/rfkjr/2024-11-02T16:46:47+00:00https://timmermanreport.com/wp-content/uploads/2024/11/rfkjr.pnghttps://timmermanreport.com/2024/11/lessons-from-the-manure-digester/luke2024/2024-11-05T03:43:20+00:00https://timmermanreport.com/wp-content/uploads/2024/11/Luke2024.pnghttps://timmermanreport.com/2024/11/lessons-from-the-manure-digester/falk/2024-11-05T03:49:07+00:00https://timmermanreport.com/wp-content/uploads/2024/11/falk.jpghttps://timmermanreport.com/2024/11/third-rock-backed-trace-neuroscience-debuts-with-101m-rna-drug-for-als/ericgreen/2024-11-11T22:19:59+00:00https://timmermanreport.com/wp-content/uploads/2024/11/ericgreen.pnghttps://timmermanreport.com/2024/11/save-the-date-tr-10th-anniversary/timmerman-report-logo-tr10\_tr-10-celebrate-logo/2024-11-13T17:21:22+00:00https://timmermanreport.com/wp-content/uploads/2024/11/Timmerman-Report-Logo-TR10\_TR-10-celebrate-logo.jpghttps://timmermanreport.com/2024/11/save-the-date-tr-10th-anniversary/timmerman-report-logo-tr10\_tr-10-logo/2024-11-13T17:22:02+00:00https://timmermanreport.com/wp-content/uploads/2024/11/Timmerman-Report-Logo-TR10\_TR-10-Logo.jpghttps://timmermanreport.com/2024/11/rfk-jr-to-hhs-biotechs-uneasy-alliance-with-china-pd-1-vegfs-scooped-up-cheap/anne-wojcicki-540x742/2024-11-14T23:00:34+00:00https://timmermanreport.com/wp-content/uploads/2024/11/Anne-Wojcicki-540x742-1.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/karenakinsanya/2024-11-14T23:01:46+00:00https://timmermanreport.com/wp-content/uploads/2021/06/karenakinsanya.jpghttps://timmermanreport.com/2024/11/rfk-jr-to-hhs-biotechs-uneasy-alliance-with-china-pd-1-vegfs-scooped-up-cheap/flier/2024-11-14T23:19:53+00:00https://timmermanreport.com/wp-content/uploads/2024/11/flier.pnghttps://timmermanreport.com/2024/09/sickle-cell-patient-cured-with-crispr-summits-kilimanjaro-setting-world-record/kilisfsummit24jimi/2024-11-17T14:30:25+00:00https://timmermanreport.com/wp-content/uploads/2024/09/kilisfsummit24jimi.jpghttps://timmermanreport.com/2024/11/coastal-culture-clash-around-ai-in-biotech/haque/2024-11-19T00:06:16+00:00https://timmermanreport.com/wp-content/uploads/2024/11/haque.jpghttps://timmermanreport.com/2024/11/coastal-culture-clash-around-ai-in-biotech/jeff\_spicoli\_drivers\_license\_id\_by\_bobbyboggs182\_dh1qve9-fullview/2024-11-19T00:22:23+00:00https://timmermanreport.com/wp-content/uploads/2024/11/jeff\_spicoli\_drivers\_license\_id\_by\_bobbyboggs182\_dh1qve9-fullview.jpghttps://timmermanreport.com/2024/11/a-tale-of-two-neds-jupiter-debuts-with-70m-fund-to-invest-in-early-stage-startups/neds/2024-11-19T04:48:17+00:00https://timmermanreport.com/wp-content/uploads/2024/11/neds.pnghttps://timmermanreport.com/2024/11/startup-snapshots-a-tetra-binder-for-obesity-and-a-mirror-peptide-engine/cristina/2024-11-21T00:06:12+00:00https://timmermanreport.com/wp-content/uploads/2024/11/cristina.jpghttps://timmermanreport.com/2024/11/startup-snapshots-a-tetra-binder-for-obesity-and-a-mirror-peptide-engine/ajay/2024-11-21T00:10:08+00:00https://timmermanreport.com/wp-content/uploads/2024/11/ajay.jpghttps://timmermanreport.com/2024/11/startup-snapshots-a-tetra-binder-for-obesity-and-a-mirror-peptide-engine/vanvalen/2024-11-21T00:12:38+00:00https://timmermanreport.com/wp-content/uploads/2024/11/vanvalen.jpghttps://timmermanreport.com/2017/04/steve-holtzman-biotech-stand-science/sholtzman/2024-11-21T18:24:34+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sholtzman.jpghttps://timmermanreport.com/2024/11/speaking-up-for-science-and-health-even-when-inconvenient/oz/2024-11-21T18:26:21+00:00https://timmermanreport.com/wp-content/uploads/2024/11/oz.jpghttps://timmermanreport.com/2024/11/speaking-up-for-science-and-health-even-when-inconvenient/steveh/2024-11-21T19:22:31+00:00https://timmermanreport.com/wp-content/uploads/2024/11/steveh.pnghttps://timmermanreport.com/2024/11/dr-oz-to-cms-amgen-and-pfizer-get-new-csos-subq-keytruda-arrives/hchang/2024-11-22T00:53:07+00:00https://timmermanreport.com/wp-content/uploads/2024/11/hchang.jpghttps://timmermanreport.com/2024/11/dr-oz-to-cms-amgen-and-pfizer-get-new-csos-subq-keytruda-arrives/statement/2024-11-22T00:58:56+00:00https://timmermanreport.com/wp-content/uploads/2024/11/statement.pnghttps://timmermanreport.com/2024/11/dr-oz-to-cms-amgen-and-pfizer-get-new-csos-subq-keytruda-arrives/adamalex/2024-11-22T01:00:23+00:00https://timmermanreport.com/wp-content/uploads/2024/11/adamalex.pnghttps://timmermanreport.com/2024/11/dr-oz-to-cms-amgen-and-pfizer-get-new-csos-subq-keytruda-arrives/brucelevine/2024-11-22T01:01:17+00:00https://timmermanreport.com/wp-content/uploads/2024/11/brucelevine.pnghttps://timmermanreport.com/2024/11/dr-oz-to-cms-amgen-and-pfizer-get-new-csos-subq-keytruda-arrives/topol-2/2024-11-22T01:01:50+00:00https://timmermanreport.com/wp-content/uploads/2024/11/topol.pnghttps://timmermanreport.com/2024/11/dr-oz-to-cms-amgen-and-pfizer-get-new-csos-subq-keytruda-arrives/vivek/2024-11-22T01:02:52+00:00https://timmermanreport.com/wp-content/uploads/2024/11/vivek.pnghttps://timmermanreport.com/2024/11/a-story-of-hope-for-kids-with-rare-disease/loren-eng-current/2024-11-24T23:26:11+00:00https://timmermanreport.com/wp-content/uploads/2024/11/loren-eng-current.pnghttps://timmermanreport.com/2024/11/how-to-quit-smoking-and-prevent-cancer-jonathan-bricker-on-the-long-run/jonathan-bricker/2024-11-25T13:20:32+00:00https://timmermanreport.com/wp-content/uploads/2024/11/jonathan-bricker.jpghttps://timmermanreport.com/2024/11/what-should-we-pay-for-a-good-death/lindseyulin/2024-11-25T19:20:16+00:00https://timmermanreport.com/wp-content/uploads/2024/11/lindseyulin.jpghttps://timmermanreport.com/2024/11/what-should-we-pay-for-a-good-death/jingyi/2024-11-25T19:28:37+00:00https://timmermanreport.com/wp-content/uploads/2024/11/jingyi.jpghttps://timmermanreport.com/2024/11/meet-the-2025-timmerman-traverse-for-damon-runyon-cancer-research-team/alnylam-corporate-logo/2024-11-26T03:31:18+00:00https://timmermanreport.com/wp-content/uploads/2024/11/alnylam-corporate-logo.pnghttps://timmermanreport.com/2024/11/meet-the-2025-timmerman-traverse-for-damon-runyon-cancer-research-team/bms-logo-rgb-pos-with-border/2024-11-26T03:32:22+00:00https://timmermanreport.com/wp-content/uploads/2024/11/bms-logo-rgb-pos-with-border.jpghttps://timmermanreport.com/2024/11/meet-the-2025-timmerman-traverse-for-damon-runyon-cancer-research-team/lincswitch/2024-11-26T03:33:25+00:00https://timmermanreport.com/wp-content/uploads/2024/11/lincswitch.pnghttps://timmermanreport.com/2024/11/meet-the-2025-timmerman-traverse-for-damon-runyon-cancer-research-team/relation1/2024-11-26T03:37:07+00:00https://timmermanreport.com/wp-content/uploads/2024/11/relation1.pnghttps://timmermanreport.com/2024/12/versant-backed-antag-gets-84m-for-weight-loss-peptide-with-combo-potential/sparre/2024-12-03T22:00:46+00:00https://timmermanreport.com/wp-content/uploads/2024/12/sparre.jpghttps://timmermanreport.com/2024/12/computational-techniques-are-driving-a-tidal-shift-in-therapeutic-protein-design/simonbarnett/2024-12-03T23:57:48+00:00https://timmermanreport.com/wp-content/uploads/2024/12/simonbarnett.pnghttps://timmermanreport.com/2024/12/lilly-beats-novo-amgens-so-so-obesity-data-atlas-stays-lean-mean/peterk/2024-12-06T02:23:54+00:00https://timmermanreport.com/wp-content/uploads/2024/12/peterk.pnghttps://timmermanreport.com/2024/12/lilly-beats-novo-amgens-so-so-obesity-data-atlas-stays-lean-mean/rahul/2024-12-06T02:26:21+00:00https://timmermanreport.com/wp-content/uploads/2024/12/rahul.pnghttps://timmermanreport.com/2024/12/lilly-beats-novo-amgens-so-so-obesity-data-atlas-stays-lean-mean/thanksrahul/2024-12-06T02:26:47+00:00https://timmermanreport.com/wp-content/uploads/2024/12/thanksrahul.pnghttps://timmermanreport.com/2021/01/a-bold-idea-for-the-nih/collinsbio/2024-12-06T02:29:27+00:00https://timmermanreport.com/wp-content/uploads/2021/01/collinsbio.jpghttps://timmermanreport.com/2024/12/ash-highlights-beam-base-editing-novos-oral-pill-advance-for-sickle-cell/kanter/2024-12-09T01:16:38+00:00https://timmermanreport.com/wp-content/uploads/2024/12/kanter.jpghttps://timmermanreport.com/2024/12/ash-highlights-beam-base-editing-novos-oral-pill-advance-for-sickle-cell/agios-leadership-sarah-768x1014/2024-12-09T01:18:41+00:00https://timmermanreport.com/wp-content/uploads/2024/12/agios-leadership-Sarah-768x1014-1.jpghttps://timmermanreport.com/2021/03/amgen-acquires-rodeo-lean-startup-with-dual-mechanism-for-crohns-colitis/thong-7609-cropped/2024-12-12T22:39:39+00:00https://timmermanreport.com/wp-content/uploads/2021/03/Thong-7609-cropped.jpghttps://timmermanreport.com/2024/12/ash-recap-dimension-captures-500m-abbvies-new-parkinsons-drug/rachel/2024-12-12T22:41:08+00:00https://timmermanreport.com/wp-content/uploads/2024/12/rachel.jpghttps://timmermanreport.com/2024/12/ash-recap-dimension-captures-500m-abbvies-new-parkinsons-drug/paulk/2024-12-12T22:43:54+00:00https://timmermanreport.com/wp-content/uploads/2024/12/paulk.pnghttps://timmermanreport.com/2024/12/ash-recap-dimension-captures-500m-abbvies-new-parkinsons-drug/vivek1/2024-12-12T22:44:28+00:00https://timmermanreport.com/wp-content/uploads/2024/12/vivek1.pnghttps://timmermanreport.com/2024/12/ash-recap-dimension-captures-500m-abbvies-new-parkinsons-drug/vivek2/2024-12-12T22:45:48+00:00https://timmermanreport.com/wp-content/uploads/2024/12/vivek2.pnghttps://timmermanreport.com/2024/12/ash-recap-dimension-captures-500m-abbvies-new-parkinsons-drug/drglau/2024-12-12T22:46:31+00:00https://timmermanreport.com/wp-content/uploads/2024/12/drglau.pnghttps://timmermanreport.com/2024/12/ash-recap-dimension-captures-500m-abbvies-new-parkinsons-drug/elondec12/2024-12-12T22:49:27+00:00https://timmermanreport.com/wp-content/uploads/2024/12/elondec12.pnghttps://timmermanreport.com/2024/12/the-past-and-future-of-rnai-therapies-kevin-fitzgerald-on-the-long-run/fitzgerald/2024-12-12T22:57:13+00:00https://timmermanreport.com/wp-content/uploads/2024/12/fitzgerald.jpghttps://timmermanreport.com/2024/12/ash-recap-dimension-captures-500m-abbvies-new-parkinsons-drug/macro/2024-12-13T14:15:30+00:00https://timmermanreport.com/wp-content/uploads/2024/12/macro.pnghttps://timmermanreport.com/2015/04/the-big-boys-love-cambridge-lets-hope-they-dont-squeeze-the-life-out-of-it/mgilman1/2024-12-13T14:19:11+00:00https://timmermanreport.com/wp-content/uploads/2015/04/mgilman1-e1428962932988.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/kite-2/2024-12-16T19:08:21+00:00https://timmermanreport.com/wp-content/uploads/2024/12/kite.pnghttps://timmermanreport.com/2024/12/vertex-pain-drug-fails-puretech-delivers-for-ipf-merck-dumps-tigit-lag3-antibodies/koch/2024-12-20T01:51:57+00:00https://timmermanreport.com/wp-content/uploads/2024/12/koch.jpghttps://timmermanreport.com/2024/12/vertex-pain-drug-fails-puretech-delivers-for-ipf-merck-dumps-tigit-lag3-antibodies/bert/2024-12-20T01:53:09+00:00https://timmermanreport.com/wp-content/uploads/2024/12/bert.pnghttps://timmermanreport.com/2024/12/vertex-pain-drug-fails-puretech-delivers-for-ipf-merck-dumps-tigit-lag3-antibodies/hordo/2024-12-20T01:55:22+00:00https://timmermanreport.com/wp-content/uploads/2024/12/hordo.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/latham/2024-12-20T20:51:11+00:00https://timmermanreport.com/wp-content/uploads/2024/12/latham.pnghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/wh-lockup-color-jpg/2024-12-20T20:52:05+00:00https://timmermanreport.com/wp-content/uploads/2024/12/WH-Lockup-Color-jpg.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/lyfe\_capital\_logo/2024-12-20T20:53:38+00:00https://timmermanreport.com/wp-content/uploads/2024/12/lyfe\_capital\_logo.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/ipa\_gray\_lg-rgb-1733152164/2024-12-20T20:55:16+00:00https://timmermanreport.com/wp-content/uploads/2024/12/ipa\_gray\_lg-rgb-1733152164.jpghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/orbimed-logo-full-color-1734618930/2024-12-20T20:55:40+00:00https://timmermanreport.com/wp-content/uploads/2024/12/orbimed-logo-full-color-1734618930.pnghttps://timmermanreport.com/2024/05/delphia-raises-67m-to-nudge-cancer-cells-beyond-the-red-line/schenkein-3/2025-01-02T14:48:51+00:00https://timmermanreport.com/wp-content/uploads/2024/05/schenkein.pnghttps://timmermanreport.com/2025/01/ai-needs-natural-language-to-give-structure-to-biology/samr/2025-01-04T00:23:38+00:00https://timmermanreport.com/wp-content/uploads/2025/01/samr.pnghttps://timmermanreport.com/2025/01/china-is-here-to-stay-as-a-leader-on-the-global-biotech-stage/davidli/2025-01-07T17:15:20+00:00https://timmermanreport.com/wp-content/uploads/2025/01/davidli.pnghttps://timmermanreport.com/2025/01/china-is-here-to-stay-as-a-leader-on-the-global-biotech-stage/dealforma/2025-01-07T17:18:09+00:00https://timmermanreport.com/wp-content/uploads/2025/01/dealforma.pnghttps://timmermanreport.com/2025/01/australias-little-known-biotech-advantages-and-risks/getts-2/2025-01-08T23:57:33+00:00https://timmermanreport.com/wp-content/uploads/2025/01/getts.pnghttps://timmermanreport.com/2023/10/aiolos-bio-with-245m-from-atlas-bain-aims-at-tslp-for-asthma/khurem-farooq1/2025-01-10T03:13:48+00:00https://timmermanreport.com/wp-content/uploads/2023/10/Khurem-Farooq1.jpghttps://timmermanreport.com/2025/01/novo-variant-benefit-sharing-win-verdiva-joins-obesity-fray-maze-aims-for-ipo/bencravatt/2025-01-10T03:15:37+00:00https://timmermanreport.com/wp-content/uploads/2025/01/bencravatt.jpghttps://timmermanreport.com/2025/01/novo-variant-benefit-sharing-win-verdiva-joins-obesity-fray-maze-aims-for-ipo/andy/2025-01-10T03:27:06+00:00https://timmermanreport.com/wp-content/uploads/2025/01/andy.pnghttps://timmermanreport.com/2022/06/nucleate-doubles-in-size-tapping-into-young-scientists-entrepreneurial-dreams/souf/2025-01-10T03:27:59+00:00https://timmermanreport.com/wp-content/uploads/2022/06/souf.jpghttps://timmermanreport.com/2025/01/novo-variant-benefit-sharing-win-verdiva-joins-obesity-fray-maze-aims-for-ipo/vidyavasu/2025-01-10T03:29:39+00:00https://timmermanreport.com/wp-content/uploads/2025/01/vidyavasu.jpghttps://timmermanreport.com/2025/01/novo-variant-benefit-sharing-win-verdiva-joins-obesity-fray-maze-aims-for-ipo/sana/2025-01-10T03:30:25+00:00https://timmermanreport.com/wp-content/uploads/2025/01/sana.pnghttps://timmermanreport.com/2025/01/novo-variant-benefit-sharing-win-verdiva-joins-obesity-fray-maze-aims-for-ipo/stanfordpeng/2025-01-10T03:36:35+00:00https://timmermanreport.com/wp-content/uploads/2025/01/stanfordpeng.jpghttps://timmermanreport.com/2022/10/variant-bio-strikes-new-pharma-bargain-shares-benefits-of-human-genetic-research/kwasik/2025-01-12T22:14:20+00:00https://timmermanreport.com/wp-content/uploads/2022/10/kwasik.pnghttps://timmermanreport.com/2025/01/moving-from-biotech-to-nature/kajadna/2025-01-12T22:22:56+00:00https://timmermanreport.com/wp-content/uploads/2025/01/kajadna.pnghttps://timmermanreport.com/2025/01/moving-from-biotech-to-nature/kajaandlulu/2025-01-12T22:28:08+00:00https://timmermanreport.com/wp-content/uploads/2025/01/kajaandlulu.jpghttps://timmermanreport.com/2025/01/jj-doubles-down-on-neuro-lilly-acquires-scorpion-umoja-pulls-in-100m/scorpion/2025-01-16T23:34:12+00:00https://timmermanreport.com/wp-content/uploads/2025/01/scorpion.pnghttps://timmermanreport.com/2017/05/12-vcs-matter-never-read-2/benauspitz\_2-12-2016-319x319/2025-01-16T23:35:27+00:00https://timmermanreport.com/wp-content/uploads/2017/05/BenAuspitz\_2-12-2016-319x319.jpghttps://timmermanreport.com/2025/01/jj-doubles-down-on-neuro-lilly-acquires-scorpion-umoja-pulls-in-100m/gridteam-auspitz-300x230/2025-01-16T23:36:22+00:00https://timmermanreport.com/wp-content/uploads/2025/01/gridteam-auspitz-300x230-1.jpghttps://timmermanreport.com/2025/01/jj-doubles-down-on-neuro-lilly-acquires-scorpion-umoja-pulls-in-100m/gilad/2025-01-16T23:37:28+00:00https://timmermanreport.com/wp-content/uploads/2025/01/gilad.jpghttps://timmermanreport.com/2025/01/jj-doubles-down-on-neuro-lilly-acquires-scorpion-umoja-pulls-in-100m/scharenberg/2025-01-16T23:39:08+00:00https://timmermanreport.com/wp-content/uploads/2025/01/scharenberg.jpghttps://timmermanreport.com/2025/01/pfizers-oxbryta-was-transformational-for-my-sickle-cell-warriors-bring-it-back/mapillar-dahn-mts-board-member/2025-01-19T04:59:05+00:00https://timmermanreport.com/wp-content/uploads/2025/01/MAPILLAR-DAHN-MTS-BOARD-MEMBER.pnghttps://timmermanreport.com/2022/05/an-old-idea-whose-time-has-come/mostafa/2025-01-27T20:00:33+00:00https://timmermanreport.com/wp-content/uploads/2022/05/mostafa.jpghttps://timmermanreport.com/2025/01/takeda-passes-torch-cargo-crashes-akero-nails-mash-trial/barclay/2025-01-30T17:06:00+00:00https://timmermanreport.com/wp-content/uploads/2025/01/barclay.pnghttps://timmermanreport.com/2023/09/freeing-the-biotech-founders-zach-weinberg-and-alexis-borisy-on-the-long-run/zach/2025-01-30T17:07:27+00:00https://timmermanreport.com/wp-content/uploads/2023/08/zach.jpghttps://timmermanreport.com/2025/01/takeda-passes-torch-cargo-crashes-akero-nails-mash-trial/juliekim/2025-01-30T17:09:39+00:00https://timmermanreport.com/wp-content/uploads/2025/01/juliekim.pnghttps://timmermanreport.com/2025/01/takeda-passes-torch-cargo-crashes-akero-nails-mash-trial/simonbarnett-2/2025-01-30T17:10:22+00:00https://timmermanreport.com/wp-content/uploads/2025/01/simonbarnett.pnghttps://timmermanreport.com/2024/11/lessons-from-the-manure-digester/screenshot-2024-11-04-195135/2025-01-30T17:11:12+00:00https://timmermanreport.com/wp-content/uploads/2024/11/Screenshot-2024-11-04-195135.pnghttps://timmermanreport.com/2025/02/the-future-of-ai-and-health-part-i-forecasts-reveals-little-consensus/sama/2025-02-02T15:52:08+00:00https://timmermanreport.com/wp-content/uploads/2025/02/sama.jpghttps://timmermanreport.com/2025/02/the-future-of-ai-and-health-part-i-forecasts-reveals-little-consensus/subha/2025-02-02T15:55:04+00:00https://timmermanreport.com/wp-content/uploads/2025/02/subha.pnghttps://timmermanreport.com/2025/02/the-future-of-ai-and-health-part-ii-andreessen-and-colleagues-weigh-in/yoo/2025-02-02T16:01:14+00:00https://timmermanreport.com/wp-content/uploads/2025/02/yoo.pnghttps://timmermanreport.com/2025/02/timmerman-report-turns-10/timmerman-report-logo-tr10\_tr-10-logo-2/2025-02-02T20:13:48+00:00https://timmermanreport.com/wp-content/uploads/2025/02/Timmerman-Report-Logo-TR10\_TR-10-Logo.jpghttps://timmermanreport.com/2025/02/timmerman-report-turns-10/timmerman-report-logo-tr10\_tr-10-logo-copy/2025-02-02T20:16:28+00:00https://timmermanreport.com/wp-content/uploads/2025/02/Timmerman-Report-Logo-TR10\_TR-10-Logo-copy.jpghttps://timmermanreport.com/2025/02/billion-cells-project-alumis-merges-bms-cuts-deeper/martin\_babler/2025-02-07T00:48:21+00:00https://timmermanreport.com/wp-content/uploads/2025/02/martin\_babler.jpghttps://timmermanreport.com/2025/02/billion-cells-project-alumis-merges-bms-cuts-deeper/george/2025-02-07T00:51:03+00:00https://timmermanreport.com/wp-content/uploads/2025/02/george.jpghttps://timmermanreport.com/2025/02/billion-cells-project-alumis-merges-bms-cuts-deeper/martin/2025-02-07T00:51:46+00:00https://timmermanreport.com/wp-content/uploads/2025/02/martin.jpghttps://timmermanreport.com/2025/02/billion-cells-project-alumis-merges-bms-cuts-deeper/billion/2025-02-07T00:55:08+00:00https://timmermanreport.com/wp-content/uploads/2025/02/billion.pnghttps://timmermanreport.com/2025/02/building-a-fully-integrated-biopharma-for-the-muscle-robert-blum-on-the-long-run/chordoma/2025-02-11T13:32:01+00:00https://timmermanreport.com/wp-content/uploads/2025/02/chordoma.pnghttps://timmermanreport.com/2025/02/building-a-fully-integrated-biopharma-for-the-muscle-robert-blum-on-the-long-run/blum/2025-02-11T13:38:18+00:00https://timmermanreport.com/wp-content/uploads/2025/02/blum.pnghttps://timmermanreport.com/2025/02/rfk-jr-in-power-nih-and-fda-on-the-chopping-block-interest-rates-loom-large/arbuckle\_stuart\_500x500/2025-02-14T01:38:25+00:00https://timmermanreport.com/wp-content/uploads/2025/02/arbuckle\_stuart\_500x500.jpghttps://timmermanreport.com/2025/02/rfk-jr-in-power-nih-and-fda-on-the-chopping-block-interest-rates-loom-large/kristen\_hege\_\_md/2025-02-14T01:39:23+00:00https://timmermanreport.com/wp-content/uploads/2025/02/Kristen\_Hege\_\_MD.pnghttps://timmermanreport.com/2025/02/zero-toll-medicine-how-individuals-can-use-crypto-and-ai-to-fix-us-health-insurance/daw/2025-02-15T15:26:49+00:00https://timmermanreport.com/wp-content/uploads/2025/02/daw.jpghttps://timmermanreport.com/2025/02/zero-toll-medicine-how-individuals-can-use-crypto-and-ai-to-fix-us-health-insurance/type-of-coverage/2025-02-15T15:40:14+00:00https://timmermanreport.com/wp-content/uploads/2025/02/type-of-coverage.pnghttps://timmermanreport.com/2025/02/defend-the-fda/makary-martin-1831134337/2025-02-18T02:01:07+00:00https://timmermanreport.com/wp-content/uploads/2025/02/makary-martin-1831134337.jpghttps://timmermanreport.com/readers-saying/rob-perez-2/2025-02-25T15:52:40+00:00https://timmermanreport.com/wp-content/uploads/2025/02/Rob-Perez.jpghttps://timmermanreport.com/2021/05/startup-profiles-perlmutter-bets-on-super-microscopy-foresites-precision-immunology/perlmutter1/2025-02-28T01:54:59+00:00https://timmermanreport.com/wp-content/uploads/2021/05/Perlmutter1.jpghttps://timmermanreport.com/2025/02/bluebird-fire-sale-regenerons-gene-therapy-for-deafness-eikon-raises-a-bundle/safina/2025-02-28T01:56:17+00:00https://timmermanreport.com/wp-content/uploads/2025/02/safina.pnghttps://timmermanreport.com/2025/02/bluebird-fire-sale-regenerons-gene-therapy-for-deafness-eikon-raises-a-bundle/ccep28-epwidethumb/2025-02-28T02:01:17+00:00https://timmermanreport.com/wp-content/uploads/2025/02/CCEp28-EpWideThumb.jpghttps://timmermanreport.com/2025/03/climbing-solo-qa-on-founding-tr/rainier2014-1024x768/2025-03-03T18:56:27+00:00https://timmermanreport.com/wp-content/uploads/2025/03/rainier2014-1024x768-1.jpghttps://timmermanreport.com/2025/03/sluggish-corporate-ai-adoption-has-motivated-entrepreneurs-to-pick-their-spots/ziv/2025-03-06T02:35:58+00:00https://timmermanreport.com/wp-content/uploads/2025/03/ziv.jpghttps://timmermanreport.com/2025/03/biotech-legend-retires-jazz-buys-glioma-drug-fda-shakeup/dinesh/2025-03-06T17:47:42+00:00https://timmermanreport.com/wp-content/uploads/2025/03/dinesh.jpghttps://timmermanreport.com/2025/03/biotech-legend-retires-jazz-buys-glioma-drug-fda-shakeup/regina/2025-03-06T17:49:10+00:00https://timmermanreport.com/wp-content/uploads/2025/03/regina.jpghttps://timmermanreport.com/2025/03/biotech-legend-retires-jazz-buys-glioma-drug-fda-shakeup/peyton/2025-03-06T17:50:01+00:00https://timmermanreport.com/wp-content/uploads/2025/03/peyton.jpghttps://timmermanreport.com/2025/03/biotech-legend-retires-jazz-buys-glioma-drug-fda-shakeup/rod/2025-03-06T18:14:07+00:00https://timmermanreport.com/wp-content/uploads/2025/03/rod.pnghttps://timmermanreport.com/2025/03/scientists-standing-up-in-seattle/arjunkumar/2025-03-09T23:09:25+00:00https://timmermanreport.com/wp-content/uploads/2025/03/arjunkumar.jpghttps://timmermanreport.com/2025/03/scientists-standing-up-in-seattle/arjun1/2025-03-09T23:10:45+00:00https://timmermanreport.com/wp-content/uploads/2025/03/arjun1.jpghttps://timmermanreport.com/2025/03/scientists-standing-up-in-seattle/arjun2/2025-03-09T23:13:00+00:00https://timmermanreport.com/wp-content/uploads/2025/03/arjun2.pnghttps://timmermanreport.com/2025/03/protagonist-delivers-bms-bargain-hunts-and-zealand-goes-major-league/abbas/2025-03-13T22:44:58+00:00https://timmermanreport.com/wp-content/uploads/2025/03/abbas.jpghttps://timmermanreport.com/2021/02/centessa-rolls-up-10-medicxi-startups-gets-250m-to-scale-up-virtual-model/es-slaoui-02/2025-03-16T01:03:36+00:00https://timmermanreport.com/wp-content/uploads/2021/02/ES-Slaoui-02.jpeghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-195/2025-03-16T01:04:34+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-195.jpghttps://timmermanreport.com/2025/03/why-cell-gene-therapy-companies-should-talk-with-rfk-jr/timhunt/2025-03-17T20:06:48+00:00https://timmermanreport.com/wp-content/uploads/2025/03/timhunt.pnghttps://timmermanreport.com/2025/03/arbor-survives-winter-gets-73-9m-to-take-gene-editing-to-the-clinic/devynsmith/2025-03-18T00:33:54+00:00https://timmermanreport.com/wp-content/uploads/2025/03/devynsmith.jpghttps://timmermanreport.com/2025/03/see-the-photos-from-tr10-east/20250306\_tr10\_030/2025-03-19T00:26:04+00:00https://timmermanreport.com/wp-content/uploads/2025/03/20250306\_TR10\_030-scaled.jpghttps://timmermanreport.com/2025/03/see-the-photos-from-tr10-west/tr10-west-coast-party-13mar25-496/2025-03-19T01:12:29+00:00https://timmermanreport.com/wp-content/uploads/2025/03/tr10-west-coast-party-13mar25-496.jpghttps://timmermanreport.com/2025/03/see-the-photos-from-tr10-west/tr10-west-coast-party-13mar25-398/2025-03-19T01:22:57+00:00https://timmermanreport.com/wp-content/uploads/2025/03/tr10-west-coast-party-13mar25-398.jpghttps://timmermanreport.com/2021/10/young-biotech-entrepreneurs-finding-community-tony-kulesa-on-the-long-run/tkulesa/2025-03-20T23:12:45+00:00https://timmermanreport.com/wp-content/uploads/2021/10/tkulesa.pnghttps://timmermanreport.com/2025/03/curevo-and-arbor-defy-gravity-sarepta-and-cargo-stumble-az-bets-on-in-vivo/chip/2025-03-20T23:14:13+00:00https://timmermanreport.com/wp-content/uploads/2025/03/chip.pnghttps://timmermanreport.com/2025/03/curevo-and-arbor-defy-gravity-sarepta-and-cargo-stumble-az-bets-on-in-vivo/annachen/2025-03-20T23:15:30+00:00https://timmermanreport.com/wp-content/uploads/2025/03/annachen.jpghttps://timmermanreport.com/2025/03/how-a-dark-horse-candidate-is-upending-the-sequencing-market/joeh/2025-03-22T12:56:21+00:00https://timmermanreport.com/wp-content/uploads/2025/03/joeh.pnghttps://timmermanreport.com/2025/03/how-a-dark-horse-candidate-is-upending-the-sequencing-market/xpandomer/2025-03-22T13:09:07+00:00https://timmermanreport.com/wp-content/uploads/2025/03/xpandomer.jpghttps://timmermanreport.com/2025/03/how-a-dark-horse-candidate-is-upending-the-sequencing-market/kokoris/2025-03-22T13:21:46+00:00https://timmermanreport.com/wp-content/uploads/2025/03/kokoris.jpghttps://timmermanreport.com/2025/03/nih-cuts-threaten-to-cede-u-s-life-science-dominance-to-china/epauline/2025-03-24T14:41:28+00:00https://timmermanreport.com/wp-content/uploads/2025/03/epauline.pnghttps://timmermanreport.com/2025/03/nih-cuts-threaten-to-cede-u-s-life-science-dominance-to-china/lgunter/2025-03-24T14:42:07+00:00https://timmermanreport.com/wp-content/uploads/2025/03/lgunter.pnghttps://timmermanreport.com/2025/03/nih-cuts-threaten-to-cede-u-s-life-science-dominance-to-china/mcummings/2025-03-24T14:42:49+00:00https://timmermanreport.com/wp-content/uploads/2025/03/mcummings.pnghttps://timmermanreport.com/2025/03/nih-cuts-threaten-to-cede-u-s-life-science-dominance-to-china/srapundalo/2025-03-24T14:43:20+00:00https://timmermanreport.com/wp-content/uploads/2025/03/srapundalo.pnghttps://timmermanreport.com/2025/03/soleno-breaks-through-tempero-takes-on-addiction-and-23andme-goes-bankrupt/bob-small-headshot-768x712/2025-03-28T02:11:08+00:00https://timmermanreport.com/wp-content/uploads/2025/03/Bob-Small-Headshot-768x712-1.jpghttps://timmermanreport.com/2020/08/ohana-biosciences-and-sperm-biology-the-other-half-of-the-fertility-equation/amber/2025-03-28T02:14:15+00:00https://timmermanreport.com/wp-content/uploads/2020/07/amber.jpghttps://timmermanreport.com/2025/03/soleno-breaks-through-tempero-takes-on-addiction-and-23andme-goes-bankrupt/tassos/2025-03-28T02:16:44+00:00https://timmermanreport.com/wp-content/uploads/2025/03/tassos.jpghttps://timmermanreport.com/2025/03/longevity-is-having-a-moment/fyfe/2025-03-29T00:48:13+00:00https://timmermanreport.com/wp-content/uploads/2025/03/fyfe.pnghttps://timmermanreport.com/2025/03/longevity-is-having-a-moment/hluks/2025-03-29T01:03:28+00:00https://timmermanreport.com/wp-content/uploads/2025/03/hluks.pnghttps://timmermanreport.com/2025/03/longevity-is-having-a-moment/guarente\_lenny-2017-1536x1024/2025-03-29T01:11:56+00:00https://timmermanreport.com/wp-content/uploads/2025/03/GUARENTE\_Lenny-2017-1536x1024-1.jpghttps://timmermanreport.com/2020/12/listening-through-the-noise-and-talking-to-those-who-will-listen/samblackman/2025-03-30T21:27:09+00:00https://timmermanreport.com/wp-content/uploads/2020/12/samblackman.pnghttps://timmermanreport.com/2025/03/looking-back-and-seeing-the-future-the-relationships-that-propel-biotech/copeland\_vertical/2025-03-30T21:34:35+00:00https://timmermanreport.com/wp-content/uploads/2025/03/Copeland\_Vertical.jpghttps://timmermanreport.com/2025/03/relationships-that-make-techbio-go-round-david-roblin-on-the-long-run/davidroblin/2025-03-31T21:57:48+00:00https://timmermanreport.com/wp-content/uploads/2025/03/davidroblin.pnghttps://timmermanreport.com/2024/10/call-for-entries-join-the-timmerman-traverse-for-damon-runyon-cancer-research/henrywill/2025-04-02T21:42:31+00:00https://timmermanreport.com/wp-content/uploads/2024/10/henrywill.jpghttps://timmermanreport.com/2023/12/abbvie-buys-cerevel-roche-buys-carmot-crowley-steps-into-the-lions-den/john\_f-\_crowley/2025-04-03T23:47:01+00:00https://timmermanreport.com/wp-content/uploads/2023/12/John\_F.\_Crowley.jpghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/steele\_photo/2025-04-03T23:48:03+00:00https://timmermanreport.com/wp-content/uploads/2025/04/Steele\_Photo.jpghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/erica/2025-04-03T23:49:32+00:00https://timmermanreport.com/wp-content/uploads/2025/04/erica.pnghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/aakre/2025-04-03T23:51:24+00:00https://timmermanreport.com/wp-content/uploads/2025/04/aakre.jpghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/lancaster/2025-04-03T23:53:05+00:00https://timmermanreport.com/wp-content/uploads/2025/04/lancaster.jpghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/alec/2025-04-03T23:55:05+00:00https://timmermanreport.com/wp-content/uploads/2025/04/alec.pnghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/gottlieb/2025-04-03T23:55:39+00:00https://timmermanreport.com/wp-content/uploads/2025/04/gottlieb.pnghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/rfkapr-1-2025/2025-04-03T23:59:39+00:00https://timmermanreport.com/wp-content/uploads/2025/04/rfkapr.1.2025.pnghttps://timmermanreport.com/2025/04/fda-gutted-novartis-kidney-drug-pays-off-and-isomorphic-raises-a-fortune/gv\_yeshwant\_krishna\_0144\_simple/2025-04-04T00:02:10+00:00https://timmermanreport.com/wp-content/uploads/2025/04/GV\_Yeshwant\_Krishna\_0144\_simple.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/fenwicklogo/2025-04-06T16:09:34+00:00https://timmermanreport.com/wp-content/uploads/2025/04/fenwicklogo.pnghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/ttlscsummit2024/2025-04-06T16:12:44+00:00https://timmermanreport.com/wp-content/uploads/2025/04/ttlscsummit2024.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/timmermantraversestackedlsc/2025-04-06T16:20:02+00:00https://timmermanreport.com/wp-content/uploads/2025/04/timmermantraversestackedlsc.pnghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/0f4c0b22-721e-4205-bf5f-9eae43985474/2025-04-06T16:29:20+00:00https://timmermanreport.com/wp-content/uploads/2025/04/0f4c0b22-721e-4205-bf5f-9eae43985474.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/625018a5-e9d7-4a9a-938d-7bfa33662736/2025-04-06T16:29:21+00:00https://timmermanreport.com/wp-content/uploads/2025/04/625018a5-e9d7-4a9a-938d-7bfa33662736.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/97981320-918c-424d-8117-e48549589ff9/2025-04-06T16:29:23+00:00https://timmermanreport.com/wp-content/uploads/2025/04/97981320-918c-424d-8117-e48549589ff9.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/99164697-13fc-46b8-87ef-3e1585a114b4/2025-04-06T16:29:24+00:00https://timmermanreport.com/wp-content/uploads/2025/04/99164697-13fc-46b8-87ef-3e1585a114b4.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/a1fc1583-6ab6-4bfb-ae11-1b4fa480f6c2/2025-04-06T16:29:26+00:00https://timmermanreport.com/wp-content/uploads/2025/04/a1fc1583-6ab6-4bfb-ae11-1b4fa480f6c2.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/d99d093e-a917-4de3-8459-5305b566b5d0/2025-04-06T16:29:29+00:00https://timmermanreport.com/wp-content/uploads/2025/04/d99d093e-a917-4de3-8459-5305b566b5d0.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/banner/2025-04-06T16:34:46+00:00https://timmermanreport.com/wp-content/uploads/2025/04/banner.pnghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/6-2/2025-04-06T16:37:35+00:00https://timmermanreport.com/wp-content/uploads/2025/04/6.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/9-2/2025-04-06T16:38:47+00:00https://timmermanreport.com/wp-content/uploads/2025/04/9.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/9895f0ff-7093-4f61-b035-2f103c27bcd5/2025-04-06T16:44:52+00:00https://timmermanreport.com/wp-content/uploads/2025/04/9895f0ff-7093-4f61-b035-2f103c27bcd5.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/184828d1-d5f0-40ce-9a8a-70e66a01324a/2025-04-06T16:44:54+00:00https://timmermanreport.com/wp-content/uploads/2025/04/184828d1-d5f0-40ce-9a8a-70e66a01324a.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/e290e25f-96bd-49d4-a3f2-0606652609b4/2025-04-06T16:44:55+00:00https://timmermanreport.com/wp-content/uploads/2025/04/e290e25f-96bd-49d4-a3f2-0606652609b4.jpghttps://timmermanreport.com/2025/04/meet-the-timmerman-traverse-for-life-science-cares-2025-team/a49f8a91-5bab-4507-9a78-0d8267a00145/2025-04-06T16:47:00+00:00https://timmermanreport.com/wp-content/uploads/2025/04/a49f8a91-5bab-4507-9a78-0d8267a00145.jpghttps://timmermanreport.com/2025/04/leaving-a-mark-on-patients/eastwood/2025-04-08T00:43:51+00:00https://timmermanreport.com/wp-content/uploads/2025/04/eastwood.pnghttps://timmermanreport.com/2025/04/leaving-a-mark-on-patients/petermarks/2025-04-08T00:46:57+00:00https://timmermanreport.com/wp-content/uploads/2025/04/petermarks.pnghttps://timmermanreport.com/2025/04/fda-in-crisis-parker-institute-snags-big-fish-merida-megaround/perrone/2025-04-11T00:33:13+00:00https://timmermanreport.com/wp-content/uploads/2025/04/perrone.pnghttps://timmermanreport.com/2025/04/fda-in-crisis-parker-institute-snags-big-fish-merida-megaround/iramellman\_600x600/2025-04-11T00:36:54+00:00https://timmermanreport.com/wp-content/uploads/2025/04/IraMellman\_600x600.jpghttps://timmermanreport.com/2025/04/fda-in-crisis-parker-institute-snags-big-fish-merida-megaround/jungchoi/2025-04-11T00:37:46+00:00https://timmermanreport.com/wp-content/uploads/2025/04/jungchoi.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2025/screenshot-2025-04-11-at-11-08-29%e2%80%afam/2025-04-11T15:08:51+00:00https://timmermanreport.com/wp-content/uploads/2025/04/Screenshot-2025-04-11-at-11.08.29%E2%80%AFAM.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc-2025/screenshot-2025-04-11-at-11-11-25%e2%80%afam/2025-04-11T15:11:46+00:00https://timmermanreport.com/wp-content/uploads/2025/04/Screenshot-2025-04-11-at-11.11.25%E2%80%AFAM.pnghttps://timmermanreport.com/2025/04/finding-new-targets-for-cancer-drugs-kevin-parker-on-the-long-run/kevin-ceo-min/2025-04-14T11:46:44+00:00https://timmermanreport.com/wp-content/uploads/2025/04/kevin-ceo-min.pnghttps://timmermanreport.com/2025/04/embracing-non-linear-career-paths-professor-martin-gaynor/screenshot-2025-04-22-at-1-03-33%e2%80%afpm/2025-04-22T17:05:19+00:00https://timmermanreport.com/wp-content/uploads/2025/04/Screenshot-2025-04-22-at-1.03.33%E2%80%AFPM.pnghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/3c0bfd66-2623-4e0f-af5b-905bbe1557b7/2025-05-02T10:02:58+00:00https://timmermanreport.com/wp-content/uploads/2025/05/3c0bfd66-2623-4e0f-af5b-905bbe1557b7.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/5e35e5c7-c2bb-4bac-b9bf-cecb078c0665/2025-05-02T10:03:01+00:00https://timmermanreport.com/wp-content/uploads/2025/05/5e35e5c7-c2bb-4bac-b9bf-cecb078c0665.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/99eb27d0-8910-4449-b91f-7fe941f4102d/2025-05-02T10:03:04+00:00https://timmermanreport.com/wp-content/uploads/2025/05/99eb27d0-8910-4449-b91f-7fe941f4102d.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/fdaa4743-43b8-4c8a-9e97-f755134bf5bb/2025-05-02T10:03:11+00:00https://timmermanreport.com/wp-content/uploads/2025/05/fdaa4743-43b8-4c8a-9e97-f755134bf5bb.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/fullsizerender1/2025-05-02T10:03:19+00:00https://timmermanreport.com/wp-content/uploads/2025/05/FullSizeRender1.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/fullsizerender/2025-05-02T10:03:21+00:00https://timmermanreport.com/wp-content/uploads/2025/05/FullSizeRender.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_2806/2025-05-02T10:06:42+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_2806-scaled.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_2933/2025-05-02T10:06:47+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_2933-scaled.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_3103/2025-05-02T10:06:50+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_3103-rotated.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_3204/2025-05-02T10:06:51+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_3204.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_3246/2025-05-02T10:06:53+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_3246.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_3507/2025-05-02T10:08:01+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_3507.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_5622/2025-05-02T10:08:05+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_5622.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_7402/2025-05-02T10:08:06+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_7402-scaled.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_7451/2025-05-02T10:08:10+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_7451-rotated.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/img\_9473/2025-05-02T10:08:12+00:00https://timmermanreport.com/wp-content/uploads/2025/05/IMG\_9473.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/3595ab16-19fe-4540-a25b-0aedfd04cb5c/2025-05-02T10:29:18+00:00https://timmermanreport.com/wp-content/uploads/2025/05/3595ab16-19fe-4540-a25b-0aedfd04cb5c.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/ebc2/2025-05-02T10:39:18+00:00https://timmermanreport.com/wp-content/uploads/2025/05/ebc2.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/ebc3/2025-05-02T10:39:21+00:00https://timmermanreport.com/wp-content/uploads/2025/05/ebc3.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/ebc4/2025-05-02T10:39:22+00:00https://timmermanreport.com/wp-content/uploads/2025/05/ebc4.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/ebc5/2025-05-02T11:00:48+00:00https://timmermanreport.com/wp-content/uploads/2025/05/ebc5-scaled.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/ebc6/2025-05-02T11:00:52+00:00https://timmermanreport.com/wp-content/uploads/2025/05/ebc6.jpghttps://timmermanreport.com/2025/05/a-sublime-experience-views-of-timmerman-traverse-for-damon-runyon-cancer-research/ebc7/2025-05-02T11:00:54+00:00https://timmermanreport.com/wp-content/uploads/2025/05/ebc7.jpghttps://timmermanreport.com/2025/05/newlimits-anti-aging-bounty-a-twist-spinout-ai-coming-to-the-fda/makary/2025-05-08T22:43:07+00:00https://timmermanreport.com/wp-content/uploads/2025/05/makary.pnghttps://timmermanreport.com/2025/05/newlimits-anti-aging-bounty-a-twist-spinout-ai-coming-to-the-fda/casey1/2025-05-08T22:44:58+00:00https://timmermanreport.com/wp-content/uploads/2025/05/casey1.pnghttps://timmermanreport.com/2025/05/newlimits-anti-aging-bounty-a-twist-spinout-ai-coming-to-the-fda/casey2/2025-05-08T22:44:59+00:00https://timmermanreport.com/wp-content/uploads/2025/05/casey2.pnghttps://timmermanreport.com/2025/05/newlimits-anti-aging-bounty-a-twist-spinout-ai-coming-to-the-fda/casey3/2025-05-08T22:45:00+00:00https://timmermanreport.com/wp-content/uploads/2025/05/casey3.pnghttps://timmermanreport.com/2025/05/newlimits-anti-aging-bounty-a-twist-spinout-ai-coming-to-the-fda/casey4/2025-05-08T22:45:00+00:00https://timmermanreport.com/wp-content/uploads/2025/05/casey4.pnghttps://timmermanreport.com/2025/05/newlimits-anti-aging-bounty-a-twist-spinout-ai-coming-to-the-fda/casey5/2025-05-08T22:45:01+00:00https://timmermanreport.com/wp-content/uploads/2025/05/casey5.pnghttps://timmermanreport.com/2025/05/biologic-drug-discovery-made-faster-peyton-greenside-on-the-long-run/pgreenside/2025-05-13T20:17:33+00:00https://timmermanreport.com/wp-content/uploads/2025/05/pgreenside.pnghttps://timmermanreport.com/about-luke-timmerman/lukeandron/2025-05-14T20:22:55+00:00https://timmermanreport.com/wp-content/uploads/2025/05/lukeandron.jpghttps://timmermanreport.com/2025/05/genentechs-bet-on-nc-gsk-buys-boston-liver-drug-septerna-entices-novo/vikas\_wh/2025-05-15T23:11:58+00:00https://timmermanreport.com/wp-content/uploads/2025/05/Vikas\_wh.pnghttps://timmermanreport.com/2025/05/genentechs-bet-on-nc-gsk-buys-boston-liver-drug-septerna-entices-novo/hhsai/2025-05-15T23:13:01+00:00https://timmermanreport.com/wp-content/uploads/2025/05/hhsai.pnghttps://timmermanreport.com/2023/04/gene-editing-therapies-delivered-in-vivo-ensomas-emile-nuwaysir-on-the-long-run/emilenuw/2025-05-15T23:14:08+00:00https://timmermanreport.com/wp-content/uploads/2023/04/emilenuw.jpghttps://timmermanreport.com/2025/05/genentechs-bet-on-nc-gsk-buys-boston-liver-drug-septerna-entices-novo/sophie/2025-05-15T23:17:25+00:00https://timmermanreport.com/wp-content/uploads/2025/05/Sophie.jpghttps://timmermanreport.com/2025/05/genentechs-bet-on-nc-gsk-buys-boston-liver-drug-septerna-entices-novo/emilenuw-2/2025-05-15T23:20:18+00:00https://timmermanreport.com/wp-content/uploads/2025/05/emilenuw.pnghttps://timmermanreport.com/2015/04/hungry-for-cash-academia-grabs-for-a-bigger-piece-of-biotech-action/jeffrey-d-marrazzo/2025-05-22T23:55:59+00:00https://timmermanreport.com/wp-content/uploads/2015/04/jeffrey-d-marrazzo.jpghttps://timmermanreport.com/2025/05/reclaiming-biotechs-edge-in-defense-of-taking-disciplined-risk/agv/2025-05-24T13:21:35+00:00https://timmermanreport.com/wp-content/uploads/2025/05/agv.pnghttps://timmermanreport.com/2025/05/glycoera-grabs-130m-to-develop-extracellular-protein-degraders-for-autoimmunity/ganesh-kaundinya/2025-05-24T16:39:28+00:00https://timmermanreport.com/wp-content/uploads/2025/05/Ganesh-Kaundinya.jpeghttps://timmermanreport.com/2025/05/5-east-asian-americans-in-biopharma-on-pivotal-moments-in-their-immigration-story/connieb/2025-05-29T02:48:51+00:00https://timmermanreport.com/wp-content/uploads/2025/05/connieb.pnghttps://timmermanreport.com/2025/05/5-east-asian-americans-in-biopharma-on-pivotal-moments-in-their-immigration-story/aileen/2025-05-29T02:51:07+00:00https://timmermanreport.com/wp-content/uploads/2025/05/aileen.pnghttps://timmermanreport.com/2025/05/5-east-asian-americans-in-biopharma-on-pivotal-moments-in-their-immigration-story/leoq/2025-05-29T02:53:38+00:00https://timmermanreport.com/wp-content/uploads/2025/05/leoq.pnghttps://timmermanreport.com/2025/05/5-east-asian-americans-in-biopharma-on-pivotal-moments-in-their-immigration-story/c5e0051a-2c6b-4684-85e2-055f780a5540/2025-05-29T02:55:13+00:00https://timmermanreport.com/wp-content/uploads/2025/05/C5E0051A-2C6B-4684-85E2-055F780A5540.pnghttps://timmermanreport.com/2025/05/5-east-asian-americans-in-biopharma-on-pivotal-moments-in-their-immigration-story/c5e0051a-2c6b-4684-85e2-055f780a5540-2/2025-05-29T02:57:06+00:00https://timmermanreport.com/wp-content/uploads/2025/05/C5E0051A-2C6B-4684-85E2-055F780A5540-1.pnghttps://timmermanreport.com/2025/05/gsk-antibiotic-hit-oric-prostate-cancer-drug-shines-taysha-goes-10-for-10/leadership-jacob/2025-05-29T23:28:35+00:00https://timmermanreport.com/wp-content/uploads/2025/05/leadership-Jacob.jpghttps://timmermanreport.com/2025/05/gsk-antibiotic-hit-oric-prostate-cancer-drug-shines-taysha-goes-10-for-10/lexeo-team\_r-nolan-townsend/2025-05-29T23:29:34+00:00https://timmermanreport.com/wp-content/uploads/2025/05/Lexeo-team\_R-Nolan-Townsend.pnghttps://timmermanreport.com/2025/06/nejm-study-linking-exercise-cancer-recovery-raises-two-concerns-what-if-its-wrong-what-if-its-right/screenshot-2025-06-03-at-8-10-47%e2%80%afpm/2025-06-04T00:21:13+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-03-at-8.10.47%E2%80%AFPM.pnghttps://timmermanreport.com/2025/06/nejm-study-linking-exercise-cancer-recovery-raises-two-concerns-what-if-its-wrong-what-if-its-right/screenshot-2025-06-03-at-8-11-22%e2%80%afpm/2025-06-04T00:23:10+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-03-at-8.11.22%E2%80%AFPM.pnghttps://timmermanreport.com/2025/06/request-an-invitation-to-the-timmerman-traverse/3-5/2025-06-05T00:14:47+00:00https://timmermanreport.com/wp-content/uploads/2025/06/3.jpghttps://timmermanreport.com/2025/06/request-an-invitation-to-the-timmerman-traverse/tten3-2/2025-06-05T00:16:37+00:00https://timmermanreport.com/wp-content/uploads/2025/06/tten3.jpghttps://timmermanreport.com/2025/06/request-an-invitation-to-the-timmerman-traverse/tten5-2/2025-06-05T00:16:38+00:00https://timmermanreport.com/wp-content/uploads/2025/06/tten5.jpghttps://timmermanreport.com/2025/06/request-an-invitation-to-the-timmerman-traverse/kili2024drcrfsummit/2025-06-05T00:21:27+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Kili2024DRCRFsummit.jpghttps://timmermanreport.com/2025/06/sanofi-buys-blueprint-bms-antes-for-biontech-bispecific-kymera-degrader-delivers/maky/2025-06-06T00:59:17+00:00https://timmermanreport.com/wp-content/uploads/2025/06/maky.jpghttps://timmermanreport.com/2025/06/finding-therapies-in-long-non-coding-rna-john-rinn-on-the-long-run/rinn/2025-06-11T22:19:34+00:00https://timmermanreport.com/wp-content/uploads/2025/06/rinn.pnghttps://timmermanreport.com/2025/06/avidity-advances-in-fshd-insmed-passes-pah-test-merck-delivers-with-oral-pcsk9/arachleff/2025-06-13T00:49:12+00:00https://timmermanreport.com/wp-content/uploads/2025/06/arachleff.jpghttps://timmermanreport.com/2025/06/avidity-advances-in-fshd-insmed-passes-pah-test-merck-delivers-with-oral-pcsk9/adamfriedman/2025-06-13T00:55:44+00:00https://timmermanreport.com/wp-content/uploads/2025/06/adamfriedman.jpghttps://timmermanreport.com/2017/12/a16z-rakes-new-450m-fund-bet-bringing-engineering-biology/vijay\_pande3/2025-06-13T00:56:01+00:00https://timmermanreport.com/wp-content/uploads/2017/12/vijay\_pande3.jpghttps://timmermanreport.com/2025/06/avidity-advances-in-fshd-insmed-passes-pah-test-merck-delivers-with-oral-pcsk9/screenshot-2025-06-12-171859/2025-06-13T00:56:37+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-12-171859.pnghttps://timmermanreport.com/2025/06/avidity-advances-in-fshd-insmed-passes-pah-test-merck-delivers-with-oral-pcsk9/screenshot-2025-06-12-155648/2025-06-13T00:56:57+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-12-155648.pnghttps://timmermanreport.com/2025/06/avidity-advances-in-fshd-insmed-passes-pah-test-merck-delivers-with-oral-pcsk9/screenshot-2025-06-12-180820/2025-06-13T01:09:37+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-12-180820.pnghttps://timmermanreport.com/2025/06/from-optimization-to-agency-reframing-the-future-of-personal-health/screenshot-2025-06-17-at-10-14-56%e2%80%afam/2025-06-17T14:15:29+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-17-at-10.14.56%E2%80%AFAM.pnghttps://timmermanreport.com/2025/06/from-optimization-to-agency-reframing-the-future-of-personal-health/screenshot-2025-06-17-at-10-14-16%e2%80%afam/2025-06-17T14:15:31+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-17-at-10.14.16%E2%80%AFAM.pnghttps://timmermanreport.com/2025/06/from-optimization-to-agency-reframing-the-future-of-personal-health/screenshot-2025-06-17-at-10-16-25%e2%80%afam/2025-06-17T14:17:01+00:00https://timmermanreport.com/wp-content/uploads/2025/06/Screenshot-2025-06-17-at-10.16.25%E2%80%AFAM.pnghttps://timmermanreport.com/2025/06/actio-bio-running-fast-and-lean-pockets-66m-for-precision-neuro-drug-rd/david-goldstein/2025-06-17T20:47:42+00:00https://timmermanreport.com/wp-content/uploads/2025/06/david-goldstein.jpghttps://timmermanreport.com/about-luke-timmerman/abi-royalty-pharma\_062525\_114-x3/2025-06-28T14:08:53+00:00https://timmermanreport.com/wp-content/uploads/2025/06/ABI-Royalty-Pharma\_062525\_114-X3.jpghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/img\_5203-2/2025-07-06T00:33:59+00:00https://timmermanreport.com/wp-content/uploads/2025/07/IMG\_5203-2.jpghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/img\_8063/2025-07-06T00:34:02+00:00https://timmermanreport.com/wp-content/uploads/2025/07/IMG\_8063-scaled.jpghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-32-01%e2%80%afpm/2025-07-06T00:34:28+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.32.01%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-22-28%e2%80%afpm/2025-07-06T00:34:29+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.22.28%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-23-03%e2%80%afpm/2025-07-06T00:34:30+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.23.03%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-26-42%e2%80%afpm/2025-07-06T00:34:33+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.26.42%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-26-50%e2%80%afpm/2025-07-06T00:34:34+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.26.50%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-26-56%e2%80%afpm/2025-07-06T00:34:35+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.26.56%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-28-04%e2%80%afpm/2025-07-06T00:34:36+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.28.04%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/img\_0416/2025-07-06T00:35:55+00:00https://timmermanreport.com/wp-content/uploads/2025/07/IMG\_0416.jpeghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-32-01%e2%80%afpm-2/2025-07-06T00:36:57+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.32.01%E2%80%AFPM-1.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-32-01%e2%80%afpm-3/2025-07-06T00:38:18+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.32.01%E2%80%AFPM-2.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-32-01%e2%80%afpm-4/2025-07-06T00:39:19+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.32.01%E2%80%AFPM-3.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-26-50%e2%80%afpm-2/2025-07-06T00:40:15+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.26.50%E2%80%AFPM-1.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-41-55%e2%80%afpm/2025-07-06T00:42:49+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.41.55%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-23-03%e2%80%afpm-2/2025-07-06T00:43:55+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.23.03%E2%80%AFPM-1.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-44-42%e2%80%afpm/2025-07-06T00:45:26+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.44.42%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-22-28%e2%80%afpm-2/2025-07-06T00:47:35+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.22.28%E2%80%AFPM-1.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/img\_0416-2/2025-07-06T00:49:17+00:00https://timmermanreport.com/wp-content/uploads/2025/07/IMG\_0416-1.jpeghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-52-15%e2%80%afpm/2025-07-06T00:52:43+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.52.15%E2%80%AFPM.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-28-04%e2%80%afpm-2/2025-07-06T00:52:58+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.28.04%E2%80%AFPM-1.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/screenshot-2025-07-05-at-8-52-15%e2%80%afpm-2/2025-07-06T00:53:56+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-05-at-8.52.15%E2%80%AFPM-1.pnghttps://timmermanreport.com/2025/07/personal-health-platforms-are-evolving-now-their-ambition-must-deepen/img\_5203-2-2/2025-07-06T00:55:21+00:00https://timmermanreport.com/wp-content/uploads/2025/07/IMG\_5203-2-1.jpghttps://timmermanreport.com/2025/07/5am-founded-renasant-bio-secures-54-5m-seed-for-adpkd-discovery/econley/2025-07-09T22:45:42+00:00https://timmermanreport.com/wp-content/uploads/2025/07/econley.pnghttps://timmermanreport.com/2025/07/merck-bets-10b-on-copd-abbvie-buys-in-vivo-car-t-fda-transparency/houston-3/2025-07-10T23:04:39+00:00https://timmermanreport.com/wp-content/uploads/2025/07/houston.pnghttps://timmermanreport.com/2023/12/the-small-molecule-drug-discovery-renaissance-jeff-jonker-on-the-long-run/jonker2023/2025-07-10T23:05:16+00:00https://timmermanreport.com/wp-content/uploads/2023/12/jonker2023.jpghttps://timmermanreport.com/2020/03/lessons-from-italy-how-the-us-can-respond-to-the-urgent-coronavirus-threat/otello-stampacchia-14\_square-crop/2025-07-19T21:04:28+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Otello-Stampacchia-14\_square-crop.jpghttps://timmermanreport.com/2025/07/omega-funds-delivering-new-medicines-and-returns-secures-647m-new-fund/screenshot-2025-07-19-131708/2025-07-19T21:05:53+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-19-131708.pnghttps://timmermanreport.com/2025/07/avalyn-pharma-gets-100m-to-deliver-inhalable-pulmonary-fibrosis-drugs/avalyn-team-lyn/2025-07-19T22:57:46+00:00https://timmermanreport.com/wp-content/uploads/2025/07/avalyn-team-Lyn.jpghttps://timmermanreport.com/2025/07/avalyn-pharma-gets-100m-to-deliver-inhalable-pulmonary-fibrosis-drugs/lynbaranowski/2025-07-22T22:44:00+00:00https://timmermanreport.com/wp-content/uploads/2025/07/lynbaranowski.pnghttps://timmermanreport.com/2020/04/building-on-our-immunology-understanding-seeing-reasons-for-hope/dougwilliams/2025-07-24T23:34:56+00:00https://timmermanreport.com/wp-content/uploads/2020/04/dougwilliams.jpghttps://timmermanreport.com/2022/08/arch-bets-50m-on-vilya-baker-lab-spinout-to-make-targeted-oral-macrocycle-drugs/sabahoney-2/2025-07-24T23:35:40+00:00https://timmermanreport.com/wp-content/uploads/2022/08/sabahoney.pnghttps://timmermanreport.com/2025/07/sarepta-crashes-abivax-soars-sanofi-buys-another-vaccine-platform/screenshot-2025-07-24-142515/2025-07-24T23:36:33+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-24-142515.pnghttps://timmermanreport.com/2025/07/sarepta-crashes-abivax-soars-sanofi-buys-another-vaccine-platform/screenshot-2025-07-24-152207/2025-07-24T23:37:41+00:00https://timmermanreport.com/wp-content/uploads/2025/07/Screenshot-2025-07-24-152207.pnghttps://timmermanreport.com/2025/07/gsk-doubles-down-on-china-sarepta-rebounds-and-fraziers-1-3b-fund/patrick-heron-headshot-1/2025-08-01T00:31:50+00:00https://timmermanreport.com/wp-content/uploads/2025/07/patrick-heron-headshot-1.jpghttps://timmermanreport.com/2021/03/amgen-acquires-rodeo-lean-startup-with-dual-mechanism-for-crohns-colitis/raymond-deshaies-desktop/2025-08-01T00:32:38+00:00https://timmermanreport.com/wp-content/uploads/2021/03/raymond-deshaies-desktop.jpghttps://timmermanreport.com/2025/08/video-phil-sharp-and-bill-haney-on-cracking-the-code/abi-royalty-pharma\_062525\_114-x3-2/2025-08-05T14:08:49+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ABI-Royalty-Pharma\_062525\_114-X3.jpghttps://timmermanreport.com/2025/08/car-t-cells-against-solid-tumors-sabah-oney-on-the-long-run/sabahoney-3/2025-08-06T13:10:50+00:00https://timmermanreport.com/wp-content/uploads/2025/08/sabahoney.jpghttps://timmermanreport.com/2025/08/car-t-cells-against-solid-tumors-sabah-oney-on-the-long-run/sabah/2025-08-06T13:12:06+00:00https://timmermanreport.com/wp-content/uploads/2025/08/sabah.pnghttps://timmermanreport.com/2025/08/orbimeds-royalty-fund-strand-advances-il-12-mrna-melintas-turnaround/christine-ann-miller-400x447-for-bio-page/2025-08-15T00:12:27+00:00https://timmermanreport.com/wp-content/uploads/2025/08/Christine-Ann-Miller-400x447-for-Bio-Page.pnghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/benscruggs/2025-08-15T00:13:14+00:00https://timmermanreport.com/wp-content/uploads/2019/11/benscruggs.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttlsc1/2025-08-24T20:08:24+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttlsc1.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttlsc25-2/2025-08-24T20:09:46+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttlsc25.2.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttlsc25-3/2025-08-24T20:10:58+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttlsc25.3.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttlsc25-4/2025-08-24T20:11:54+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttlsc25.4.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttlsc25-5/2025-08-24T20:13:09+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttlsc25.5.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttlsc25-6/2025-08-24T20:14:19+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttlsc25.6.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttenchantments/2025-08-24T20:15:31+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttenchantments.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttenchantments25-2/2025-08-24T20:16:27+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttenchantments25.2.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttenchantments25-3/2025-08-24T20:17:45+00:00https://timmermanreport.com/wp-content/uploads/2025/08/ttenchantments25.3.jpghttps://timmermanreport.com/life-science-cares-2024/9-3/2025-08-24T20:56:53+00:00https://timmermanreport.com/wp-content/uploads/2025/08/9.jpghttps://timmermanreport.com/2025/08/timmerman-traverse-for-life-science-cares-raises-another-1-1m-to-fight-poverty-in-2025/ttlsc-25-7/2025-08-25T13:24:22+00:00https://timmermanreport.com/wp-content/uploads/2025/08/TTlsc.25.7.jpghttps://timmermanreport.com/2025/08/lower-cost-accessible-cell-gene-therapies-jen-adair-on-the-long-run/jennifer-adair/2025-08-28T15:46:00+00:00https://timmermanreport.com/wp-content/uploads/2025/08/jennifer-adair.pnghttps://timmermanreport.com/2025/09/corsera-health-led-by-maraganore-and-meanwell-aims-to-prevent-heart-disease/john-maraganore-1600x1600/2025-08-30T19:20:25+00:00https://timmermanreport.com/wp-content/uploads/2025/08/John-Maraganore-1600x1600-1.jpghttps://timmermanreport.com/2025/09/atlas-adds-400m-kite-buys-in-vivo-car-t-company-abbvie-bets-on-psychedelics/akantor/2025-09-05T01:12:49+00:00https://timmermanreport.com/wp-content/uploads/2025/09/akantor.pnghttps://timmermanreport.com/2025/09/atlas-adds-400m-kite-buys-in-vivo-car-t-company-abbvie-bets-on-psychedelics/hhs/2025-09-05T01:13:24+00:00https://timmermanreport.com/wp-content/uploads/2025/09/hhs.pnghttps://timmermanreport.com/2025/09/atlas-adds-400m-kite-buys-in-vivo-car-t-company-abbvie-bets-on-psychedelics/viswa/2025-09-05T01:15:27+00:00https://timmermanreport.com/wp-content/uploads/2025/09/viswa.pnghttps://timmermanreport.com/2025/09/atlas-adds-400m-kite-buys-in-vivo-car-t-company-abbvie-bets-on-psychedelics/viswa-2/2025-09-05T01:16:28+00:00https://timmermanreport.com/wp-content/uploads/2025/09/viswa-1.pnghttps://timmermanreport.com/2025/09/novartis-ceo-vas-narasimhan-drawn-to-analytics-grounded-expectations-for-ai/screenshot-2025-09-05-at-10-58-10%e2%80%afam/2025-09-05T15:26:24+00:00https://timmermanreport.com/wp-content/uploads/2025/09/Screenshot-2025-09-05-at-10.58.10%E2%80%AFAM.jpghttps://timmermanreport.com/2025/09/next-big-thing-kilimanjaro-2026-for-damon-runyon-cancer-research/ttdamonrunyon2026banner/2025-09-08T21:52:39+00:00https://timmermanreport.com/wp-content/uploads/2025/09/TTdamonrunyon2026banner.pnghttps://timmermanreport.com/2025/09/next-big-thing-kilimanjaro-2026-for-damon-runyon-cancer-research/banner2/2025-09-08T22:05:45+00:00https://timmermanreport.com/wp-content/uploads/2025/09/banner2.pnghttps://timmermanreport.com/2025/09/next-big-thing-kilimanjaro-2026-for-damon-runyon-cancer-research/biomedrealt\_logoleft\_withtagline\_4\_-1753803674/2025-09-08T22:14:13+00:00https://timmermanreport.com/wp-content/uploads/2025/09/biomedrealt\_logoleft\_withtagline\_4\_-1753803674.pnghttps://timmermanreport.com/2025/09/next-big-thing-kilimanjaro-2026-for-damon-runyon-cancer-research/browneconsulting-logo-tagline-1754922301/2025-09-08T22:14:50+00:00https://timmermanreport.com/wp-content/uploads/2025/09/browneconsulting-logo-tagline-1754922301.pnghttps://timmermanreport.com/2025/09/next-big-thing-kilimanjaro-2026-for-damon-runyon-cancer-research/wolf\_greenfield\_full\_logo\_primary-1755095904/2025-09-08T22:14:51+00:00https://timmermanreport.com/wp-content/uploads/2025/09/wolf\_greenfield\_full\_logo\_primary-1755095904.pnghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/ebc2-2/2025-09-10T23:12:30+00:00https://timmermanreport.com/wp-content/uploads/2025/09/ebc2.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2025/ttlsc1-2/2025-09-10T23:14:34+00:00https://timmermanreport.com/wp-content/uploads/2025/09/ttlsc1.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2025/ttlsc25-2-2/2025-09-10T23:14:36+00:00https://timmermanreport.com/wp-content/uploads/2025/09/ttlsc25.2.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2025/ttlsc25-3-2/2025-09-10T23:14:37+00:00https://timmermanreport.com/wp-content/uploads/2025/09/ttlsc25.3.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2025/ttlsc25-4-2/2025-09-10T23:14:38+00:00https://timmermanreport.com/wp-content/uploads/2025/09/ttlsc25.4.jpghttps://timmermanreport.com/sickle-forward-2024/kilisfsummit24peyton-2/2025-09-10T23:19:01+00:00https://timmermanreport.com/wp-content/uploads/2025/09/kilisfsummit24peyton.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/88eab052-bc86-4fe2-ab55-e8567aabc812\_1\_105\_c/2025-09-10T23:24:09+00:00https://timmermanreport.com/wp-content/uploads/2025/09/88EAB052-BC86-4FE2-AB55-E8567AABC812\_1\_105\_c.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc-2022/day-2-hut/2025-09-10T23:24:10+00:00https://timmermanreport.com/wp-content/uploads/2025/09/Day-2-Hut.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/1-7/2025-09-10T23:25:20+00:00https://timmermanreport.com/wp-content/uploads/2025/09/1.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/2-5/2025-09-10T23:25:21+00:00https://timmermanreport.com/wp-content/uploads/2025/09/2.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/3-6/2025-09-10T23:25:22+00:00https://timmermanreport.com/wp-content/uploads/2025/09/3.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/madisonhut-3/2025-09-10T23:26:50+00:00https://timmermanreport.com/wp-content/uploads/2025/09/madisonhut.pnghttps://timmermanreport.com/2021/05/appia-bio-seeks-off-the-shelf-cancer-therapy-with-rare-inkt-cells/baltimore\_1\_crwbqpg-9a2d6c69-fill-310x412-c100/2025-09-11T23:05:19+00:00https://timmermanreport.com/wp-content/uploads/2021/05/Baltimore\_1\_crwBQpg.9a2d6c69.fill-310x412-c100.jpghttps://timmermanreport.com/2025/09/an-ipo-revival-novartis-buys-tourmaline-tribute-to-a-biology-pioneer/catharine/2025-09-11T23:09:09+00:00https://timmermanreport.com/wp-content/uploads/2025/09/catharine.jpghttps://timmermanreport.com/2025/09/leveraging-ai-at-the-fda-product-reviews-and-beyond/kannarkat-joseph-1/2025-09-12T20:36:35+00:00https://timmermanreport.com/wp-content/uploads/2025/09/Kannarkat-Joseph-1.jpghttps://timmermanreport.com/2025/09/leveraging-ai-at-the-fda-product-reviews-and-beyond/fordiapicture/2025-09-12T20:37:00+00:00https://timmermanreport.com/wp-content/uploads/2025/09/FordiaPicture-scaled.jpghttps://timmermanreport.com/2025/09/first-cincor-now-allrock-versant-westlake-pump-50m-into-pah-startup/catherine-pearce/2025-09-16T00:24:27+00:00https://timmermanreport.com/wp-content/uploads/2025/09/Catherine-Pearce.jpghttps://timmermanreport.com/2025/09/first-cincor-now-allrock-versant-westlake-pump-50m-into-pah-startup/bill-marshall-headshot/2025-09-16T00:25:26+00:00https://timmermanreport.com/wp-content/uploads/2025/09/Bill-Marshall-Headshot.jpghttps://timmermanreport.com/2025/09/first-cincor-now-allrock-versant-westlake-pump-50m-into-pah-startup/justin-thompson/2025-09-16T00:26:03+00:00https://timmermanreport.com/wp-content/uploads/2025/09/Justin-Thompson.jpghttps://timmermanreport.com/2025/09/arch-backed-ollin-secures-100m-for-bispecific-antibodies-for-eye-diseases/ehrlich/2025-09-16T22:24:59+00:00https://timmermanreport.com/wp-content/uploads/2025/09/ehrlich.jpghttps://timmermanreport.com/2025/09/predicting-leukemia-risk-at-scale-dr-lachelle-weeks-on-the-long-run/lachelleweeks/2025-09-17T21:13:56+00:00https://timmermanreport.com/wp-content/uploads/2025/09/lachelleweeks.jpghttps://timmermanreport.com/2025/09/roche-buys-89bio-novartis-doubles-down-on-monte-rosa-atyr-flames-out/warmuth/2025-09-18T21:50:03+00:00https://timmermanreport.com/wp-content/uploads/2025/09/warmuth.pnghttps://timmermanreport.com/2025/09/roche-buys-89bio-novartis-doubles-down-on-monte-rosa-atyr-flames-out/mlanger/2025-09-18T21:52:21+00:00https://timmermanreport.com/wp-content/uploads/2025/09/mlanger.pnghttps://timmermanreport.com/2025/09/next-big-thing-kilimanjaro-2026-for-damon-runyon-cancer-research/logo-green\_ffff-1758292824/2025-09-23T01:10:53+00:00https://timmermanreport.com/wp-content/uploads/2025/09/logo-green\_ffff-1758292824.pnghttps://timmermanreport.com/2025/09/a-song-of-science-and-hope-bruce-levine-mags-mccarthy-on-the-long-run/brucelevine-2/2025-09-29T19:52:07+00:00https://timmermanreport.com/wp-content/uploads/2025/09/brucelevine.pnghttps://timmermanreport.com/2025/09/a-song-of-science-and-hope-bruce-levine-mags-mccarthy-on-the-long-run/mags/2025-09-29T19:52:34+00:00https://timmermanreport.com/wp-content/uploads/2025/09/mags.pnghttps://timmermanreport.com/2025/10/pfizer-buys-metsera-glp-1s-genmab-nabs-merus-for-8b-sanofi-commits-to-vc/hafler/2025-10-02T21:03:37+00:00https://timmermanreport.com/wp-content/uploads/2025/10/hafler.jpghttps://timmermanreport.com/2025/10/pfizer-buys-metsera-glp-1s-genmab-nabs-merus-for-8b-sanofi-commits-to-vc/jedwards/2025-10-02T21:06:16+00:00https://timmermanreport.com/wp-content/uploads/2025/10/jedwards.jpghttps://timmermanreport.com/2025/10/consumer-healths-digital-convergence-and-whats-still-missing/screenshot-2025-10-05-at-3-51-17%e2%80%afpm/2025-10-05T19:52:18+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-05-at-3.51.17%E2%80%AFPM.pnghttps://timmermanreport.com/2025/10/consumer-healths-digital-convergence-and-whats-still-missing/screenshot-2025-10-05-at-3-53-20%e2%80%afpm/2025-10-05T19:53:44+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-05-at-3.53.20%E2%80%AFPM.pnghttps://timmermanreport.com/2025/10/consumer-healths-digital-convergence-and-whats-still-missing/screenshot-2025-10-05-at-3-58-08%e2%80%afpm/2025-10-05T19:59:12+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-05-at-3.58.08%E2%80%AFPM.pnghttps://timmermanreport.com/2025/10/consumer-healths-digital-convergence-and-whats-still-missing/screenshot-2025-10-05-at-4-02-21%e2%80%afpm/2025-10-05T20:03:18+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-05-at-4.02.21%E2%80%AFPM.png